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Abstract
Brief investigations were carried out towards the synthesis of 2,4-disubstituted quinolines 
and 2,6-disubstituted piperidines using titanium alkylidene chemistry, but these were 
unsuccessful.
A route towards the diversity based stereoselective synthesis of 2-substituted azepane 
derivatives was explored via titanium alkylidene chemistry. Thioacetals i were reacted 
with low valent titanium(II) species ii to produce titanium(IV) alkylidenes that were 
reacted with resin-bound esters iii. Cleavage of the resulting enol ethers led to a small 
library of amino ketones iv, but reductive amination to give azepanes, remained elusive. 
However, hydrogenation of the a-phenylethylamino group in ketones iv gave racemic 
azepanes v.
I.CpJilPOEDals ii
ill Hg 40  psi ^
3. resin w a sh  iv  Pd(O H )2/C  y
4. 10% TFA /D C M  20%
Diversity based synthesis of cyclic imines, both 6 and 7 membered, has been carried out 
using trityl protected amines vi and vii. Alkylidene formation followed by reaction with a 
range of resin-bound esters iii gave enol ethers. Cleavage and deprotection under mild 
acidic conditions followed by treatment with base cyclised aminoketone products to cyclic 
imines viii and ix.
1) Gp2TI[P(OEt)3]2 
N ^ P h  2) O r ^ O ^ R  iii
R" ^N"
3) 4%  TFA, 1 % EtaSIH, DOM viii
4) 4M NaOH w a sh
1)Cp2Ti[P(OEt)3]2
P h S N Ph
R N'
3) 4% TFA, 1 % EtgSiH. DOM ix
4 )  4M NaOH w a sh
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Chapter 1 : General Introduction
1.1 Why Make Small Molecules?  -  Chemical Biology
Small molecules are the life-source of pharmaceutical companies. It is low molecular 
weight biologically active molecules that comprise the majority of successful drugs on the 
market. Identifying and accessing biologically active compounds requires detection 
methods suitable for fast and accurate screening of vast numbers of compounds in order to 
increase the chance of finding a hit lead compound.
1.1.1 Method of Identification:- Assays how Biologically Active Compounds 
are Identified
Traditional drug discovery has relied on screening the drug candidates on known specific 
protein targets, after their function has been determined.^ Small molecule targets that are 
biologically active can affect cellular processes by binding to proteins or protein receptors, 
as their nature determines and in doing so can produce a phenotypic response. In screening 
compounds on cell or organism-based assays, an insight into biological processes which 
are not fully understood can be gained.* In general, bioactive small molecules interfere 
with protein function, and this is how they modulate gene function giving rise to chemical 
genetics, although in some cases these molecules can also bind to nucleic acids and 
modulate their activity.^ Chemical genetics is the use of bioactive small molecules to 
modulate gene function in an attempt to learn what that gene(s) does. This is in contrast to 
classical genetic techniques, that require manipulation of the genome of a subject to 
discover gene function, e.g. deletion of a gene to see what is missing. Chemical genetic 
screens probe the ability of small molecules to change any part of cell function, providing a 
usually controllable, rapid and reversible effect over the small molecule’s target.*’^
1.2 Privileged Structures
Discovery of these bioactive small molecules, useful as potential therapeutic agents, can be 
carried out under two ideologies. Structure based rational design is a method based on 
understanding the mechanism of the potential action of the drug, through knowing the 
target protein and possible binding sites etc. This method requires detailed knowledge of 
the target pathway and protein. The second is to screen a large number of diverse 
compounds (library) and observe the hits that produce the desired response or phenotype in
2the screens. In order do this a wide range of small molecules must first be synthesised, to 
provide a greater chance of finding a molecule which is bioactive, selective and potent. 
Previously, libraries were extremely diverse in an attempt to cover as much chemical space 
as possible.
Chemical space is a description of all the possible structures of low molecular weight drug­
like compounds in relation to each other. There are a phenomenal number of these 
compounds, some estimates include 10^ **-10^ **** (depending on the program used)"*, though 
only a proportion of these molecules are likely to have acceptable drug-like properties, and 
their position in chemical space depends upon the descriptors chosen to define the 
molecule. Multiple descriptors are used to pinpoint a molecule’s exact location in 
chemical space. These descriptors annotate the small molecule’s structure, observed 
activities and properties and produce a multidimensional plot of chemical space 
encompassing the molecules plotted for. The descriptors can be defined using computer 
programs and algorithms or phenotypically using cell assays.^
With this knowledge you would expect that companies screening greater numbers of more 
structurally diverse compounds than ever before, therefore covering more chemical space, 
would find an increase in the number of lead compounds discovered, proportional to this 
effort. This is not the case however, and the number of drugs reaching market has not 
increased accordingly.^
Recently, however, another approach to determining leads using chemical space has been 
employed. Libraries can be directed towards one core structural moiety that has been 
shown to have a high degree of success in binding to a range of receptors. This 
information can be gained from previous high-throughput screens in which certain 
structural motifs have been shown to have an increased percentage of hits in a variety of 
assays, compared to other structural motifs.^ This appears to limit the range of the 
combinatorial chemistry reducing the coverage of chemical space, but in fact the practice 
focuses the synthesis in the direction of structures most likely to interact with biological 
targets.
These moieties are known as privileged structures and can provide a starting point for the 
synthesis of a directed library of diversity in the structure. The aim of directed libraries, is 
to target the diversity orientated synthesis towards privileged structures and therefore 
increase the chance of finding a useful lead compound. Natural products are also an 
important consideration for a starting point in both target orientated synthesis and the
3combinatorial library approach, as well as the final drug product e.g. anthrcyclines, taxoids 
and vinca alkaloids.* However their complex structure and stereochemistry considerations 
often make them difficult targets for lead optimisation. Routes have to be redesigned to 
produce analogues and the physiochemical properties required for in vivo experiments and 
oral bioavailability all require consideration. Research into diversity orientated synthesis 
of natural product-like compounds is on going, however, and promises to yield structures 
which are diverse and naturally, bioactive.^
1.3 Chemical Genetics
1.3.1 Forward Chemical Genetics
Forward chemical genetics uses a cellular based assay to determine the bioactivity of small 
molecules. Cells are distributed onto plates, usually 96 well plates, and a dose of each 
library member is administered to an individual well. The plate is then given a set 
incubation time before it is screened for a phenotypic response to the library member. Cell 
based assays are useful for determining whether a compound has bioactivity. Knowledge 
of the specific target is not required at the beginning^ as it can be determined later through 
affinity chromatography separations, common in biochemistry. The separation and 
identification of the target protein can be carried out, using a biochemical approach, by 
attaching the ligand or bioactive small molecule to a solid support, e.g. sepharose. The cell 
or tissue extracts are then exposed to this affinity column and proteins that bind to the 
ligand can be drawn out.^’^  The gene coding for the bound protein can then be 
determined.*
Problems can arise from using biochemical target identification techniques. In 
immobilising small molecule substrates for the affinity columns, their function can be 
impaired so they behave differently from in vivo. The process of immobilisation can also 
cause trouble as functional sites are needed for immobilisation and, if present in the 
molecule, they may be needed to bind the target protein. Background protein binding is 
another issue, if the affinity for the target protein to the ligand is low, many proteins can 
bind, making isolation and identification of the desired target more difficult. In addition to 
this, more abundant proteins are more easily viewed, as less enrichment is required than 
less expressed ones, e.g. transcription factor proteins are less abundant than certain kinases, 
so even if a strong affinity occurs it will be difficult to observe transcription factor proteins 
above background.^ Therefore affinity based separation is much easier and more useful for
characterising abundant protein targets that bind strongly to their ligands than for weaker 
binding and less prevalent protein targets/
1.3.2 Reverse Chemical Genetics
If the desired bioactive molecule is to bind to a protein already known, another approach 
may be employed. This is called reverse chemical genetics and uses purified protein based 
assays. The target protein is expressed, isolated and screened to find a bioactive small 
molecule or ligand that binds to it. This protein-1 igand interaction can then be used to 
identify a phenotypic response within a cell-based assay and hopefully if the function of 
the protein is not known it can be determined. If the function is known, the effect of the 
ligand on the other genes and receptors in the cell can be studied, providing valuable 
information on selectivity should the bioactive small molecule be a suitable drug 
candidate. Figure 1 is taken from a paper by Blackwell and Zhao^ and provides a clear 
diagram of both forward and reverse chemical genetics.
a Forward approach
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With these methods of evaluating the biological activity of large numbers of compounds, it 
is important to consider the methods of synthesising them. One of the greatest aids to 
library synthesis is solid-phase methodology. Several methods for providing libraries of
5compounds exist using solid-phase and related technologies and they each create different 
degrees of diversity in the library.
1.4 Library Synthesis
1.4.1 Solid-Phase Chemistry
Combinatorial synthesis was first developed for the synthesis of small molecule drug 
candidates in the early 1990’s. Previously, solid-phase chemistry - immobilisation of 
compounds onto solid supports inert to reaction conditions, had only been utilized in 
peptide synthesis."* This was developed by Merrifield in the early 1960’s, and had the 
benefit of allowing easy purification by the removal of excess reagent by washing the 
compound attached to solid support, a chloromethylated co-polymer of styrene and 
divinylbenzene, with various solvents.*** This support was successful because it allowed 
flow of reagents through its porous gel structure, providing access for reactants, 
particularly when solvents with swelling properties were used (e.g. DCM, THF). The 
advantages of solid-phase chemistry, ease of purification by filtration and use of excess 
reagent to drive reactions, fuelled research into expanding the methodology to small 
molecule synthesis.
The new field posed several challenges, differing from that of peptide chemistry. 
Optimisation on solid-phase now required a range of bond-forming reactions, instead of 
just peptide coupling and de-protection strategies, and limitations of heterogeneous 
reaction conditions and the small quantities of compounds produced were also 
challenges.** One major problem with using an insoluble support is the difficulty in 
observing reaction progress and intermediate compounds attached to resin.
Standard spectroscopic and analytical techniques give a little insight into the compounds 
loaded onto resin. IR provides an insight for certain marker functionalities, e.g. carbonyl 
groups, but does little to help with structure. Combustion analysis is useful for 
determining the heteroatom content, e.g. N, S, F, Cl, Br, and as such can provide a 
reasonably accurate indication of loading of a resin e.g. chloromethyl polystyrene, but is 
obviously ineffective for carbon and hydrogen. Mass Spectrometry is useful for the 
analysis of support-bound intermediates. Depending on the linker MALDI-TOF and TOF- 
SIMS techniques are available.*^ Gel-phase NMR is not very useful due to the broadening 
of the signals, but there has been research into this however, and magic angle spinning 
(MAS) gel phase NMR is a technique available which greatly aids the identification of
compounds bound to r e s i n . H o w e v e r ,  cleaving the product from the a sample of the 
resin after each step and then using standard analytical techniques can often be the simplest 
approach and is the one we adopted.
Traditionally there are two ways of producing libraries of compounds for high throughput 
screening by combinatorial synthesis. The first is parallel synthesis, a technique useful for 
the generation of small libraries, as it requires the synthesis of each compound to be carried 
out individually. Automation is possible however and this can speed up the time taken for 
production. The second is a process similar to genetic recombination,"* the ‘split and mix’ 
technique, figure 2** shows three cycles, each with three different compounds, ( 3 x 3 x 3  = 
27) member library. The latter approach requires deconvolution and has been steadily 
diminishing in popularity.
Couple I A I
Resin
Recombine and mix
Couple I D I
Recombine and mix
Split
Figure 2.11
Couple 1 G 1 LhJ LlJ
^D H
^D G ^ dh
^ F H
^ F H
QxCFG
The solid-supports are usually small spherical beads of polymer and are used in the form of 
loose resin. This usually has to be weighed out and contained within individual reaction 
vessels, however a recent advancement discards the need for tedious weighing by the use 
of stratosphere® plugs. Figure 3 shows loose resin and plugs of resin.
Figure 3. 13
The resin can be contained in ‘tea-bag’ containers that permit the reactions to take place 
while localising the resin to an easily handled container, and the used of specific solid- 
phase equipment is negated. The research carried out in this thesis utilised IRORl 
macrokans, figure 4.
Figure 4. 14
Other solid-supports include support sheets, crown-shaped pins and small disks. 12
Since the advent of solid supports for small molecule synthesis, several different methods 
of ‘support’ have been developed as well as a wide range of polymers for solid support. 
These polymers provide a wide range of properties differing from Merrifield’s original 
polymer, though chloromethylpolystyrene and hydroxymethyl polystyrene are still widely 
used today, and were used in the synthesis of nitrogen heterocycles detailed later in this 
work. Polymers have been developed which have varying swelling properties allowing
8differing degrees of permeability of reagent into the polymer matrix. This permits 
controlled exposure to reagents, and aids in the purification process by swelling and 
squeezing the polymer support in different solvents, but is also a concern when choosing 
the solvent for a reaction, particularly if the ideal solvent for solution phase does not swell 
the resin. In general solvents that swell the majority of resins are dipolar aprotic solvents 
(e.g. DMF, DCM) as polystyrene is a hydrophobic polarizable substance, and swelling is 
poor in alkanes, protic solvents (e.g. MeOH) and water.
1.4.2 Soluble Polymer-Supported Synthesis
The polymer chemistry used in solid phase synthesis has been expanded to the use of 
soluble polymers in liquid-phase synthesis also known as ‘soluble polymer-supported 
synthesis’. Here the objective is to use a soluble polymer backbone attached to reagents or 
reactants. Separation is facilitated by the use of the macromolecular properties inherent in 
the bound compounds to separate the polymer bound substance at the end of the reaction.*^ 
The support, sometimes called a precipitation tag,"* is usually a polyethylene glycol derived 
polymer, employed because they are soluble in a range of solvents e.g. DMF, DCM, 
toluene acetonitrile, water and methanol, but can be precipitated using ethers and higher 
alcohols.*^ Precipitation with solvent followed by washing excess reagents away provides 
the advantage of solid-phase. The tagged product can then be made soluble again 
providing a homogeneous medium for the following reactions. This negates problems 
associated with the solid supported substrates as the reaction is homogeneous and therefore 
unequal distribution of attachment and reaction on the polymer sites is avoided. As the 
reactions behave more like solution-phase reactions there is less optimisation required to 
get the reaction to go. However, optimisation is necessary to reduce the number of 
polymer bound side products, as this remains a problem, and the product will require 
further purification after cleavage.*^ Furthermore, different polymer-supported compounds 
have to be reacted in different flasks or separation and identification becomes a problem.
1.4.3 Fluorous Chemistry
Fluorous chemistry is a growing field of separation platform chemistry."* This technique 
involves tagging a compound with a cleavable perfluorocarbon side chain. The compound 
can then undergo standard reaction conditions homogeneously and the benefits of solid- 
phase chemistry can be conveyed during work-up. As the solubility of the compound is 
affected by the perfluorocarbon side chain, loading of the product onto a fluorous phase 
silica gel and elution with fluorophobic solvent systems (protic solvents) will remove all
non-fluorinated by-products. Subsequent elution with a fluorophilic solvent system 
(aprotic solvents) will elute all fluorous compounds from the column.
This methodology has been expanded to fluorous mixture synthesis, a technique that 
allows some of the advantages of combinatorial chemistry used in solid-phase library 
production detailed above to be extended to a solution-phase library syn thesis .T h is  is 
achieved by tagging with varying degrees of perfluorocarbon side chain e.g. C 4 F 9  to 
Once tagged, a series of one pot reactions can be carried out in an 'internal 
parallel’ approach leading to no change in library size, or the mixture can be subjected to a 
number of one-pot reactions followed by separation into two other groups and further 
parallel reactions carried out on these new lines, figure 5.^  ^ This amplifies the number of 
compounds produced in the library and has been used to produce a library of 560 
compounds in this m anner.F o llow ing  the final reaction in the sequence the varying 
degrees of fluorination in the molecules can be used to separate out the mixture of 
products. Again using fluorous phase chromatography the compounds can be cleaned up 
by elution of a fluorophobic solvent and a concentration gradient in the elution of the 
fluorophilic solvent allows separation of the various tagged compounds eluted.
1 . T ag 2 . Mix 3 . M ixture S y n th e s e s  4 . D em ix  5 . D etag
Figure 5.^ ^
1.4.4 Linkers
M l -------  M2
I Pl"F"|_ (p 7 |
An important factor in all of the above methods used to allow automation is the attachment 
and detachment of the compounds to the separation platform used. This is achieved in 
solid-phase chemistry, soluble polymer-supported synthesis and fluorous synthesis by the 
use of a cleavable linker. The linker is of great importance, as it must not interfere with the 
reactions carried out on resin until it is necessary to cleave it, and therefore the compound, 
from the support, figure 6. In the original work carried out by Merrifield, an ester linker
10
was utilised as the triethylammonium salt of a protected amino acid could be attached via 
O-alkylation with a chloromethylated polystyrene r e s i nC l ea vag e  was carried out using 
under ester hydrolysis conditions (NaOH and ethanol). The use of such strong hydrolysing 
conditions is acceptable when there is little other functionality that can be affected by it. 
However, the development of selective and easily cleavable linkers was essential for the 
use of solid-phase chemistry in small molecule synthesis. Research carried out by Wang 
into the synthesis of a more acid-labile linker provided the para-alkoxybenzyl linker, this 
was easily cleaved in the presence of trifluoroacetic acid and lead to products of higher
purity. 19
K ] o r i  linker \- [
p r o d u c t  I o e a v a g e
C onditions ^ K
If cleavage Is not selective:
KER
Figure 6.
The field was expanded by other methods used to introduce synthetically orthogonal 
cleavage conditions including the use of a photolabile linker. This, rather than relying on 
chemical compatibility with product functional groups, requires irradiation to secure 
cleavage.
An example of a development that has an interesting and important application, 
considering chemical genetics and the high throughput screening of libraries is that of 
biocompatible linkers. These linkers have been designed to allow cleavage of the 
compound into aqueous buffer following synthesis on solid support, and therefore permit 
the compounds to be screened directly from resin. This has important implications for 
automation as cleavage directly into screening wells for biological assays can be carried 
out. An example of a biocompatible linker is that of an enzyme-labile linker, designed to 
be cleaved by enzyme-initiated fragmentation, that leads to the release of the bound 
substrate.^® The linker is attached to resin via a stable amide bond, figure 7. The linker 
contains an acylating arm that a nucleophilic atom on the substrate can bind to, to attach
11
the compound to resin, and an acyl handle for the enzyme, a lipase or esterase, to bind and 
cleave.
A m ide link to resin
—  Acyl h andle for e n zy m e
"Acylating arm  for sub strate  
im m obilisation
Figure 7.
T en tagel bound linker
Cleavage of the acetyl group in 1 initiates a fragmentation reaction that produces a quinone 
methide 2, retained by the resin and quenched by water or another nucleophile, and 
releases the bound molecule 3 from the linker, (Scheme 1).
:
X
X = NH. 0 ,  CRz
E n zym e
O X
Q uinone M ethide
HO^X"^
3
X = NH: am in e (-C O j)
X = O: a lco h o ls  (-C O 2 )
X = CRg: carboxylic ac id s
Scheme 1.
Other advances include asymmetric induction from the linker and partial or sequential 
release l i n k e r s . I t  is not my intention to give a comprehensive review of linkers as these 
are available^ but I will focus on three important developments relevant to our research: 
a) Linkers that leave no trace at the site of attachment, b) Safety catch linkers that require
12
activation before cleavage so ensuring the purity of products, c) Chameleon catch linkers 
that change their nature and maximise the diversity introduced.
A) Traceless Solid-Phase Synthesis
Linkers provide a handle or functionality to facilitate cleavage in the final step of the 
synthesis, but they also pose a problem: in cleaving the linker, trace functionality can be 
left behind, reminiscent of the attachment to resin, and this can affect the biological 
function of the small molecules synthesised. Traceless synthesis is the synthesis of 
compounds on resin, that once cleaved, leaves no obvious residue from the site of 
attachment that would interfere with structure activity studies. The term ‘traceless’ has 
been debated over and because what constitutes an ‘obvious residue’ varies, some have 
argued that it is not useful.^^ However if a synthesis avoids the presence of a single or 
small range of functionality at the site of cleavage we regard it as traceless. Generally 
what remains of the site of cleavage is an aliphatic or aromatic C-H.^^ The most widely 
used traceless linkers are silicon derived. Such linkers take advantage of the labile aryl- 
silicon bond, that is easily cleaved under acidic conditions.^^ However other examples exist 
including the recent development of linkers that can be cleaved under mild conditions 
using samarium diiodide. The strategy^"  ^ utilises the ability of Sml2 to reduce the 
heteroatom of a  - heteroatom substituted carbonyl compounds 4 bound to solid phase, 
leaving C-H in its place 5, (Scheme 2).
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Scheme 2.
B) Safety Catch Linkers
An advancement that combined photolabile linkers with that of ensuring control of 
cleavage is the use of a photolabile safety catch linker. A safety catch is a masked handle 
for cleavage that can be revealed prior to administering the cleavage conditions. An 
example of such a safety catch mechanism is the dithiane protected benzoin photolabile 
linker, formed by alkylation of an meta hydroxybenzaldehyde 6 with 
chloromethylpolystyrene 7, followed by addition of the lithiated dithiane 8 to complete the 
synthesis of linker 9 synthesis, (Scheme 3).
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This chemistry utilizes the benzoin ester’s photosolvolytic cleavage with irradiation at 350 
nm, which is possible only once the dithiane group has been removed. The linker was 
tested by coupling with a simple Fmoc-protected amino acid 10, to form the safety catch 
protected and immobilised substrate 11. Unmasking conditions revealed the cleavable 
benzoin ester 12, which once subjected to irradiation produced the immobilised benzofuran
13 and the desired amino acid 14, (Scheme 4). 25
0 ^ 0
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Scheme 4.
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The linker 9 once constructed on resin can be attached to reactants via the secondary 
alcohol, this can be activated with a carbonyl-1,1-diimidazole to increase the reactivity of 
the linker, figure 8.^
Figure 8.
o=<
Ph
14
A safety catch linker has also been used in the development of recyclable resins. This 
regeneration of the linker at the end of the reaction may be desirable to companies wishing 
to make many similar compounds. The first of these resins was the REM resin, an acrylate 
ester 14 immobilised onto hydroxymethyl polystyrene resin, and was used in the synthesis 
of tertiary amines 15. Michael addition of a secondary amine 16 and alkylation with a 
primary alkyl halide provides a quartemised amine 17 and activates the linker towards 
cleavage. Elimination of the tertiary amine regenerates the a ,p  unsaturated ester linker, 
this can then be used in at least 4 cycles without deterioration in yields provided the 
quarterisation is driven to completion, (Scheme 5). Benzyl and aryl sulfone analogues, 
figure 9, that reduce undesired Hoffmann elimination prior to quarterisation and withstand 
far harsher reaction conditions, but work in exactly the same manner, have also been 
synthesised.^^
G T '
R^X
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Figure 9.
Another example is the use of the dihydroquinoline core and its conversion to a resin 
bound quinoline, for use as a safety catch linker, (Scheme 6).^^ The linker 18, attached to 
compounds through an amide bond to the quinoline nitrogen, has a two stage safety catch 
approach in that it will not cleave from the product molecule until activated 19 and then a 
second step effects cleavage from the altered linker to yield quinoline attached to resin 20 
and the products 21, (Scheme 6).
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Scheme 6.
The starting resin used is chloromethyl polystyrene and the first step is formation of the 
azide 22 using Finkelstein and Sn2 displacement conditions. Treatment of the azide with 
trifluoromethanesulfonic acid provokes a one carbon degradative Schmidt rearrangement 
to form an imminium ion intermediate 23. This intermediate can be treated to methanol 
and water to produce a resin bound aniline 24 or reacted with an alkyne group to produce 
resin-bound 4-phenyl-1,2-dihydroquinoline 25, (Scheme 7). Acylation with substrates to 
be manipulated can then be carried out, forming the amide bond (18 stable form) and 
following reaction sequences, the linker can be treated to oxidisers e.g. DDQ 
(dichlorodicyanoquinone), CAN eerie ammonium nitrate, and cleaved by addition of a 
nucleophile.^^
Cl
NaNg, Nal, DMF,
90°C
3 TfOH, DCM, 0°C-r.t.
22
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Scheme 7.
One problem remains, however, if the nature of the linker remains unchanged in the 
synthesis, the final cleavage step can introduce impurity in the form of unreacted starting 
material or by-products attached to resin. Cyclative cleavage of compounds from resin is
16
an excellent technique for combating this problem, particularly important as many 
heterocycles are well known to be good pharmacophores, with many of them considered 
privileged structures. The method provides the advantages of a safety catch approach as 
products will only be released when functionality allowing cyclisation has been introduced 
and unmasked, and any by-products from incomplete transformations will be left behind. 
An example of cyclative termination is shown in Scheme 8 .^  ^ Acid 26 was elongated to 
include a Micheal acceptor 27. Activation of the linker by conversion to a sulfonium salt 
28 allowed cyclative cleavage via an addition followed by an elimination generating a 
cyclopropane 29. No cleavage would occur unless both the sulfonium ylide and Micheal 
acceptor were present.
A nchoring Elongation
29
Activation
C yclative «n  9  
C le a v a g e
Scheme 8
This cleavage could be regarded as traceless as there is no additional undesired 
functionality at the site of cleavage.
C) Chameleon Catch Methodology
Since the start of research into solid-phase linkers, more sophisticated techniques for 
cleaving have been developed. One example is the use of the cleavage step to introduce 
further diversity into the molecule. By using this method a wide range of functionality can 
be introduced. In the case of a simple ester linker 30, hydrolysis, aminolysis, and 
reduction, provide access to acids, amides and alcohols respectively.^^
Thus ester linker 30 could be cleaved to give acids or alcohols but could also be converted 
to an acid labile enol ether linker 31 using the Tebbe reagent.^^ Switching the nature of an
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easily accessible ester linker 30, to an enol ether 31 is similar to a ‘safety catch’ activation, 
as only the enol ether is affected by mild acid conditions. It also provided direct access to 
amines 32 via reductive amination from the cleavage product ketone 33, (Scheme 9). The 
enol ether could also be derivatised further on resin allowing access to thiazoles 34 as well 
as Diels-Alder products when the correct starting material was used and the method was 
later utilised in the synthesis of isoxazoles.^^
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Scheme 9.
The alkylidenation step, which switches the nature of the linker was achieved using the 
Tebbe reagent. This has the disadvantage that only methylenation was possible and no 
other groups could be introduced during the alkylidenation step. Petasis alkylidenation, 
which involves generating a Schrock carbene 36 from a dialkyltitanocene 37 requires 
elevated temperatures and led to premature cleavage from resin, (Scheme 10).^  ^ This was 
unfortunate as benzylidenation as well as methylenation is possible with these reagents. 
The main limitation to Petasis reagents is that there cannot be hydrogen atoms beta to the 
titanium in the dialkyltitanocene or p-elimination rather than a-elimination is the 
predominant process at raised temperatures.
Scheme 10.
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The Hartley group, however, combined cleavage diversification, with the traceless 
chameleon catch technique and took the methodology much further. The titanium 
alkylidene 37, bearing functionality, was reacted with a range of ester groups 30 to give 
enol ethers 38. Cleavage with possible concomitant cyclisation then gave a range of 
bicyclic aromatic heterocycles 39, (Scheme 11).^^’^ ^
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The titanium alkylidene was accessed through Takeda’s method of reductive 
desulfurisation of dithianes or dithiophenyl thioacetals, with low valent titanium(II) 
complex 40 generated from titanocene dichloride 41. The titanium alkylidene then reacted 
easily with ester groups in a Wittig-like manner to produce substituted enol ethers 38. The 
Takeda method of generating the Schrock carbene 37 has the advantage that it tolerates a 
wide range of functionality and hydrogens P to the titanium are permissible, (Scheme 12). 
Furthermore a wide range of thioacetals 42 are easily accessed in one step from the 
corresponding aldehydes.
Cp2TiCl2
41
P(OEt)3
Mg. THF  
4  angstrom  
m olecu lar s ie v e s
CP2TI[P(0EI)3]2
40
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TiCp2
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37
Scheme 12.
The solid-phase provides the advantage that the titanium by-products and impurities from 
the reaction, usually requiring a silica gel column to purify, can be easily washed away. In 
combination with the safety catch mechanism permitted by the chameleon catch linker, the 
methodology provides a route to a variety of products that are pure once cleaved from 
resin, and require little if any post cleavage modification to achieve the desired 
heterocycles. Through this traceless methodology a range of heterocycles were produced;
benzofurans^^ e.g. 43, benzothiophenes^"* e.g. 44, indoles^"* e.g. 45, alkylated indoles^^ e.g.35 33 33
46 and quinolines^"^ e.g. 47 have all been synthesised, figure 10.
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Recent advances in the benzofuran synthesis methodology within the Hartley group have 
provided a route to resin-bound substrates for Suzuki cross-coupling substrate. The 
synthesis was the first to incorporate an organoboronate with a Schrock carbene and 
allowed a greater opportunity for diversity in the synthesis of benzofurans.^^ 
Alkylidenation of the resin bound esters 30 with a titanium benzylidene 49 bearing a 
boronate group formed the enol ethers on resin 50. Cross-coupling on resin, followed by 
cleavage then gave ketones 51 off resin. Deprotection and cyclisation under acid 
conditions gave the disubstituted benzofurans 48, (Scheme 13). No chromatography was 
necessary at any stage and a range of benzofurans was produced in high purity.
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Scheme 13.
Following these successes, the chemistry was extended to the formation of 2-substituted 
quinolines, an important class of medicinally relevant heterocyclic privileged structures.^"^ 
Unlike the previous heterocycles formed using titanium benzylidenes, the route required 
the generation of titanium alkylidene 52 that did not benefit from benzylic stabilisation. 
Reaction with the resin-bound esters 30 gave resin bound enol ethers 53, as before. These 
were cleaved under mild acid conditions to give dihydroquinoline derivatives 54. Post­
cleavage modification was required in the form of oxidation to form the quinoline ring
20
system 55, (Scheme 14). The method used, however, provided the advantage of solid 
phase as separation platform, as the oxidant chosen was manganese dioxide, and could 
simply be filtered off following the mild oxidation reaction.^'^
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Scheme 14.
It was at this stage I began my research into novel titanium alkylidene reagents that would 
allow access to other heterocycles. However, before discussing my own research on solid- 
phase synthesis, I will briefly show that solid supports can be used in other ways to 
facilitate automated synthesis.
1.4.5 Polymer Supported Reagents
In addition to immobilising and manipulating what eventually becomes the desired 
product, the solid support methodology has also been extended to immobilisation of 
reagents and catalysts. This provides the benefits of removing catalysts or spent reagent 
and the possibility that major by-products can be immobilised onto a polymer support. 
The advantage of this method of polymer-assisted synthesis is that the products of each 
individual reaction are not immobilised on resin negating the need for an attachment step 
and a cleavage step in the synthesis. It has two other main advantages; the product can be 
purified for the next step, so no accumulation of by-products attached to the resin that 
could be cleaved with the final product occurs, and the intermediates can be characterised. 
This prevents a synthesis of many steps finishing with no cleavable product and little way 
of knowing which step went wrong. However when carrying out high throughput 
synthesis, purification by mass directed HPLC (high performance liquid chromatography) 
is generally reserved for the final product.
Another advantage of this methodology is that the reagent or catalyst recovered, where 
possible, can be recycled/regenerated, giving a greener approach to the chemistry in hand. 
An example of this would be in the Suzuki coupling, using polymer bound palladium 
complex 56 to couple organoboranes 57 and alkenyl bromides 58 to form allylic 
compounds 59, (Scheme 15).^^’^ ^
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There are three main methods for reagent and catalyst immobilisation:^^
1. Entrapment of the catalyst or reagent within a preformed polymer network.
2. Ion-pairing, ionic bonding between corresponding cationic and anionic sites on the 
polymer support and reagent.
3. Covalent bonding, in which, the reagent is permanently bound to the polymer 
support
1.4.6 Scavengers
Another approach is to use solid supported scavengers, reactive species immobilised on 
resin to react with by-products or products of the reaction selectively and therefore provide 
a method of isolation by, as before, simple filtration. Below is a brief overview of 
methods based on this idea detailed in a review by S. Ley and co-workers^^
1. Reactant sequestration: excess reagent is removed by the selective binding of
scavenger resin to it.
2. Scavenging-enabling reagents: reaction of starting materials of low reactivity
with an activating reagent, producing a compound of higher reactivity and 
therefore greater ability to bind to scavenging resin.
3. Tagged reagents: the presence of a functional group in a reactant that will not
interfere in the reaction but will allow easy sequestration with a scavenging 
resin in the reaction work-up.
4. Molecular adsorption: addition of a large hydrophobic tag at the end of the 
synthesis to allow adsorption of the desired compound onto porous graphitised 
carbon to provide a support for extensive washing.
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5. Catch and release purification: Selective binding of the desired product onto 
solid-phase to allow purification by washing and filtration. Subsequent 
cleavage from resin must not introduce further impurities.
Before turning to the main work of the thesis, i.e. the synthesis of heterocycles not 
previously tackled using titanium alkylidene chemistry; I shall first consider two small 
pieces of work where different uses of isotopic labelling were briefly explored.
1.5 ^^O-Labelling Experiments
The earlier work by the Hartley group showed that heterocycles, including benzofurans, 
could be generated from resin-bound esters. I extended this work by synthesising 
benzofuran 60, figure 1 1 .
Figure 11.
Considering the cleavage of resin-bound enol ethers 61 to give benzofurans 62, if cleavage 
could be made dependant on cyclisation , then only unmasked phenols would cyclise and 
induce product release. It had been shown that under the standard cleavage conditions, 
cyclisation occurred post cleavage as ketone 63 and hemiacetal 64 were present in the 
reaction mixture if exposure to acid was shorter than 1 h,^  ^(Scheme 16).
Scheme 16
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If the ketone had been generated by standard acetal hydrolysis, then cyclative termination 
might still be possible if water was excluded, but this did not seem to work, so we wished 
to confirm whether an S^l or Sn2 mechanism was competing. Consider the possible 
mechanism in Scheme 17, if oxygen 18 labelled acetate were used, an unlabelled ketone 
65, would be observed under standard acetal hydrolysis, but either SnI or Sn2 would lead 
to incorporation of an oxygen 18 label into ketone 6 6 .
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labelled acetic acid was employed to determine exactly how the enol ether was 
cleaved. This is a good label as the mass spectrum must show a clear difference in the 
fragment peaks containing the label when compared to the unlabelled corresponding 
fragment. Use of an isotope with 1 a m.u. more than the prevalent natural atomic mass is 
not desirable as depending on the results this can be confused with the natural abundance 
of carbon-13 within the molecule.
The labelled acetic acid 67 was immobilised onto Merrifield resin 7 using standard resin 
loading techniques, (Scheme 18).
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Scheme 18.
The ortho nucleophile of the thioacetal substrate 6 8  was blocked using TBDMS protection. 
This prevents the intramolecular attack needed for concomitant cyclisation, however other 
nucleophiles are present in the form of trifluoroacetate anion to compensate in the study, 
and this protection also allows a handle for the GCMS analysis and prevents a possible 
volatility problem. Salicaldehyde 69 was converted into dithiane 70 before protection with 
TBDMSCl to give the desired thioacetal, (Scheme 19).
TBDMSCI
n im idazo leOH DCM, OH
SH  SH 65%6 9
83%  — Si
Scheme 19.
24
The labelled resin bound ester 30a was reacted with the titanium alkylidene 71 formed 
from thioacetal 6 8  to give the ketone 65 or 6 6  and, depending on the method of cleavage, 
the would either be incorporated into the ketone or not, (Scheme 20).
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Scheme 20.
Alkylidenation of unlabelled resin bound 30b ester was carried out. An unlabelled 
standard was required for the GCMS. Cleavage was followed by a quick and simple 
reduction of the ketone 65 to the corresponding alcohol 72 so that exchange with 
atmospheric water did not cause loss of the label producing false results.
Two methods of reduction of the cleavage product, ketone 65, were tried. Doyle and West 
reported a reduction of ketones in acidic media using silanes."^ ® This was a particularly 
interesting reduction as it would have led to a one pot reduction and therefore less 
manipulation of the compound off resin. The reaction was unsuccessful, however, and 
only ketone 65 was observed. This was disappointing at the time but later investigations 
into the use of tiethylsilane to reduce a trityl cation produced under similar cleavage 
conditions, detailed in chapter 6 , showed that this result was desirable in the long run. 
Sodium borohydiide on the other hand was successful and enough alcohol 72 was isolated 
to provide a MS standard, (Scheme 21).
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Both the ketone 65 and the alcohol 72 were analysed by GCMS in the hope that a fragment 
could be identified that contained the alcohol and ketone oxygen atoms, necessary to 
analyse the labelled experiment effectively. Suitable fragments A and B were produced 
from each, figure 1 2 .
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Figure 12.
The reaction was repeated with labelled rein-bound acetate. Cleavage and the immediate 
reduction of the product ketone 6 6  gave alcohol 72 or labelled alcohol 73. The GCMS 
trace revealed a 1:4 ratio of 211 peak to 209, this represents a 20% inclusion of ^*0 in the 
sample, figure 13.
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It is clear therefore that 20% of the reaction does not follow the acetal hydrolysis 
mechanism and cleavage occurs at the benzylic position of the resin linkage. This 
mechanism could be either SnI or Sn2. The study does not distinguish between these 
mechanisms and it is possible that the exclusion of all other external nucleophiles, 
prohibiting Sn2 at the benzylic site could lead to cyclative cleavage. Carrying out cleavage 
from resin under these conditions however, is not possible giving limited value in 
distinguishing between the two mechanisms.
7.6 Radiolabel Immobilisation
In order for scientists to understand what metabolites are produced and where they affect 
the body, it is necessary to label drug candidates with radioactive isotopes before 
administering the compounds to test subjects. The choice of label depends on the position 
of the atom in the compound and on the information required. An example is PET 
(positron emission tomography) a method using a ^^ C radioisotope to investigate the 
biodistribution of labelled materials around the body.'^  ^ Tritium and '^^ C are also 
commonly used isotopes, used to discover the structures of metabolites of drugs. 
Considerations important when designing an isotopic labelling sequence are the position of 
the isotope i.e. can you label in positions likely to be incorporated into the main 
pharmacophore of subsequent metabolites, and also the lability of the isotope used. "^^ C is 
less labile than tritium but usually requires a more complicated process of incorporation, as 
carbon atoms are more difficult to introduce to compounds than hydrogen atoms.
In this research a method for loading '^^ C radiolabelled carboxylate salts onto Merrifield 
resin was developed. This provides an easily accessible route to ’"^ C labelling in the 2 
position of the heterocycles formed using our methodology. The route, in addition to 
labelling in an integral site of the heterocycle using non-labile "^^ C, also incorporates the 
advantages of solid-phase technology.
A major advantage of using radiochemistry in combination with solid-phase technology is 
the ability to immobilise radioactivity to one site. Handling radioactive solids is far easier 
than volatile liquids or gases. In addition to this, the purification of solid-supported 
compounds in combination with the chameleon catch strategy employed with our 
methodology, should ensure radiochemical and chemical purity upon cleavage.
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The salts of low molecular weight carboxylic acids are handled rather than the volatile free 
carboxylic acids. To avoid liberating the radiolabel under the standard resin loading 
conditions, using an excess of the free acid and Merrifield resin 7 at elevated temperatures, 
a modified method of immobilising carboxylate salts onto resin was developed, (Scheme 
2 2 , table 1 ).
Scheme 22.
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Initial studies involved phase transfer catalysts and in situ conversion of the less reactive 
chloride on the resin to the more reactive iodide. However these were not successful based 
on colorimetric tests'^  ^and JR analysis. Loading was achieved finally by using crown ether 
sequestration of the sodium from the salt and then reaction of the naked carboxylate anion 
with chloromethylpolystyrene resin 7, a procedure not commonly used for ester
formation. 43
Table 1.
Resin Reaction Conditions Result
Merrifield resin  
load ing : 1 .9  m m ol/g
NaOAc (2 eq), KI (0.5 eq), 
DMF, 80°C, 0/N
IR: CO stretch. Colour test: Cl +ve
Merrifield resin  
load in g : 1 .9  m m oi/g
NaOAc (2 eq), TBAI (0.5 eq), 
DMF, 80°C, O/N
IR: CO stretch. Colour test: Cl +ve
Q ^ c i
Merrifield resin  
load ing : 1 .9  m m ol/g
NaOAc (2 eq), 15-Crown-5 ether 
4%, KI, DMF, RT, O/N
IR: CO stretch. Colour test: Cl +ve
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Merrifield resin  
ioad ing : 1.9 m m oi/g
NaOAc (2 eq), 15-Crown-5 ether 
4%, DMF, 80°C, O/N
IR: CO stretch. Colour test: Cl -Hve
Merrifield resin  
load ing : 1.9 m m ol/g
NaOAc (2 eq), 15-Crown-5 ether 
11%, DMF, 80°C, O/N
IR: CO stretch. Colour test: Cl -ve
Merrifield resin  
load ing : 1.9 m m ol/g
NaOAc (1.1 eq), 15-Crown-5 
ether 11%, DMF, 80°C, O/N
IR: CO stretch. Colour test: Cl +ve
From this it is clear that the conditions, which load the resin completely, are 11 mol% 15- 
crown-5 ether and the carboxylate salt (NaOAc), and that this is an improvement on the 
traditional method for loading carboxylic acids which requires 3 eq cesium carbonate, 0.5 
eq potassium iodide and 2 eq carboxylic acid. Most importantly the use of a large excess 
of radioactive acetate can be avoided.
This technique was applied to the loading of -labelled sodium acetate 74 onto 
Merrifield resin 7. The radioactivity was monitored and used as an indication of loading. 
All activity not accounted for in the scintillation samples of the reaction mixture, washings 
and NaOH traps (attached to catch volatile radioactivity), is presumed to be loaded onto 
the resin. This measurement is therefore an accurate account of the loading achieved, 
(Scheme 23).
Scheme 23.
1 eq
11 m ol % 15-crow n-5 Q Ç 'a
DMF
A
30c
The washings contained 15 MBq of the 145 MBq used, indicating the resin 30c is 90% 
loaded. Time constraints (the research was carried out during my industrial placement), 
prevented the synthesis of labelled heterocycles using this resin, however the clear benefits 
of immobilising radioactivity on resin makes this research worthwhile.
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Chapter 2: Quinolines
2.1 Why Make Quinolines
Quinolines are an extremely important core moiety used in medicinal chemistry. The 
moiety can be seen in drugs that treat everything from malaria to HIV. In addition to the 
therapeutic effects exhibited by these compounds, there is also a connection with the 
quinoline core and molluscacidal p ro p ertie s ,an  application that could be of importance to 
the pesticide market.
Many of the natural product quinoline compounds isolated have been from the Galipea 
genus, and it is from a plant of this group, galipea officinalis, that cusparine and galipine 
were isolated."^  ^ Both cusparine 75 and galipine 76 figure 14, showed activity against 
mycobacterium tuberculosis, a relevant discovery due to the resurgence of this disease and 
the development of drug resistant strains.
iMe
O
Cusparine
iMe
.OM e
OM e
Galipine
Figure 14.
Galipea longiflora provided a natural product that is a possible anti-leishmanial therapeutic 
agent, in the form of chimanine D 17*^ The compound is active against the fatal visceral 
form of the disease which is caused by the protozoan flagellate leishmania.^^ Another 
quinoline moiety drug used to treat leishmaniasis is aminoquinol 78."^ ^
Chimanine D
Aminoquinol
Other medicinal applications of quinoline based drug compounds include, local 
anaesthetics e.g. Cinchocaine 79,^° antifungal agents e.g. 5-Chloro-8-hydroxyquinoline
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80/^ anti-arthritic and anti-inflammatory agents e.g. Timegadine and
immunosuppressant drugs such as Brequinar 82^^ used in organ transplant operations, 
figure 16.
N 0  
7 9
Cinchocaine
C Ï . . 1N^N
Figure 16.
81
Timegadine
N
OH 80
5-Chloro-8-hydroxyquinoline
COjH
Brequinar
Quinoline drugs are relied on heavily as the main therapeutic control of malaria.^^ The 
oldest treatment for malaria, dating back to the 16‘^  century, is quinine 83, figure 17 and 
contains the quinoline structure.^^’^  ^ It is the basis for a wide range of anti-malarial drugs. 
Quinine is a natural product isolated from cinchona bark from Cinchona officinalis but has 
been isolated from most other cinchona species as well as a few other sources. It is used in 
tonic and bitter drinks, and its activity is stereochemistry independent. Quinine is effective 
against the plasmodium falciparum parasite, the most deadly form of malaria. The drug is 
important in the treatment of the disease as many of the more recent and widely used anti- 
malarial drugs on the market are now less effective due to the development of drug 
resistant s tra in s .A ttem p ts  to eradicate malaria with the wide spread use of chloroquine 
84, figure 17, described later, after the second world war and the use of pestisides and land 
drainage were unsuccessful. The subsequent chloroquine-resistant strains of malaria 
however, had not received prolonged exposure to quinine, as throughout history there had 
been complications with the widespread use and isolation of the drug. As a result drug 
resistance to quinine itself has been slow to develop.^"^
MeO-
Quinine
Figure 17.
8 4
Chloroquine
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Chloroquine 84 is an anti-malarial of some importance. As with quinine, the 
stereochemistry has little effect on the compounds biological activity. The development of 
drug-resistance in malaria has been a problem with this drug, due to its irresponsible use. 
The drug was incorporated in table salt in Brazil in an attempt to wipe out malaria, 
however this led to the emergence of chloroquine resistant strains of the parasite shortly 
after these measures were introduced.
The therapeutic agent has been used to treat discoid lupus erythematosus and rheumatoid 
arthritis, due to is analgesic properties. Chloroquine is also useful in the treatment of HTV- 
1. The drug has an anti-retroviral effect by interfering with post-transcriptional production 
of the virus in the cell.^^ As well as the anti-retroviral effect, it has the advantage of 
decreasing the success of AIDS opportunistic pathogens. In addition to this the drug is 
socially more acceptable than other HIV-1 alone therapies, having a beneficial effect on 
patient compliance. It is cheap, and can convey the possibility of reducing the transfer of 
the virus from mother to child through breast-feeding. This is of great importance when 
the majority of HIV infections occur in sub Saharan Africa, where patients have little 
money to fight the infection, and an estimated 2 0 0 0 0 0  new infections a year are caused by 
mother-child breast feeding.^^
The wide range of therapies quinoline-based compounds provide demonstrate the ability of 
this core moiety to effect responses at many different biological targets. While it is clear 
the quinoline structure effects therapeutic action in many examples, the mechanism of 
action of the agent is unknown in many cases. The most accepted explanation of the anti- 
malarial effect of these compounds is that they interfere with heme detoxification in red 
blood cells, and that this has a range of knock on effects, mainly increasing the oxidative 
stress on the parasite. Other research^^ into the selectivity and selection of proteins that the 
quinoline based drugs affect has highlighted two enzyme targets the drugs interact with. 
The research was based on screening the quinoline drugs against the purine binding 
proteome of whole homogenized mouse, red blood cells, and red blood cells infected with 
Plasmodium falciparum.
The rationale behind this was that due to the similarity of structure between quinoline 
compounds and purine-based nucleotides, quinolines may be binding to proteins that 
would normally bind to purine nucleotide compounds. The two target proteins were 
identified as being human aldehyde dehydrogenase 1 and quinone reductase 2. These were 
identified as the targets of quinoline drugs from the red blood cells and red blood cells 
infected with P. falciparum. Interestingly, the targets are both within the human genome
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and not the parasites. The aldehyde dehydrogenase 1 was shown to be only weakly 
inhibited by chloroquine, and it was postulated that this enzyme’s inhibition may actually 
be responsible for some of the drugs side effects more than the anti-malarial effect.^^
On the other hand the mechanism of action can be explained by the inhibition of the 
quinone reductase 2. Quinone reductase 2 is responsible for the metabolic detoxification 
of quinones, that are found in all respiring plant and animal cells and are potentially toxic 
compounds. The presence of increased levels of quinones puts the cell under higher 
oxidative stress, and the parasite is subjected to conditions it cannot withstand.^^
It is unlikely that the other therapeutic effects of drugs like chloroquine (HIV therapy, 
discoid lupus and arthritis treatment) can be explained by the inhibition of quinone 
reductase 2 alone. The breadth of therapeutic targets means that the quinoline core is 
considered to be a privileged stmcture and therefore it is desirable to incorporate it into 
libraries for lead discoveries.
Most quinoline drugs and natural products are substituted in the 2 and 4 position of the 
quinoline ring. Methodology previously developed within the Hartley group provided a 
route to the traceless diversity orientated synthesis of 2 -substituted quinoline structures on 
solid-phase. Initially I undertook to develop a route for the solid-phase synthesis of 2,4- 
disubstituted quinolines.
2.2 Previous Solid-Phase Syntheses of Quinolines
2.2.1 Decoration of Quinoline Structure on Soiid-Phase
Methods exist both for the construction of quinolines on solid-phase and the decoration of 
the structure by immobilising the pre-constructed quinoline core. This section will deal 
with the embellishment of the structure on solid-phase.
2,4-disubstituted quinolines have been synthesised^^ on solid-phase by the immobilisation 
of quinoline-4-carboxylic acid 85 onto Wang resin^^ either directly via coupling to the 
hydroxyl group of the resin 8 6  or through a diamine linker 87,^* (Scheme 24). The 
immobilised quinoline core was then oxidised to the N-oxide 8 8  using m-CPBA and 
activated by acylation with benzoyl chloride. Nucleophilic attack at C-2 then gave a range 
of resin bound products including indole 89. Following this the quinolines were cleaved
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from resin using trifluoroacetic acid in DCM. A variety of substituted pyrroles and 
enamines were also used as nucleophiles, (Scheme 25).^^
i) resin, P yB O P, NMM, 
□M AP, DMF, 20°C , 2 4  h
ii) m -C PBA , DCM, 20°C ,
2 4  h
R esin  = W ang with or without linker: 
Q.OH
Q ^ cx^ ÎI-r^nh,
i) PhCOCI, DCM, 0°C , 15 min
ii) in d ole, DCM, 0-20°C , 2  h
PyBO P: B enzotriazol-1-y l oxytrispyrrolidinophosphonium  
hexaflu orop h osp h ate  
NMM: N -m ethylm orpholine  
DMAP: 4-A/,A/-dimethylaminopyridine 
DMF: D im ethylform am ide  
m-CPBA: m efa -ch lo ro p erb en zo ica c id  
TFA: Trifluoroacetic acid  
DCM: D ich lorom eth ane
50%  TFA/DCM
8 3 %
Scheme 24.
I) BzCI, DCM, 0°C , 15 min
ii) A/-methylpyrrole, DCM, 
0 -2 0 'C , 2  h 
iii) TFA/DCM
Scheme 25.
i) BzCI, DCM, 0°C , 15  min
DCM, 0 -20°C , 2  h 
iii) TFA/DCM
n=1 87  %
n= 2 1 0 0  %
n=3 1 0 0 %
Other examples of immobilised quinolines include a quinoline moiety added to solid-phase 
via an alkyne group in a Sonogashira coupling, to furnish a substrate suitable for furan 
formation,^^ (Scheme 26). The starting aryl iodide 91 was immobilised by reaction with 
Merrifield hydroxymethyl polystyrene resin 92 using standard Mitsunobu conditions. 
Sonogashira coupling was then carried out between the resin-bound aryl iodide 93 and the 
quinoline moiety bearing an alkyne and an acetate group to protect the phenol 
functionality, 94. Following coupling, deprotection and cyclisation was carried out using 
potassium carbonate and 18-crown-6, forming the furan ring 95. Cleavage from resin was 
then achieved under Lewis acid conditions to reveal the tricyclic heterocycle 96.
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Scheme 26.
Ar-I
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D EAD . PPhg, 
DIEA, THF 9 3
3 a ,  % L ,
P d [(P P h 3 )2 C y , Cul,
EtaN-THF (1:3)
D EA D idiethylazodicarboxylate  
DIEA:A/,A/-diisopropylethylamine 
THF: Tetrahydro furan
K2 CO 3 , 1 8 -crow n - 6  
D M F -H 2 0 (1 9 :1 ) ,6 0 °C
AlCU
DOM, 2 5 “C
Another example is attachment of quinoline structures to oligonucleotides for the 
enhancement of the oligonucleotide’s binding affinity. The object of this research was to 
develop oligonucleotides with quinoline appendages that would bind transiently to a
complimentary strand of RNA from a target host.6 0
2.2.2 Synthesis of Quinoline Core on Solld-Phase
The development of syntheses for the formation of quinoline cores on solid-phase has been 
a recent addition to combinatorial chemistry. A route was developed using hydroxyethyl 
polystyrene resin as a solid support, (Scheme 27). A nitrophenol derivative 97 was 
attached via coupling conditions to resin. Aldol reaction using a range of aryl methyl 
ketones was carried out to form the (3-hydroxy ketones 98. This was followed by a tin(II) 
chloride mediated reductive cyclisation to form both the quinoline products 99 and the 
corresponding A^-oxides 100. The A-oxide products were converted to the quinolines 23 by 
reduction with titanium(III) chloride. Lewis acid mediated amide formation could be 
carried out with a variety of amines and cleaved the compounds from resin providing the 
quinolines 25. Using this methodology there are two opportunities to introduce diversity 
into the molecule, through the ketone and primary amine components, but the synthesis is 
not traceless as there is always amide functionality left at the site of attachment.^^
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Scheme 27.
The simplest and most often used methodologies for quinoline synthesis on solid-phase are 
those adapted from their solution phase counterparts. The multicomponent reaction 
developed by Grieco and Bahsas^^ produced heterocycles using immonium salts as 
dienophiles and Diels-Alder conditions. This was extended by Kobayashi^^ to allow 
imines as dienophiles using lanthanide Lewis acids as catalysts, and has been developed 
and optimised for the solid-phase synthesis of quinolines,^ (Scheme 28). The synthesis 
begins with a resin bound (S)-4-nitrophenylaniline. The immobilisation of this Fmoc 
protected compound 1 0 2  onto resin is followed by deprotection and acylation of the amine 
103 to form the amide 104. Reduction of the nitro group with tin chloride gave the aniline 
105 which was used in the multicomponent reaction to yield resin bound 
tetrahydroquinolines 106. The oxidation of the thioether was effected using m-CPBA to 
give the sulfoxide 107 and pyrolysis transformed the tetrahydroquinolines 107 into the 
resin-bound quinolines 40. Cleavage from resin was achieved using TFA/water to yield 
quinolines 109, with the opportunity to introduce diversity at the 2 position of the 
quinoline ring and the amide functionality present. The synthesis is not traceless however, 
as a carboxylic acid group is always left at the site of attachment to resin.
N O ,
A J
: 2 0  % piperidine, DMF
r%.Si
102°
A " : COCI, EtN'Pfz, DCM
NHg
1 03
r.t. 1 6  h
PhPh
NHNH
m -C PBA , DCM R 2 C H 0 ,  P h S C H = C H 2 , Y b ( 0 T f ) 3
NH 1 0 6NH r.t. 4  h
D CM /M eC N  (2:1)
O 2 , DMF, 80°C  
1 6 h
R2
TFA/H 2O (95:5) 
r.t., 2  X 0 .5  h
HO.
R2
1 8 -4 7 %
Scheme 28,
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Another example of a solution phase synthesis, again based on the multicomponent 
approach, adapted for solid-phase, is the adaptation^^ of the Doebner quinoline synthesis.^^ 
The synthesis was achieved using Rink resin^^ 110 and immobilisation of an Fmoc- 
protected amino acids, followed by deprotection to give amine 111, (Scheme 29). 
Acylation of the amino group with pyruvyl chloride gave tricarbonyl compounds 112 for 
the multicomponent reaction. The resin bound quinoline product 113 was then cleaved 
using TFA to give the final amides 114. As all products contained the amide group at the
site of cleavage, so this is not a traceless synthesis. 65
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110
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Scheme 29.
The most impressive synthesis of quinolines on solid-phase is also adapted from a solution 
phase route, the Borsche modification^*’^  ^ of the Friedlander synthesis, (Scheme 30). In 
the Borsche modification the problem of self condensation of aniline bearing ortho- 
benzaldehydes 115 associated with the Friedlander synthesis^® was avoided by converting 
the aldehyde functionality into an imine 116 by reacting with p-toluidine prior to 
generating the aniline functionality. Condensation of anilines 117 with the ketones 118 
then produced quinolines 119.
R3
N O ,
/^Tol xTol
p-toluidine/EtO H % NaoS/EtO H /reflux jrv
N O ,
115
'N H ,
11 6
iiaf
1 1 7
R2 piperidine or 
NaOH/EtOH/reflux
NHz
1 1 9
Scheme 30.
In the adaptation to solid-phase,^^ attachment to resin was carried out via the p-toluidine 
functionality and the resin used was TentaGel-Br, due to the compatibility of TentaGel and 
ethanol, the solvent used in quinoline formation. The toluidine was prepared by O- 
alkylation of Boc protected aminophenol 120, followed by removal of the Boc group.
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(Scheme 31). Condensation with orr/io-nitrobenzaldehyde 121 was followed by the 
reduction of the nitro group to the aniline 1 2 2  using sodium sulfide in water and ethanol.
Br
N H Boc
i) NaH, DMF, 12  h
ii)TFAÆ)CM 12  h
Scheme 31.
NH ,
N O ,
121
EtOH, reflux, 3  h NOz
NagS.GHgO 
EtOH 
reflux 
2 0  min
NHg
122
The reaction of the resin-bound aniline 122 with a range of ketones 123 gave a variety of 
substituted quinolines 124 and regenerated the toluidine resin to start the cycle again,
(Scheme 32), 71
fgO E to n  reflux 
 ^ 2 0  min
NHg
122
EtOH
NOz 1 23121
NHz 1 2 4
reflux
EtOH
piperidine
Scheme 32.
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6 0  %
C O ,E t
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K etone = EtO ,C
o-n itrob en za ld eh yd e =
M eO
M eO N O ,
As can be seen from above, the previous synthesis of quinolines differ little from their 
solution phase routes. The methodology developed within the Hartley group however.
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provides a solid-phase route to quinolines that is novel and unique.^'^ A downside of the 
solid-phase Friedlander synthesis is that the products require post cleavage purification. 
This problem has been avoided in the Hartley groups methodology, and, as well as being 
considered a traceless synthesis, the route utilises one of the cheapest resins available, 
Merrifield's chloromethyl polystyrene resin.
2.3 Solid-phase Route to Quinolines
2.3.1 Route to 2-Substituted Quinolines
Previously quinolines had been synthesised by Calum Macleod and myself (as an 
undergraduate) using novel titanium alkylidenes 52 to react with resin-bound esters 30 to 
produce resin-bound enol ethers 53.^ "^  This switch in the nature of the linker follows 
chameleon catch methodology and allows selective cleavage of only the reacted sites on 
the resin, preventing the need for further purification. The enol ether 53 is cleaved under 
mild acid conditions and the dihydroquinoline produced 54 was oxidised with the solid 
reagent manganese dioxide, preventing the need for elaborate purification as the oxidant is 
filtered off during work up, giving quinolines 55, (Scheme 33).
O Q r ^ O H
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Scheme 33.
The synthesis of the substrate for alkylidene formation was carried out using simple ortho- 
nitrobenzaldehyde starting materials 121. The 2-nitrobenzaldehydes 121 were 
alkylidenated using the Wittig reaction with methoxymethyl-triphenylphosphine 125. The 
resultant enol ethers 126 were a mixture of cis and trans isomers. Cleavage of the enol 
ethers with acid and the formation of the thioacetals 127 in situ was carried out in one 
procedure using acetic acid and boron trifluoride as activators / catalysts. Reduction of the 
nitro group yielded anilines 128. Protection of the anilines with di-tert-buiy\ dicarbonate 
gave carbamates 129 after purification by re-crystallisation using isopropanol. Silyl 
carbamate 130 was formed by deprotonation of the carbamate in the presence of 
chlorotrimethylsilane. This was then used directly in the Takeda reaction following 
preparation of the low valent titanium(EI) reagent, Cp2Ti[P(OEt3)]2 40 by reduction of 
titanocene dichloride with magnesium in the presence of triethyl phosphite and molecular
oxidation
r 2 MnOg
41 -67  %
40
sieves. Reaction of the low valent titanium complex 40 with the thioacetal functionality of 
silyl carbamates 130 formed the alkylidenating reagents presumed to be titanium 
alkylidenes 52. These were transferred into flasks, each containing a kan of Merrifield 
resin-bound ester 30. Alkylidenation of the ester carbonyl group occurred overnight. The 
solution was then decanted and the resin-bound enol ether 53 was then washed thoroughly, 
dried and cleaved using 10% TFA in DCM for 1 h. Following cleavage the products were 
a mixture of the TFA salt 131, dihydroquinoline 54 and possibly quinoline, though the 
NMR spectra were inconclusive. The yield at this point is a good indication of how well 
the alkylidenation worked. Oxidation was then carried out using manganese dioxide in 
DCM at reflux for 2 h to yield quinolines 55. Scheme 34 shows the yields obtained by 
Calum Macleod and my own yields (in parenthesis), obtained in the work I carried out 
towards expanding the library.
N O ,
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A variety of quinolines were prepared using the above route and are detailed below, figure
18.34
67%  5 5 a d '
5 2 %  5 5 cd '
N" 'P h
O M e
4 6 %  55b d '
O M e
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41 % 5 5 c f 5 4  % 5 5 c g ‘ ^ 0
Figure 18.
As a postgraduate I initially repeated the synthesis of thioacetal 129a in 26% overall yield. 
An improvement to the synthesis was sought to avoid the triphenylphosphine and triphenyl 
phosphine oxide by-products introduced in the first step by the Wittig reaction to form enol 
ether 132. Two solutions were postulated to reduce the by-products. The first was a 
Peterson alkylidenation,^^ using lithiated methoxymethyl-trimethylsilane 133 and 2- 
nitrobenzaldehyde 121 (Scheme 35). However, the a-silylated adduct 134 failed to form.
.O^ S^iMea 
13 3
N O ,
121
BuLi
X
2. KH
1 3 2
Scheme 35.
Following this result the focus moved to producing easily removable, water-soluble by­
products, and the formation of a phosphonate ester 135 was attempted using 
methoxymethyl chloride and triethylphosphite, (Scheme 16).^^
MOMGI + P (0 B )3
Scheme 16.
1. LDA
1 3 5 1 3 2
NO;
The Michaelis-Arbuzov^"^ to form the phosphonate ester 135 was successful using an 
excess of MOMCl to triethyl phosphite, but reaction conditions could not be found which 
promoted formation of enol ether 132. Had the reaction worked, the Homer-Wadsworth-
42
Emmons type reagent would have been ideal as the by-product would be easily removed 
during the work-up due to its water solubility.
I have extended the range of quinoline products by preparing quinoline 55ce' in good yield 
from the resin-bound ester 30e, figure 19.
6 2 %  5 5 c e '
Figure 19.
An interesting observation was that deuterium was incorporated into quinoline 55 to give 
3-deuteroquinoline D-55ce', on one occasion. This was clear from the integration of the 
doublet signal at 7.18 ppm in the HNMR spectrum corresponding to H-3, and the presence 
of a small singlet at 7.87 ppm corresponding to H-4 of the deutero compound when the 
spectrum is taken in CDCI3, figure 20.
D -5 5 c e
Figure 20.
Shaking the compound with DCI/D2O failed to force the exchange to completion. The 
exchange had taken place when a 'HNMR spectrum had been taken in CD3OD prior to 
oxidation and repeating the synthesis without this intervention gave unlabelled quinoline.
Presumably enamines 136 had been deuterated by the mechanism shown in (Scheme 37).
D:xx3tk-coXk- s
1 3 6  ■■ H -  H
Scheme 37.
Quinoline 55ce' was very insoluble in most deuterated solvents and the 'HNMR and
13CNMR spectra for characterisation were obtained in deuterobenzene.
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2.3.2 Route to 2,4-Disubstituted Quinolines
The 2-substituted quinolines had been successfully prepared using the above route 
(Scheme 34). I then set out to investigate a variation of the route to permit the synthesis of 
2,4 disubstituted quinolines. The new route started from 2-nitroacetophenone 137, and 
used the same procedures to give aniline 140, (Scheme 38). Purification was required after 
the thioacetal formation, as telescoping the reaction through to the N-Boc compound 141 
yielded no desired product. Chromatography was necessary as there are large amounts of 
triphenylphosphine and triphenylphosphine oxide residues present from the Wittig 
reaction. Reduction of the nitro group went cleanly, with no need for further purification, 
and in good yield. Problems arose with the route after the Boc protection to form product 
141. The NMR spectra were complicated due to the presence of rotamers of the Boc group 
and diastereotopicity as a result of the chiral centre.
0  001
I I 1
II SH  SH
Nof
Fe powder. 
NH4CI
Eton,
HgO
f  THP,re«ux,0/N
141 0 ^ 0  84% 140
X
88% *
* con tam in ated  with b o c  anhydride 
yieid  ca icu ia ted  relative to 'HNMR 
integrations
Scheme 38.
Attempts to remove impurities proved tedious and unsatisfactory and so the project was set 
aside in favour of new chemistry. At this time another member of the Hartley group, Mairi 
Gibson was undertaking research into the stereoselective synthesis of 2-substituted 
piperidines on solid-phase. Development of a route to produce 2,6-disubstituted 
piperidines offered an opportunity to expand the methodology and chemical knowledge.
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Chapter 3: Piperidines
3.1 Why Synthesize Piperidines ?
Piperidines are medicinally important privileged structures/^ found within nature in 
abundance. In addition to being a widely used reagent in organic synthesis, piperidine 
itself is used in setting epoxy resins and in forming rubber as well as being the core 
structural moiety in wide range of pharmaceutical drugs. Drugs containing the piperidine 
ring include one of the most important and widely used analgesics, morphine, as well as 
Ritalin 142, figure 21, a drug used in the treatment of attention deficiency/hyperactivity 
disorder (ADHD)/'®
N I Y  O M e
142
Figure 21.
An example of an isolated piperidine natural product is (+)-febrifugine 143. This chiral 
piperidine compound is a potent antimalarial compound, the activity of which is similar to 
chloroquine, discussed earlier.^^
,xOH '0H _
r  T  Î  r
" 143 O 144 °
Figure 22.
Its racemate and the diastereomer, (+)-isofebrifugine 144, show far less activity than (+)- 
febrifugine, illustrating the importance of enantiopurity, figure 2 2 .
3.2 Previous Solid-Phase Routes to Piperidines
Research into the asymmetric synthesis of piperidines, has been extensive and is well 
reviewed.^^’^  ^ Syntheses that employ the benefits of solid-phase and combinatorial 
technologies, however, have not been widely investigated. There are few examples of 
piperidines constructed on solid-phase and only one reported asymmetric route.^® 
Research into the diversity oriented synthesis of piperidines has been carried out using a 
multicomponent reaction and solid phase technology to access a range of bicyclic 
piperidine derivatives. A hetero-[4+2]cycloaddition between I-aza-4-borono-l,3-
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butadiene 145 and resin-bound maleimide dienophile 146 produced solely the endo- 
products 147, (scheme 39, only one enantiomer is shown though both are present 
throughout). In one pot, the multicomponent reaction sequence was continued with the 
allylboration reaction using aldehydes 148 as a source of diversity and the means of 
constructing the a-hydroxy functionality in alcohol 147. The presence of the aldehyde 
during the [4+2] cycloaddition did not interfere the reaction. The a-hydroxy functionality 
is desirable as it is a motif present in biologically interesting alkaloids. Cleavage from 
resin using mild TFA/DCM conditions gave piperidine-like products 149. One downside 
of this reaction sequence is that if  the reaction is incomplete, the cleavage step will release 
the resin bound maleimide starting material, contaminating the product 150/^ Furthermore 
the sequence is not traceless as all products contain a carboxylic acid moiety.
PhM e, 80°C , 7 2  h
o - O
NM02 ^ rac-147
146 N-R
0.5%  TFA/DCM
Racemic piperidines synthesised on solid-phase
6 2 %\ Ar -  CgH),
OH Ar = 4-Br-C6H4,54%
01  ^ NMej O OH
NMe; rac -149
Ph OH
OH
only on e en an tiom er show n 150
Scheme 39.
The selectivity of the allylboration, leading to only one stereoisomer, can be explained 
using the cyclic chair transition state 151, and the formation of only the endo cycloadduct 
in the previous step, (Scheme 40).
R^CHO
N-R3
Scheme 40.
4 - % - t
NR#
151
(R0 )2B" NR'R
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The reaction can be made asymmetric using a proline derived auxiliary 152 to selectively 
block one face, but this has not been applied to solid-phase, (Scheme 41),
152
Scheme 41
OM e
N Ph + PhC H O  PhM e, 80°C , 7 2  h
Ohf^  N 00 r  "^ C(CH3)20Me
d r . = > 9 7 .5  : 2 .5
Other examples that exist of solid-phase synthesis of piperidines include the formation of 
polysubstituted piperidines again by Diels-Alder reaction but this time using a 
heterodienophile in the form of a benzylideneamine 153, (Scheme 42). This imino-Diels- 
Alder cycloaddition of 2-amino-1,3-butadienes 154 forms resin-bound enamines 155 on 
solid phase using Wang resin-bound imines 156, attached via the nitrogen or carbon atom, 
and a Lewis acid in the form of ytterbium triflate. Hydrolysis of the enamines to from the 
piperidinones 157 is followed by cleavage from resin to form piperidinones 158 with good 
diastereoselectivity. Again the sequence is not traceless with all the products containing a 
phenol. Reaction with resin bound imine 156 gives a different substitution pattern but the 
reaction is still not traceless.
1 5 3
RaN
15 4
N
1 5 6
Scheme 42.
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Reduction of the enamine moiety 159 could be carried out on resin to furnish piperidines
160 with total diastereoselectivity, (Scheme 43). 81
Ph 1 5 9
N aBH 4 , AcOH  
THF, reflux, 8  h
TM SOTf
Ph
Ph 1 6 0
DCM
P h  161
only th is d ia stereom er  
4 6 %
Scheme 43.
Sulfonylethoxycarbonyl-modified resin 162, was used to immobilise amino acetals 163 
prior to cyclisation and allylation to form resin-bound 2-substituted and 2,4 disubstituted 
piperidines 165. Cleavage from resin was followed by acétylation of the nitrogen atom, 
giving free acetylated 2 and 2,4 disubstituted piperidines 167, (Scheme 44).^^
1 6 3  R
H,N
Et
G Et
D IPEA, THF, r.t.
16 4
BFaO Etg, D C M ,0 “C-r.t. 
R
A c 1 6 7
R= Ph, 80  % 
R= H, 7 8 %
Scheme 44.
ACjO, pyridine 
cat. DM AP, r.t.
N aO M e,
N
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R = 4-pyrldyl 71 % 
R = 4-BrCgH4 8 5 %  
R = 'Pr 8 6  %
I 
0  0
165
R = H 7 8 %
Isolated a s  HCI 
salt
In the above example the 2,4-anti diastereomer was prepared selectively due to 
pseudoaxial nucleophilic attack on the iminium ion, shown below, (Scheme 45). The 
chiral centre in the starting amino acetal ultimately comes from a phenylethyoxy group
(chiral pool), during its synthesis 82
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Scheme 45.
The only example of asymmetric solid-phase synthesis of piperidines during my Ph.D. was 
by Zech et A polymer bound galactosylamine chiral auxiliary was condensed with 
aldehydes to form imines 170. These were then reacted with Danishefsky’s diene 171^  ^
under Lewis acid conditions to form resin-bound dihydropiperidinones 172, with control 
over the newly formed chiral centre, (Scheme 46).
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Scheme 46.
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TM SO ( [ t ° ^
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O P iv i, 
172 ^
The mechanism for the reaction is postulated below, (Scheme 47). Attack is from the back 
as the pivalate group blocks the front face. The orientation of the iminium ion is controlled 
by A^’^  strain.*"^
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O Piv
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Scheme 47.
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The dihydropiperidinones 172 could be reduced to the resin bound piperidinones 173 with 
acceptable purity using a sterically hindered oxygenophilic Lewis acid, methylaluminium 
bis(2,6-di-rgrr-butyl)-4-methylphenoxide (MAD), and bulky hydride source, L-Selectride.
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Utilization of the enone functionality present in the dihydropipeiidinone was also possible 
allowing the formation of 2 ,6 -disubstituted piperidinones 174 by reaction with 
organocuprate reagents, (Scheme 48).
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Scheme 48.
As a silyl linker was employed, cleavage from resin was achieved through a fluoride 
source, tetrabutylammonium fluoride (TBAF), giving dihydropiperidinones (piperidinones 
and 2,6-disubstituted piperidinones in 13-90%, 32-53% and 38-75% yields, respectively.^® 
The auxiliary was not removed in this solid-phase synthesis but Kunz and co-workers 
recently carried out solution phase work with a related sugar auxiliary and published 
auxiliary cleavage conditions accordingly.^^
3.3 Hartley Group Route to Piperidines
While the quinoline research was drawing to a close, another member of the Hartley group 
Mairi Gibson was researching the stereoselective synthesis of 2-substituted piperidines on 
solid-phase using the simple and cheap chiral auxiliary, a-phenylethylamine.^^
Mairi’s research started with the synthesis of racemic piperidines using titanium 
alkylidenes 175 and resin-bound esters as a source of diversity. Reduction of the 
dithiophenyl or thioacetal moiety in the N-silyl Boc protected substrate 27 using low valent
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titanium complex 40, produced the titanium(IV) alkylidene 175. Reaction of this 
alkylidene with resin-bound ester 30d gave resin-bound enol ether 177, which could be 
monodeprotected and selectively cleaved using mild TFA/DCM conditions. The resulting 
Boc protected amine was further deprotected using stronger TFA conditions and cyclised 
to the imine 180 using sodium hydrogen carbonate solution. This was then reduced to the 
piperidine 181 on hydrogenation, (Scheme 49).
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Scheme 49.
This procedure worked well for the formation of 2-phenethylpiperidine 181 but proved 
difficult for the synthesis of a library of piperidines using various resin-bound esters. The 
silyl carbamate protecting group is unstable and can form isocyanates and this instability 
was probably responsible for the variable results.
With the problems of protecting groups hampering efforts to produce racemic piperidines, 
Mairi’s research was refined in a manner that not only solved the protection problem, but 
also provided the considerable advantage of an asymmetric synthesis.^^ This is particularly 
important owing to the plethora of chiral piperidine drugs and medicinally interesting 
natural products containing the piperidine core reported in the literature. The major 
advantage of the synthesis over Zech et aVs asymmetric solid-phase synthesis with chiral 
control, is that the source of chirality is a simple and cheap chiral auxiliary available in 
both enantiomeric forms. The a-phenylethylamine auxiliary doubles as a protecting group 
and source of the nitrogen atom for the product piperidine ring. Furthermore, use of a 
chiral reagent rather than a chiral linker is much more versatile. Another important
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consideration is that one source of diversity in the synthesis, the resin-bound esters are 
produced from simple carboxylic acids ensuring a wide choice of appendages in the final 
products.^^
The chiral substrates for the Takeda reaction were produced by Parikh-Doering 
modification^^ of the Swem oxidation^^ of the alcohol 182 produced by a literature 
p ro c e d u re .T h e  resultant aldehyde 183 was then condensed with (/?)-a-phenylethylamine 
(R)-1S4 and (5)-a-phenylethylamine (5)-184 as required, under reductive amination 
conditions, to produce two dithiophenyl thioacetals, (S)-1S5 and {R)-1S6 respectively, 
(Scheme 50).
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The substrates were then subjected to low valent titanium complex 40 to form a titanium 
reagent, presumably the titanium alkylidene 187 (from substrate (i?)-186), again reaction 
with the resin-bound ester 30 followed by selective cleavage of the subsequent enol ether 
provides a range of ketones 188, (Scheme 51).
Scheme 51.
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The ketones were then neutralised using potassium carbonate in dry DCM, cyclised using 
a large excess of sodium sulfate as a desiccant and the resulting iminium ion 189 was 
reduced diastereoselectivly to give auxiliary-bound piperidines 191 using sodium 
triacetoxyborohydride in a one pot procedure, (Scheme 52).
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Stereocontrol arises from a number of factors. Axial attack is preferred because this leads 
directly to a chair conformation with the nitrogen lone pair antiperiplanar to the incoming 
group. The orientation of the a-phenylethylamine auxiliary, leading to the 
enantioselectivity, is controlled by strain.^^’^  ^ The a-phenylethylamine auxiliary was 
used by Fujita and co-workers in the stereoselective synthesis of piperidines using iridium 
catalysis.^^ The same auxiliary has been used in the enantioselective synthesis of (S)- 
coniine by Shipman and co-workers,^"^ who also used allylic 1,3 strain to anchor the a- 
phenylethylamine auxiliary into one conformation and therefore reduce the iminium ion 
with diastereoselevtivity. The lowest energy conformation for a system under A^’^  strain is 
that in which the hydrogen atom, in this case of the auxiliary, is co-planar with the 
substituent of the imine, with our example the phenethyl group.^^ Therefore axial attack on 
conformation 190 is disfavoured due to the phenyl group of the auxiliary blocking the 
upper face, (Scheme 53). The removal of the chiral auxiliary under hydrogenation 
conditions was possible to give 2 -substituted piperidines, however due to time constraints 
optimisation of the cyclisation and hydrogenation conditions and the determination of the 
enantioselectivities of the route were not possible within Mairi’s PhD research. This work 
and further development of the route has subsequently been successfully carried out by 
Louis Adriaenssens, another member of the Hartley group.
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3.4 2,6-Disubstituted Piperidines
Following the success of Main’s work and the lack of solid-phase asymmetric routes to
2,6-disubstituted piperidines in the literature in 2003, a route utilising much of Mairi’s 
experience was devised to form this synthetically and medicinally interesting class of 
compounds.
2,6-Disubstituted piperidines are abundant in nature and are a core moiety in many drugs. 
They are common components of ant venom, e.g. solenopsin A 193 and isosolenopsin A 
194 are alkaloids isolated from the fire ant and exhibit cytotoxic, haemolytic, necrotic, 
antibacterial, insecticidal and antifungal p ro p ertie s .A n o th er example is lobeline 195, a 
nicotinic receptor antagonist that could have applications in the treatment of
methamphetamine abuse, a field not catered for with current pharmaceutical products. 9 4
(2R ,6R )-(-)-S o len op sin  A
1 9 3
Figure 23.
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My route started with a ring opening reaction on 2,3-dihydrofuran 196 to form the alcohol 
197, in good yield.^^ Swem oxidation under modified conditions'^ gave the aldehyde 198. 
This could potentially be reacted with a variety of Grignard reagents or organolithium 
reagents to form the secondary alcohols. Initially, methyllithium was used and the 
resulting alcohols were oxidised back to give ketone 199. Reductive amination with the
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chiral auxiliary 184 gave amines 200. The aim was then to separate diasteromers 200, and 
subject both diastereomers separately to Takeda’s conditions'^ to form alkylidenes 201 and 
then react these with the resin-bound esters 30 to give the enol ethers 202. Selective 
cleavage, again, would follow under mild acid conditions and after neutralisation and 
cyclisation, the resultant iminium ion 204 would then be reduced selectively using a mild 
reducing agent to the auxiliary bound 2,6 disubstituted piperidines 205. Hydrogenation 
conditions to remove the auxiliary would be the final step in the synthesis to provide 2 ,6 - 
disubstituted piperidines 206, (Scheme 54). Unfortunately the isolation of the separate 
diastereoisomers proved difficult. Attempts were made using crystallisation and trituration 
to separate the compounds but separation was not achieved. Problems with separation the 
diastereomers and a shift of focus in the research led to this route being left incomplete. At 
this time the opportunity to develop a route to a completely new moiety was presented and 
research into the asymmetric synthesis of 2 -substituted azepanes was undertaken.
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If the route to 2,6-disubstituted piperidines were to be further developed an important 
consideration in this methodology would be the reduction o f the chiral iminium ion. It is a 
fundamental concern of this route as to how the two chiral centres would affect 
stereocontrol in the reduction o f the iminium ion. It could be reasoned that one 
diasteromer 207 would work well with the (/?)-auxiliary as the chiralities would be 
matched, while the other diastereomer 208 would give poor stereocontrol, figure 24.
A xial a ttack , d ia s te r e o m e r  h e lp s  to  d ire c t a ttack . 
H
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Figure 24.
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Chapter 4: Literature Synthesis of 2-Substltuted 
Azepanes
4.1 Why Synthesize Azepanes ?
Figure 25.
The azepane structure 209, figure 25, is a moiety present in many potential and proven 
biologically active alkaloids.^^ As such it has been the source of interest for medicinal 
applications, but also has other advantages e.g. chelating agents for paramagnetic MRI 
imaging metals,^^ discussed later. In addition to these applications, the ring formation is 
synthetically challenging due to loss of entropy and is therefore of interest to chemists 
developing synthetic methodology. Many enantioselective syntheses of azepanes rely on 
sugar starting m a t e r i a l s , i n  particular those derived from D-mannitol. These are 
important members of the chiral pool but limiting also, as the substitution of the ring with 
many hydroxyl groups is inevitable.
4.2 Previous Syntheses of Azepanes: Background
Accessing substituted azepanes asymmetrically has presented problems in the past.^^ Seven 
membered rings are on the verge of medium ring size and there is a loss of entropy in 
reaching the transition state of the ring-forming reaction, posing a challenge for those 
wishing to synthesize them. There are many non-productive conformations the linear 
precursors to seven membered rings can adopt, decreasing the percentage of molecules in 
the orientation needed for reaction and so slowing the rate of formation. One of the most 
popular method of preparing chiral azepanes is through the derivatisation of sugar 
analogues. Sugar-derived azepane structures by default have many hydroxyl groups 
attached to the ring. These can be desirable; as they increase the water solubility and 
prevent poor b io av a ilab ility ,b u t they can also be unwanted because of the effect they 
could have of structure activity relationships in drug design. Ring closing metathesis 
(RCM), is a fashionable and sophisticated a lte rn a tiv e lead in g  to fewer appendages on 
the ring, if desired, as well as the ability to introduce functionality e.g. hydroxyl groups. 
Azepanes can also be accessed via corresponding cyclic imines. However as the synthesis 
of cyclic imines will be dealt with in detail later on, the synthesis of these compounds shall
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be omitted here. The synthesis of chiral 2-substituted azepanes and the solid-phase 
synthesis of azepanes will be the focus of this discussion.
4.3 Methods of Constructing Chiral 2-Substituted Azepanes
4.3.1 Ring Closing Metathesis
Ring closing metathesis (RCM) is one of the more frequent ways of constructing the 
azepane ring. Indeed, a range of Grubbs’ catalysts 210 were effective in Fiirstner and co- 
workers^®  ^synthesis of the chiral azepane segment 211 of (-)-balanol 212, (Scheme 55).
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Scheme 55.
Azepanes synthesised using RCM include bacterial ribosome glycoside antibiotics,^®^ 
potent glycoside inhibiting polyhydroxylated azepanes,^®^ and the natural products (-)- 
tuberostemonine,^®^ and (-)stemoamide.^®^
Chiral oxime ethers have been used to attach a chiral auxiliary in a synthesis of 2- 
substituted azepanes.^®^ The chiral induction comes from oxime ethers 213 derived from 
(R) or (5)-0-(l-phenylbutyl)hydroxylamine and formed by condensing this auxiliary with 
unsaturated aldehydes. In the example given^®  ^oxime 213 was reacted with phenyllithium 
214 to give only one alkoxylamine 215a. Allylation of the amine 215 gave the diene 216 
which was a substrate for the RCM reaction, (Scheme 56). This was carried out using 
Grubbs catalyst 210 and the alkene moiety created was hydrogenated under palladium on 
carbon conditions to give auxiliary bound 217 enantioselectively, but in poor yield.
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The low yield during the RCM gave rise to concerns that the basic nitrogen atom in amine 
216 was coordinating to the ruthenium atom of the catalyst 210. Therefore alkoxylamine 
215 was converted into the benzyloxycarbamate 218, (Scheme 57). The resulting diene 
218, cyclised smoothly in respectable yield to give alkene 219 and hydrogenation gave the 
corresponding enantomerically enriched azepane 2 2 0 .
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R: 9 0  % e e .Br
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Scheme 57.
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An alternative auxiliary is phenylglycinol. Thus (R)-phenylglycinol 221 was condensed 
with 5-hexene-2-one 222 and the aminal produced immediately reacted with acryloyl 
chloride to form amide 223, (Scheme 58). At this point the diastereomeric ratio was 75:25 
in favour of the anti configuration of the methyl and phenyl groups and this major isomer 
was isolated to continue the sequence with. RCM using Grubbs’ catalyst 210 followed by 
hydrogenation using palladium hydroxide gave the bicyclic lactam 224. Reduction of the 
aminal bond and lactam carbonyl was carried out simultaneously using DIBAL as a 
hydride source to form auxiliary bound azepane 225. Removal of the auxiliary was 
achieved by hydrogenation to give 2 -substituted azepanes 226 in good enantiomeric 
excesses.
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A small range of azepanes was prepared with the 2-alkyl group being either methyl or 
ethyl. Formation of 2-isobutyl azepane derivative gave very poor yields of the bicyclic
lactam (8 %), indicating the introduction of further diversity may be problematic. 108
4.3.2 Ring Expansion
Formation of the azepane by ring expansion is a powerful method and Chong and co­
workers used aziridinium ion formation and regioselective ring opening of this transitional 
species to provide a route to azepanes with total diastereoselectivity and in good yield. 
The research aimed at preparing new azepane based agents to produce stable complexes 
and increase hepatobiliary clearance of toxic paramagnetic gadolinium (Gd) ions, used in 
MRI imaging.^^’®^ The synthesis started with reduction of 2,6-pyridinedicarboxylic acid 
227 to give cij-2,6-bis(methoxycarbonyl)piperidine^®^ 228, (Scheme 59). Benzyl 
protection of the nitrogen followed by reduction of the ester groups then gave the N- 
benzylated diol 229. The diol was converted into the dihalide 230 using thionyl chloride, 
providing the substrate for azepane formation. The authors expected simple Sn2 
displacement of both chlorine atoms with azide under the conditions used, however the 
piperidine derivative 231 was not isolated. Instead a seven membered azepane compound 
232 was produced exclusively, presumably via the aziridinium ion intermediate 233.
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Another ring expansion that utilizes a bicyclic aminal 234 derived from the same chiral 
phenylglycinol auxiliary as used in the RCM routes above was used to produce 2,3- 
disubstituted azepane 235 and 2,3,7-trisubsituted azepane 236 diastereoselectively by 
addition of phenyllithium to the nitrile 234. Reduction of the resulting cyclic imine 237 
provided the bicyclic aminal 239 with a degree of stereoselectivity, (Scheme 60). This 
compound could then be treated to lithium aluminium hydride reduction to provide 2,3- 
disubstituted azepanes 235 or reacted with methyllithium to give 2,3,7-trisubstituted 
azepane 236.^^°’^ ^^  A range of similar azepanes were prepared by using other 
organolithiums and Grignard reagents in the two steps involving these.
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Azepane amino acids substituted at the a position have been synthesised using the Schmidt 
rearrangem ent.^This is a direct route to lactams from the chiral ketones, prepared by 
diastereoselective alkylation, avoiding the hydrazones required for the Beckmann 
rearrangem ent.^T hus chiral P-keto ester 240 was treated with sodium azide and 
methanesulfonic acid to effect the rearrangement to lactam 241, (Scheme 61). Selective 
reduction of the lactam carbonyl group involved using borane-dimethyl sulfide complex to 
give the a-amino ester 242. A range of alkyl groups could be used providing a variety of 
a-amino esters
oPh, p
N aN j, MeSOgH, [ « j u  B H 3 . C H 3 S C H 3 , THF  
'C O gE t ------------------------------------ ► L T  P h -----------------------------------
COoEt
2 4 0  DCM, reflux, 30 min 241 -i5°c, 1 d ay  ^ ^  2 4 2
9 1 %  5 6 %
ee; > 9 5  % e e :  > 9 5  %
Scheme 61.
4.3.3 Enolate Alkylation
Synthesis of a-alkylated a-amino acids 243 has been carried out by Kawabata et a l  using 
memory of chirality in a deprotonation and subsequent intramolecular enolate alkylation 
step.^ "^^  The key step is the cyclisation of bromoalkane 244. Displacement of the halide by 
an enolate derived from the chiral parent Boc protected amino acid derivative gave the (5)- 
enantiomer 245 in 83% ee but low yield, (Scheme 62). The authors postulated a 
mechanism considering the memory effect of the enolate. Two stable confomers, 246 and 
247 give rise to two different enolate conformations 248 and 249. Conformation 248 
arises from the deprotonation of a hydrogen that is eclipsed with the floppy and less 
sterically hindered N-(CH2)3Br group, whereas in conformation 247 the target hydrogen 
atom for the bulky KHMDS base is eclipsed with a sterically demanding Boc group, 
(Scheme 62). Alkylation then occurs more rapidly than interconversion of 248 and 249 by 
rotation about the C-N bond.
e>2
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Solvent effects support this explanation, as decreased enantioselectivity is observed when a 
less coordinating solvent is used, e.g. PhMe instead of DMF, consistent with increased 
deprotonation of 247 due to the coordination of the potassium cation by the Boc group.
4.3.4 N-Alkylation
A route that used A-alkylation to access the azepane core employed the 2- 
phenylethylamine auxiliary to access cyclic |3-amino acid derivative 250.^^^ The lithiated 
a-phenylethyl amine derivative 251 was reacted with a,p-unsaturated ester 252 in an 
asymmetric Michael addition reaction to form adducts 253 with 95% diastereoselectivity, 
(Scheme 63). Following the removal of the benzyl group using eerie ammonium nitrate 
(CAN) (hydrogenation cleaved the C-Cl bond) intramolecular alkylation was investigated 
using base and iodide as a catalyst to give the auxiliary-bound cyclic P-amino acid 250. 
Removal of the auxiliary proved troublesome, an observation that concurs with our own 
research using the a-phenylethylamine auxiliary (see later).
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4.3.5 Af-Acylation
A chiral auxiliary can also be introduced by acylation of a preformed lactam. Modification 
of TCC (trans-cumylcyclohexanol) auxiliary protected lactam 254, by introduction of 
benzotriazole, a good leaving group occurs by reduction to the aminol and addition of 
benzotriazole as a nucleophile to give 255. This provides access to A -^acyl iminium ion 
256. Phenylmagnesium bromide alkylates this stereoselectively giving a route to 2- 
substituted chiral azepane 257, (Scheme 64). The diastereoselectivity is dependent on the 
selective addition the Si face of the iminium ion as rotomer 256 is favoured over rotomer 
258. The TCC auxiliary then controls the face of attack by the organometallic reagent 
giving the auxiliary bound 2-substituted azepane 257, (Scheme 64).
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Another route that afforded 2-substituted azepanes enantioselectively used N-acylation and 
an auxiliary derived from (i?) or (5)-phenylglycinol, (Scheme 65). The (/?)-phenylglycinol 
259 condensed with keto acid 260 to form imine 261. Given time (3 days), the imine 
rearranged to a cyclic aminal that further cyclised to a bicyclic lactam products 262 and 
263 with some degree of diastereoselectivity for the 2,4-syn product 262 (d.r. = 67:33
syn: anti). 108
M e
R-259
y '
o 262
2 6 0  o
Scheme 65
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4.4 Methods for Constructing Azepanes on Solld-Phase
Hydroxyazepanes have been investigated as DNA minor groove-binding l i g a n d s A s  
knowledge of the genome expands and the chemical understanding and manipulation 
provided by chemical biology continues to grow, therapeutic agents that bind directly to 
DNA to affect protein production are an increasing area of interest. Azepanes with 
hydroxyl appendages are thought to be flexible enough to allow the hydroxyl groups to 
interact and hydrogen bond with the N-3 of purine, a hydrogen-bond acceptor in the form 
of the urea carbonyl of the pyrimidine bases, or the 2-amino of guanine, directing the 
molecule attached into the minor groove.^^ The hydroxyl functionalities provide a high 
level of water solubility for the molecule, increasing the bioavailability of these structures. 
Such hydroxyazpanes are accessed, as in many other syntheses of azepanes, through 
epoxides derivatised from D-mannitol. An example of a DNA-binding molecule, derived 
from D-mannitol, was reported by Johnson and T h o m a s .P ro te c tio n  of D-mannitol 264, 
using dimethoxypropane and catalytic toluenesulfonic acid gave its triacetonide, which 
was selectively deprotected using acidic aqueous methanol to give monoacetonide 265. 
This could be selectively converted into either one of two epoxides 266 and 267, (Scheme 
66)."*
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Scheme 66.
The epoxides 266 or 267 could then be treated with amine derivatives. For example 
epoxide 266 was reacted with aniline 268 to give polyhydroxyazepane 269. Elaboration of 
the structure then provided the bis-azepane 270, which was tested as a minor groove 
binding ligand, (Scheme 67).^^
266
H,N
Scheme 67.
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This built upon the research of Merrer and co-workers who discovered that the ring 
opening of bis-epoxides 266 and 267 could be controlled by the solvent used in the 
re a c tio n .M e rre r  found that in an aprotic medium the foimation of the piperidine ring by 
6-exo cyclisation was favoured, in accordance with Baldwin’s rules and kinetics. The 7- 
endo ring closure yielding the azepane structure could be induced, however, by using
protic media or aprotic conditions in conjunction with a Lewis acid. 1 1 6
Merrer and co-workers later used solid-phase synthesis to access an azepane structure. The 
polyhydroxylated azepane moiety was constructed on resin to allow elaboration by peptide 
synthesis. The formation of the azepane structure was carried out as before, this time using 
a crowded amine derived from Rink resin 271 as the nucleophile to open the èw-epoxide 
267 to give resin-bound azepane 272. Following capping of the excess amine sites on 
resin, as complete loading was not desirable due to the reaction conditions required, 
derivatisation of the free hydroxyl groups was possible, illustrating the potential of 
producing libraries of peptide mimetics, when coupled to amino acids. The resin-bound 
functionalised azepane 273 was then cleaved from resin using standard conditions to give 
the compound 274, (Scheme 68).^^
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The route has the advantage of being traceless and in theory might be extended to employ 
other 6fj-epoxides. However it currently does not allow access to 2-substituted azepanes 
and its versatility has not been investigated.
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Chapter 5: 2-Substituted Azepanes
5.1 Previous Hartley Group Work on Azepanes
Considering the success of Mairi Gibson’s work in forming chiral 2-substituted piperidines 
and the gap in the literature concerning the diversity based synthesis of azepanes on solid- 
phase, an important tool for drug companies to cover chemical space, expansion of the 
methodology to the larger azepane ring system was undertaken. Mairi had started 
exploring the synthesis of racemic azepanes following the route shown, (Scheme 69). 
However the thioacetal 280 was never tested under Takeda conditions and the focus of her
work remained the synthesis of chiral piperidines. 117
O
2 7 5
S P h
P h S '
P hSH , BFg.OEtz
DOM, 0°C, 1 h
S P h
PhS"
4 3  % from ox im e  
2 8 0
27 6  9 4 %
-B o c ,
B0 C2O, 4-D M A P  
M eCN , r.t., 16 h
S P h
PhS"
2 7 9
PySO g, D M SO
EtgN, DOM 
0°C , 1 h
PhS" " O
2 7 7  8 4  %
LiAIH., THF
NHzOH.HCI, N aO A c  
EtOH/HgO, r.t. 1 h
S P h
------------------------------P h S  ^  ^  N
0°C , r.t., 1 6  h 2 7 8  5 4  %
.OH
Scheme 69.
5.2 Choice of Auxiliary
The chiral auxiliary chosen for the solid-phase synthesis of 2-substituted azepanes was a- 
phenylethylamine (a-PEA).^^ It is cheap, readily available in both enantiomers, and should 
be reductively cleaved with ease.^^ a-PEA has been used as a chiral resolving agent and as 
a chiral ligand in asymmetric catalysis, but we wished to use it as an auxiliary directing the 
reduction of a seven membered cyclic iminium ion in our synthesis. Stereocontrol over the 
chiral centre produced had already been demonstrated in the piperidine series "^  ^through 1 ,3  
stereoinduction from the difference in size of the groups (CH3 vs. Ph) around the benzylic 
carbon in the auxiliary, as has already been discussed.
The intermediate iminium ions 281 in our synthesis would be locked into a ring system and 
so E  or Z depending on the R group (2-substituent) used. Alignment of the auxiliary
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hydrogen atom in the same plane as the imine bond in the cyclic iminium ion of our 
intermediate and the consequent differentiation of the two faces of attack at the prochiral 
iminium ion centre, should provide the selectivity required, figure 26.
281 H
Attack d irected  to top fa c e  
a s  phenyl group b lock s on ly  the bottom  fa c e  
in order to a llev ia te  allylic 1 ,3  strain
Figure 26.
5.3 Synthesis of Thioacetai Substrates
The synthesis was started from the 2,3-dihydropyran 275, which was ring opened in the 
presence of propanedithiol to produce thioacetal 282. Swem oxidation^^ produced the 
crude aldehyde 283 contaminated with pyridine and triethylamine salts, which was used 
without further purification in a reductive amination reaction with the a-phenylethylamine 
auxiliaries 184. The crude products were orange oils 284 and 285 that produced colourless 
crystals on standing. Unfortunately NMR and mass spectrometry showed that the crystals 
were amide 286. This by-product was produced by the condensation of the auxiliary and 
acetic acid from the reducing agent used, and was easily removed along with the other 
impurities, salts carried on from the Swem oxidation, by column chromatography, 
(Scheme 70).
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Scheme 70.
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(/?)-Substrate 285 was treated to 4 eq. of low valent titanium complex 40, to generate an 
organotitanium reagent, presumably titanium alkylidene (R)-287. As before the low valent 
titanium(II) complex 40 was formed by reduction of titanocene dichloride by magnesium 
in the presence of triethyl phosphite. Reaction between 3 eq. of titanium(IV) alkylidene 
287 and a resin-bound ester 30d produced enol ether {R)-2S9, following a chameleon catch 
strategy. Selective cleavage of the enol ether moiety, leaving behind any unreacted resin- 
bound ester, provided the alkylammonium (/?)-salt 290 in low yield, (Scheme 71).
CpzTiClz, Mg. P (0 Et)3  
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Ph
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The modest yield indicated that there might be a problem with the formation of the 
titanium alkylidene reagent from the dithiane. The mechanism presumably involves step­
wise reduction of the thioacetal (R)-285 with a first oxidative addition giving rise to 
organotitanium 291 and a second oxidative addition resulting in bimetallic 292. This is the 
reagent subjected to the resin-bound ester. Most probably formation of the Schrock 
carbene (R)-2S7, (Scheme 72), is the rate determining step in the alkylidenation reaction as 
have been shown for similar reactions.
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Unpublished results from other Hartley group members indicate that the first oxidative 
addition is generally instantaneous, while the second oxidative addition is slower. In the 
case of benzylic dithiane 293 stabilisation of the formed carbon dianion in bimetallic 294, 
is achieved through conjugation with the aromatic ring and this is a good substrate for the 
Takeda reaction, (Scheme 73).
0  
O S iM e,
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C p 2Ti[P(OEt)3]2
2 9 3
cpzxr
Scheme 73.
We reasoned that in the absence of this stabilisation it might be better to use a 
diphenyldithioacetal substrate as oxidative addition to the C-S bond would be easier 
because the phenylthiolate anion is more stable than an alkylthiolate.
Dithiophenyl thioacetals {R)-295 and {S)-296 were prepared from 2,3-dihydropyran 275. 
This was converted into alcohol 276. Swem oxidation then gave aldehyde 277 and this 
was followed by reductive amination with the a-phenylethylamine chiral auxiliary to 
produce thioacetals (R)-295 and (5")-296 in moderate yield following column 
chromatography. The low yield of the R substrate was due to an extended delay before 
purification, (Scheme 74).
71
0
2 7 5
BFg.OEtj, PhSH
^  P h S '
2 7 6  85%
DCM
Py.SO g, EtgN S P h
P h S '
DM SO, DCM 2 7 7
NHj
M olecular s ie v e s  
N a(0 A c)3 BH 
DCM
M olecular s ie v e s  
Na(0 Ac)3BH 
DCM
(S )-1 8 4
S P h iPh
P h S P h S
2 9 6 2 9 5
S  = 40%  from ROM
Scheme 74.
It was possible that the low yield of ketone (/?)-290 was due to titanium alkylidene (R)-2S7 
failing to react with the resin-bound ester, so a complementary strategy using a lower 
loading resin was also investigated. This was pursued after re-treatment of one kan with 
titanium alkylidene (R)-2S1 and doubling the equivalents of low valent titanium complex 
40 both failed to increase yields. These experiments indicated that protection of the N-H 
of the auxiliary was not necessary because slow intramolecular protonation of the titanium 
alkylidene (R)-2H7 would effectively decrease the amount of this species and increased 
equivalents would have increased the yield. The steric hindrance of the high loading 
Merrifield resin used could have contributed to low yields on the resin. This concern is 
also discussed by Kunz and co-workers in their work with galactose auxiliaries in chiral
piperidine synthesis discussed earlier 80
The resin was therefore changed from 1.89 meq mmol' Merrifield resin to lower loading 
chloromethylpolystyrene stratosphere resin plugs, small pre-formed plugs of resin that can 
be treated as loose resin, but have the advantage of being a standard weight/quantity. The 
resin plugs were placed in the polypropylene IRORI ® macrokans. This has the benefit of 
avoiding mechanical degradation of the plug leading to loss of resin and yield, figure 27.
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The loading was carried out as before using the caesium salt of the carboxylic acid and 
chloromethylpolystyrene Stratosphere ® plug. The resultant resin-bound ester 30d was 
treated to alkylidenation conditions using the dithiane substrate 284, to little effect, so 
increased equivalents and dithiophenyl derivative 296 were used, but the difference in 
yield remained low, (Scheme 75).
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Scheme 75.
Following the lack of results concerning the resin and substrate conditions tried, extensive 
investigations into the extremely dry reaction conditions required for a successful Takeda 
reaction were carried out. The presence of even a small trace of water can affect the 
reduction of titanocene dichloride to give the low valent titanium species, Cp2Ti[P(OEt)3]2 
40. Removing every trace of water through extensive drying of reactants, glassware and 
solvents, and by heating the magnesium and the molecular sieves in a hot (250-300°C) 
oven overnight prior to the reaction being carried out solved the problem.
With the problem of low yields finally solved a small library of amino ketones was 
prepared in moderate to good yield off resin using a range of resin-bound esters. No post 
cleavage modification or purification was required, (Scheme 76).
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Having isolated the product in both the salt and free ketone form, initial attempts were 
made to cyclise and reduce the compounds using the same procedure as used in the 
piperidine chemistry previously described.^^ Following neutralisation of the TFA salt 299 
off resin using potassium carbonate followed by sodium sulfate in excess and a mild 
reducing agent, sodium triacetoxy borohydride were used in the hope that the intermediate 
iminium ion would be reduced stereoselectively, as in the piperidines. The product 
obtained from the reaction however, was nothing more than the neutral ketone 290, 
(Scheme 77).
Scheme 77.
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As the recovered ketone was pure and there was enough material to work with again, 
further cyclisation attempts were made using mini Dean-Stark apparatus.
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Dean-Stark removal of water from the ketone 290 followed by addition of the selective 
reducing agent sodium triacetoxyborohydride to the proposed cyclic iminium ion was the 
next alternative investigated. One equivalent of acetic acid was used to aid the formation 
of the iminium ion by facilitating dehydration and providing a counterion for the iminium 
cation. This reaction also failed to produce cyclised product, however due to excessive 
heating and a loss of toluene in the reaction set up this result is not surprising. The 
reaction was carried out again using no acetic acid and starting from the TFA salt as it 
comes off resin 301. However, still ketone 297 was recovered, (Scheme 78).
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5.4 Alternative Routes to Amino Ketones
In order to investigate alternative methods of cyclisation and reduction, it was necessary to 
scale up the synthesis of amino ketones. The yields of the ketones from resin were now 
improved to the level of the substrates used to produce piperidine heterocycles. The yields 
of the Takeda reaction however, were not the only limiting factor in providing enough 
amino ketone to carry out research into cyclisation and reduction. Each polypropylene 
macrokan used in the solid-phase Takeda reaction could contain only -0.3 meq 
(milliequivalents). Therefore scale up would be wasteful in kans and resin.
5.4.1 Intramolecular Takeda Reaction
Two routes were explored in an attempt to access more ketone. The first was to utilise a 
solution-phase Takeda reaction by attempting an intramolecular alkylidenation of an easily 
obtained starting material. This was carried out by reacting the substrate 284 used for the 
solid-phase reaction with an acyl chloride 302, formed by refluxing thionyl chloride with 
2-phenylpropionic acid 303. Ideally the dithiophenyl thioacetal substrate should have been 
used, but as it was a test reaction and the dithiane substrate was available 284 it was used. 
Formation of the amide substrate 304 was simple but it required column chromatography
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before it was subjected to the low valent titanium complex 40 to produce the alkylidene, 
(Scheme 79).
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Scheme 79.
Previously work by Takeda and co-workers^^ have shown intramolecular alkylidenations 
are possible when the titanium alkylidene is formed from dithiophenyl thioacetal and 
reaction is with an internal ester moiety in substrate 306. The product enol ether 307 was 
isolated but the intermolecular reaction competed and oligomers were also formed 308. 
Attempts were made to decrease the chance of intermolecular reaction by using high 
dilution conditions, but this was not successful and the yield remained moderate. The 
reason for the preferred intermolecular reaction was assigned to the need for the 
intermediate in the reaction to form an oxatitanacycle 309, this is greatly strained in the 
seven membered ring, but far less so in the intermolecular reaction intermediate 310. The 
authors confirmed the nature of the oligomers isolated by hydrolysing them to the 
monomers obtaining the same hydroxyl ketone 311, as from the hydrolysed enol ether 
307,’  ^ (Scheme 80).
76
C p 2 T i [ P ( O E t ) 3 l 2
P h S 3 0 6
Intram olecular interm ediate
Q : r
Intram olecular Interm olecular
 ^ O ligom ers  
3 0 8
H ,®
3 2  %
H ,0
Ph 309
Interm olecular interm ediate
Ph
31 0Cp2Ti
Ph "  ^  P h -
31 1 2 2  % from 3 0 6  311 2 6  % from 3 0 6
Scheme 80.
Takeda and co-workers also showed that intramolecular alkylidenations in amides were 
possible in the synthesis of pyrrolidines 312 using the amide substrates 313. The reaction 
proceeds as before forming the oxatitancyclobutane ring, however an unexpected result for 
the authors was direct reduction in situ giving the pyrrolidine ring directly. None-the-less 
the yields of the products were good and clearly the intramolecular reaction with the amide 
functionality had occurred, (Scheme 81).^^^
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An important observation is that all the amides used in the above intramolecular 
alkylidenation research were benzanilides. This has implications on the reactivity of the 
substrate as the carbonyl group of the amide will be more electropositive owing to the 
competition of the aryl ring for the delocalisation of the lone pair on nitrogen. The 
subsrates in our synthesis are not benzanilides and therefore will be less reactive towards 
the nucleophilic Schrock carbene.
With this in mind reflux conditions were used, as had been implemented in the afore 
mentioned intramolecular ester alkylidenation, in the hope that it would encourage the 
reaction to go. The product desired from the reaction was the enamine 305 or the amino 
ketone 290 should it be hydrolysed on work-up. Unfortunately neither was produced and 
the reaction failed to give recognisable product after column chromatography, (Scheme 
79).
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The compounds or mixtures of compounds isolated provided two likely products, though 
neither was pure. The first was unreacted starting material 304 of which approximately 30 
mg was recovered from the 321 mg used. This was important as it showed that the 
reaction had not fully formed the alkylidene needed to react intramolecularly. Only 30 mg 
was recovered, however, so the majority of substrate had been converted into the 
alkylidene and therefore the reaction could have produced some product albeit in low 
yield. The major recognisable product was amide 315 formed by quenching alkylidene 
314, Evidence for both rotomers present: Ôh (400 MHz, CDCI3): 1.40 [3H" ,^ d, J  7.1 Hz,
NCH(CH3>], 2,00 (3H®, d, J 7.8 Hz, NCHCH3), 2.54 [20^, m, CH2C(0 )N], 2.65 [2H®,m, 
CH 2C(0 )N)], 2.73-2.90 (2H'^*®, m, CH2CH2N), 3.12-3.20 (2H**'^, m, CH2PI1), 4.97-5.04 
(IH®, m, NCH), 5.95-5.98 (IH^, m, NCH), 7,07-7.26 (m, Ar-H).
This shows that the alkylidene did form, but did not react intramolecularly or 
intermolecularly and merely hung around until the work up of the reaction. Some evidence 
exists for a small proportion of material recovered being the product of monoinsertion 316. 
ÔH (400 MHz), CDCI3): 1.45 (3H, d, J  6.9, CHCH3), 2.18 (2H, t, J  7.3, CH2SCH2), 2.26 
(2H, t, J  7.4, HSCH2), 5.21 (IH, bs/m, CHCH3). None of these compounds were further 
purified or fully characterised, (Scheme 82).
Q u en ch ed  alkylidene
C %  ^  ^  A  Cp2TI[P(0Et)3]2 Â  H2O
m ono-insertion  product 
3 1 6
Scheme 82.
The failure of the reaction was not unexpected. The use of 1,3-dithiane instead of a 
dithiophenyl thioacetal would have contributed slightly to the problem, but as the main 
reaction products identified by ^HNMR spectroscopy were those resulting from quenching 
of titanium alkylidene 314, this was not the main reason for the reaction failing. The 
decreased reactivity of the amide with respect to benzanilides used in the literature could 
have been a considerable factor, with the alkylidene requiring a more electrophilic target 
than the amide used. The steric hindrance surrounding the carbonyl group of the amide 
bond could also have made it more difficult for the reacting centres to approach each other.
Ph Ph  ^  O
3 0 4  3 1 4
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Had the reaction worked and the enamine 305 been isolated, it could have been treated to 
mild anhydrous acid to produce the cyclic iminium ion with greater ease and the reduction 
could have proceeded since the difficult step of ring closure had already occurred.
5.4.2 Grignard Addition to Nitriie Group and Sn2 Dispiacement
The second route was to form the ketone functionality by introducing diversity via a 
Grignard reaction to a nitriie group. Addition of an organometallic to the nitriie group of 
6 -bromocapronitrile 317, following a procedure detailed by Buchwald and Red i n g ^wh o  
used a similar route to access cyclic imines, bromo-ketones 318 and 319 could be 
achieved. The Sn2 displacement of the bromine using the chiral auxiliary 184 provides the 
amino ketone substrates 297 and 298j for cyclisation in two steps from available starting 
materials, (Scheme 83).
B r  R - M g B r ^  R  
3 1 7 M eOH
R=a: 2 9 7  16 %
R = b :2 9 8  3 3  %
3 1 9
Scheme 83.
Yields of the initial Grignard addition were poor in the case of the phenethyl derivative. 
Attempts to increase it were made by changing from the Aldrich supplied Grignard reagent 
to freshly prepared reagent. This increased the yield from 2% to 10%. While the yield for 
the phenethyl derivative was disappointing, the butyl derivative was isolated in reasonable 
yield, and after Sn2 displacement enough amino ketone 298j was produced to test a wide 
variety of cyclisation conditions. The Sn2 displacement was also a problem however, and 
the yields were not optimal. A polar protic solvent, MeOH was used to solvate the 
transition state and encourage the reaction. An alteration was made in the route by using 
Finkelstein reaction c o n d i t i o n s t o  convert the bromide leaving group into an iodide 
leaving group, in the hope of increasing yields. Formation of the iodo ketone 320 was 
carried out using sodium iodide and the crude product was used (sodium iodide being the 
only contaminant) in the Sn2 displacement reaction, (Scheme 84).
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Nal, a ce to n e
319 quant, crude  
3 2 0  u se d  directly
Scheme 84.
Full conversion of the bromine-substituted ketone 319 to the iodo ketone 320 was observed 
and could be confirmed by the ^^CNMR analysis. The heavy atom effect applies to the 
iodine substituted compound and by using the equation for estimating the chemical shift of 
a carbon in an aliphatic chain (Eq 1), an approximation of the chemical shift of the carbon 
adjacent to the iodine can be obtained, using substituent constants, table 2 .
Table 2
Substituent Constants : z
a P Y Ô
I Alkyl Alkyl Alkyl
-7.2 9.4 -2.5 0.3
H H H H
0 0 0 0
H H H H
0 0 0 0
Alkyl
9.1
Equation 1: b c  = -2.3 + l z  + I>S + I.K
Where z is the substituent constant (in this case the substituent constant changes from 
bromine in the starting material to iodine in the product), 5  is a steric correction (for
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primary, secondary tertiary or quaternary substituted carbons), and JST is a conformational 
increment for y-substituents. JST is 0 for freely rotating substitutents as in this case, and the 
sum of all the substituent constants z, can be obtained by adding the values apportioned to 
the a, p, y, Ô substituents of the carbon in question. In the case o f the iodo compound the 
bonds from the carbon atom [-CH2-CH2-I] are freely rotating; there is a steric correction of 
0 and the sum of the substituent constants z  are obtained from table 1 giving the 
equation 2:
Equation 2; Ô c=  - 2.3 + (-7.2 + 9.1 + 9.4 + 0.3 + -2.5) + 0 + 0
Predicted NMR 5 c for [-CH2-CH2-I ] is 6.8 ppm
Observed NMR 6 c for [-CH2-CH2-I ] is 6.82 ppm
Using the same equation with the bromine compound gives a predicted 8c [-CH2-CH2-Br ] 
of 32.9 ppm because of the a substituent change, bromine (z = 18.9) compared with iodine 
(z = -7.2). The observed chemical shift was 32.52 ppm.
Unfortunately no difference in the overall yield was observed, (Scheme 85).
N 3 1 7 3 1 9 5 4 % >100% , N al con tam in an t on ly  
u se d  crud e 3 2 0
M eOH H ,N
Scheme 85.
298J
3 2  % o v er  2  s te p s
Once the amino- ketones 297 and 298j were formed, simple purification was possible in 
the work-up by using acid/base extraction. Following solvent removal IM HCl was added 
and an ether wash used to remove all non-amine by-products or starting materials. After 
this the aqueous acid layer was extracted with chloroform to remove the product as a salt, 
leaving behind the primary amine of the auxiliary 184. The excess auxiliary 184 could be 
recovered by basification of the remaining solution and extraction with DCM .
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The general problem of using alkyl halides with primary amines is over alkylation, but this 
did not occur. The recovery of halo ketone starting material 319 highlights this, and can be 
put down to the steric hindrance of the amine g roup .Syn thes i s  of the amino ketones 297 
and 319 by carrying out the Sn2 displacement before addition of the Grignard reagent was 
also tried, and this drastically improved the efficiency of the Sn2  reaction, giving nitriie 
321. Even with increased equivalents of alkyl halide 317, the by-products isolated were 
starting materials, not over alkylation products. The subsequent Grignard reaction failed 
however, probably due to the N-H present in the molecule, (Scheme 8 6 ), even though 2 eq 
of Grignard reagent were used.
31 7
HgN
1 8 4
NOBr
321M eO H . 48  h
84%  with 2 .8 e q  nitriie
Scheme 8 6 .
63%  with 2 eq  auxiliary
2 eq  RM gCi p
Ph 2 9 7
The successful route to amino ketones 297 and 298j potentially provides access to a 
diversity based synthesis of chiral azepanes in solution phase and is complementary to the 
solid-phase enantioselective approach.
5.5 Cyclisation Methods Researched
With access to a larger quantity of substrate, research into the cyclisation-reduction of the 
amino ketones to give azepanes was carried out. It was hoped that the Dean-Stark removal 
of water under acidic conditions would give a mixture of cyclic enamine and iminium ion 
322 that would be reduced by using sodium triacetoxy borohydride and give the azepane 
323. Unfortunately this was unsuccessful and starting material 298j, was recovered.
298j
Scheme 87
D ean -Stark  con d ition s ».
p. PhM e, m olecu lar s ie v e s
4 8  h J
Ph
3 2 2
N aB H (0 A c )3
3 2 3 h4
Ph
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A 30% solution of potassium hydroxide in MeOH and a solid pellet of KOH in THF were 
also used to encourage cyclisation-dehydration. The expected enamine products 324 and 
325 were not obtained and under both conditions starting ketone was recovered, (Scheme 
88).
11 M U  KOH 3 0 %  M eOH
 -  -
298) Ph or or N '
KOH pellet, TH F h 4  v “ *
P h  Ph
Scheme 8 8 .
Next the use of a Lewis acid to coordinate to the oxygen atom and encourage cyclisation of 
the amino group was investigated. The chosen Lewis acid was chlorotrimethylsilane. This 
reagent had the benefit of being oxyphilic, and being able to provide a chloride counterion 
for the iminium cation. Ketone 290 was treated with an excess of the TMSCl (3eq) and the 
mixture left stirring overnight during which time solvent evaporated. More DCM and 
TMSCl were added, a further 11.8 eq, (a total of 16.6 eq) and the reaction mixture stirred 
for 5 h. At this time the reducing agent was added in excess (19.6 eq) to account for the 
possible reaction with the TMSCl, and the reaction mixture stirred overnight, (Scheme 89).
i) TM SC l. (1 6 .6  eq  total)
ii) N a(0 A c)3BH P h  " N ' 
0 9 - 6  eq ) 3 0 0
Scheme 89.
Following work-up it appeared by the NMR data that the reaction had been successful. 
Having no data to compare it with the disappearance of the carbonyl ^^ C in the carbon 
NMR seemed very promising and further attempts to optimise and induce stereoselectivity 
continued, pending the obtaining of full characterisation data. The reaction was repeated 
using lower temperatures and different reducing agents (e.g. L-selectride) in an effort to 
control the diastereoselectivity. Each reaction had to be repeated to effect conversion to 
what was thought to be cyclised product. The attempts to influence the diastereoselectivity 
of the reaction were unsuccessful, and following the acquisition of a mass spectrum, it was 
clear that the cyclised product 300 had not been produced.
GCMS gave rise to one fraction and the LRMS showed a peak that appeared to be the 
molecular ion at m/z ratio 248. Analysing the M.S. data in conjunction with the H and 
NMR data, which was complicated due to diastereomers, led to the conclusion that the 
products were alcohols 326. The m/z ratio was wrong for the molecular ion of these 
compounds, and 248 must be a fragment. A general fragmentation pattern in compounds
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containing benzylic methyl substitution is loss of ’CH3. Loss of this from the alcohols 326, 
would give the m/z fragment 248 due to ion 327. Other m/z ratios present in the LRMS 
were 105 corresponding to 328 and 158 corresponding to 329. HRMS was sought on that 
structure and this confirmed the analysis, figure 28
.N  ,.H El m a s s  s p e c
m /z  [M] = 26 3  
32 6
3 2 7
m /z =  2 4 8  (50 %)
3 2 8
m /z  = 1 0 5  (1 0 0  %)
3 2 9
m /z = 1 5 8  ( 8  %)
Figure 28.
Use of excess TMSCl had allowed the mild reducing agent sodium triacetoxyborohydride 
to reduce the ketone to an alcohol. In spite of investigating a range of conditions, 
cyclisation to the seven membered ring failed, table 3. Interestingly another group member 
however, Louis Adriaenssens has now successfully applied the TMSCl-sodium 
triacetoxyborohydride procedure to the cyclisation of 5-amino ketones to give chiral 
piperidines.
R eaction  C onditions
Starting Material: 298) 
A
See Table 3 P r o d u c t;  3 2 6  
B
Table 3
Starting 
Material (scale 
in mol)
Reaction Conditions Product/s
Obtained
Yield
A i) TMSCl (5 eq), DCM (2 mL), A+B after first 35% B
R.T. reaction.
0.383 mmol
ii) NaBH(OAc)3 (6  eq) B only after
second
i) TMSCl (10 eq), DCM (2 mL), treatment
R. T.
ii) Na(OAc)3BH (12 eq)
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A
0.19 mmol
i) Microwave 50 W, 60 °C, 24 psi 
AcOH 1 drop, MS 4Â, MeOH, 
(2 mL)
ii) NaBH4 (2  eq)
A+B N/A
A
0.19 mmol
i) Microwave 200W, 85 °C, 94 psi, 
MS 4Â, tosic acid (1 crystal), 
MeOH. (2 mL)
ii) Na(OAc)3BH (2 eq)
A 51%
Recovery
A
0.17 mmol
i) Microwave 150 W, 55-75 ®C, 3 
psi, TMSCl (18.5 eq), Et3N (1 
eq), DCM (0.8 mL)
ii) Na(0 Ac)3BH (20 eq)
B + impurities N/A
A
0.195 mmol
i) Microwave 200 W, 58 °C, 4 psi, 
TMSCl (8.1 eq), DCM
ii) Na(0 Ac)3BH (9.1 eq)
B 75%
Crude
Finally with all cyclisation attempts failing, the structures of the alcohols 326 were 
confirmed by preparing an authentic sample by reducing the ketone 298j with sodium 
borohydride, (Scheme 90).
298j
H,N^H
Ph
NaBH^, M eOH
3 2 6  6 9 %
H
• V
Ph
Scheme 90.
5.6 Proposed Route to Racemic 2Substituted Azepanes
Attempts to produce azepanes enantioselectively were discontinued and the focus switched 
to producing racemic azepanes. Removal of the auxiliary by cleaving the benzylic C-N 
bond using hydrogenation was investigated. This would provide the free primary amino
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ketone, that would hopefully cyclise and reduction under the same conditions would 
produce racemic 2 -substituted azepanes.
Amino ketones 297 and 298j were subjected to a range of hydrogenation conditions in an 
effort to produce the primary amino ketones 331 that could cyclise with far greater ease 
than the sterically hindered amines 298j and 297, reducing in situ to racemic azepanes 330, 
(Scheme 91).
Scheme 91.
H ydrogenation C onditions
Removal of the auxiliary at 40 psi and 40 °C using palladium hydroxide on carbon as a 
catalyst worked to some degree with ketone 297 giving azepane 330d in 34% together with 
38% recovered starting material after shaking overnight. This result shows that cyclisation 
once removal of the auxiliary has been accomplished is facile, but that the removal of the 
auxiliary is more problematic. When ketone 298j was treated to a higher pressure of 
hydrogen under the same conditions, fully cyclised and reduced product 330j was isolated. 
Though the exact yield was uncertain, as the product was isolated as a hygroscopic 
hydrochloride salt 330j that resisted drying, it is assumed to be near quantitative, (Scheme 
92).
40°C , 2 9 0  = 40  P si, 
3 1 9  = 90  Psi
N -
O /N , P d (O H )2 /C 20%  H
ssod
3 4  %,
with 3 9  % recovery of 2 9 0  
330j
> 100%
(H ygroscop ic iso lated  a s  HCl sa lt)
Scheme 92.
At this time a paper was published that reported removal of the same chiral auxiliary from 
piperidines using atmospheric hydrogenation conditions and HCl acid,^^ but application of 
this method was unsuccessful.
Another method for the removal of the benzyl group is catalytic transfer hydrogenation. 
This was not tried but could have yielded positive results. The use of formic acid and
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palladium on carbon as a catalytic support was first described in the 1970’s as a useful 
selective //-benzyl deprotection reagent for peptide synthesis. A paper by Jerina et al also 
describes using a short column of palladium on carbon and passing the reaction mixture 
over it and illustrates how this method is useful for automated systems. Using the column 
prevents the need to separate the catalyst from the product at the end of the reaction and 
the column can then be re-used once cleaned.
Later examples using the phenylethylamine auxiliary 184 include its use in a 
stereoselective Michael addition to an acrylate derivative 331, to produce a 
diastereoselective synthesis of inhibitors of enzymes linked to athritus. Giving matrix 
metalloproteinase analogues 332^^  ^ (Scheme 93).
H Y   ^ \ ^ - \ ^ C 0 2 'Bu j) HCOaH-MeOH ^ ^ ^ ^ C O j ' B u
T ^ C O o ' B u  ® 1 8 4  I T  T  T  P H / n n n o / „ \
331
I I I I P d /C  ( 1 0 % )
I 7  f ^ C O z M e  i ^ ^ G O j M e  ^  r ^ C O , M e
^ C O j M e  M eO H  P h  N i f  P h ^ N l f  ii) a q . N a H C O jY
9 0 :10  m ajor d s
91 % 3 3 2
Scheme 93.
Clearly the use of a chiral auxiliary as a protecting group in the preparation of racemic 
azepanes was rather wasteful so an alternative route using a different protecting group and 
generating cyclic imine intermediates was investigated.
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Chapter 6: Literature Routes to Cyclic Imines
Cyclic imines have applications for the pharmaceutical industry as potential leads for 
treatment of Alzheimer’s disease^^^ and examples have been reported to have anti- 
cance/^^ and anti-bacterial p r o p e r t i e s A n  example of a related amidine compound that 
exhibits anti-cancer activity against leukaemia and melanoma cell lines in mice is 
compound 333, figure 29.^^^
, 'N
3 3 3
Figure 29.
Cyclic imines are also extremely useful synthetic intermediates. They provide access to 2- 
substituted heterocycles, through nucleophilic addition to the imine bond^^° and chiral 
heterocycles, through stereoselective reduction of the imine bond.^^ '^^^  ^ Cyclic imines can 
also be used to generate aromatic he t e r ocyc l e s , ami no  acid a n a l o g u e s a n d  as a 
substrates for the Ugi reaction.
6.1 Previous Syntheses of Cyclic imines
The following review of cyclic imine synthesis is designed as a general introduction to the 
types of reactions that have previously been used to produce them. For a full review of the 
synthesis of six membered cyclic imines up to 1998 please see the review by M-G. A. 
Shvekhgeimer.^^^
6.1.1 Halogénation of the Nitrogen Atom
One of the oldest methods for preparing cyclic imines is via the addition of a halogen to 
the nitrogen atom of a saturated heterocycle 334 to give the corresponding N- 
chloropyrrolidine^^^ or A-chloropiperidine 335,^^^ followed by base-induced elimination, 
(Scheme 94). The transformation can be carried out using a variety of r e a g e n t s , o n e  
example being A-chlorosuccinimide, and following treatment of base, the cyclic imine 336 
can be isolated.
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N
Cl r 1 KOH
3 3 4
Scheme 94.
N R N R N
^  Ci 33 6
3 3 5
6.1.2 Organometallic Addition to Lactim Ethers
One of the most general methods for the preparation of 2-substituted cyclic imines is the 
reaction of lactim ethers 337 with nucleophiles, Grignard reagents or organolithium 
reagents being the most c om m o n, ( S ch e me  95). The lactim ethers or cyclic imidates 
337, are synthesised via reaction of the corresponding lactams with dimethyl sulfate, 
methyl fluorosulfonate or trimethyloxonium tetrafluoroborate.^^^ Reaction with an 
organolithium, a more effective nucleophile than Grignard reagents, proceeds through an 
addition/elimination sequence, liberating lithium methoxide. The reaction provides access 
to 5, 6 , and 7 membered cyclic imines 338, 336, 339 in good yield, though the choice of 
organolithium reagent is limited to less reactive organolithiums to ensure the imine 
products over the amines 340.^ ^®
cyclic  im idate cyclic im ine cyc lic  am in e
n = 1 : 3 3 8  "
n = 2 : 3 3 6  
n = 3 : 3 3 9
im idate RLi im ine yield am in e yield
Scheme 95.
n = 1 n-BuLI ift\ „  3 4 %  2 4 %
n-Bu N
„.BUU 21%
Ph-U  4 7 %
P-BUU S%  ( ( ^ 2  33%
P h -U  6 7 %  ^
This is due to the problem of double addition of the alkylating reagent. The more reactive 
the organolithium reagent, the higher the quantity of double alkylated products 340, though 
if this is the desired process it can be optimised by using 5 eq of organolithium reagent to 
yield cyclic 2,2-dialkyl amines , (Scheme  96).
Scheme 96.
N 3 3 7  N 3 4 0
cyclic im idate......................................... ......... ...................
cyclic 2 ,2 -dialkylam ine
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6.1.3 Organometallic Addition to Cyciic Imides
Surprisingly few examples rely on simple condensation of a carbonyl group with a primary 
amine/"^ '^^"^  ^ This is the method of ring closure employed in our chemistry. An example of 
this method is demonstrated by Giovannini et al, who produced a range of 5, 6 and 7 
membered cyclic imines 336, 338, 339 using the corresponding lactams 341 as starting 
materials^"^^, (Scheme 97). The authors removed the hoc protecting group with acid before 
adding a 30% aqueous sodium hydroxide wash to form the cyclic imine from the amino 
ketone 342. In addition to sodium hydroxide solution, sodium carbonate has also been 
used to effect ring closure successfully.
i) BuLi, THF, -78°C  Q
[ ^ o ______”)Jg° )^°____ .
" H 3 4 1  iii)R .M gB r n . 1 , 2 . 3  b ) 3 0 % N .O H  '
3 4 2
Scheme 97.
n = 1 : 3 3 8  
n = 2 : 3 36  
n = 3 : 3 3 9
Hydroxyl amines have been used as synthetic precursors to cyclic i mines. The reaction of 
titanium trichloride with a cyclic hydroxylamine under anhydrous conditions, followed by 
a basic work-up with sodium hydroxide gives rise to cyclic imines. The dehydration 
reaction produces imine products in 53 -  99% yield.
6.1.4 Organometallic Addition to Al-trimethyisiiyI lactams
A similar method for the general synthesis of 2-substituted 5,^ ' '^ '^^^  ^ 144,145 yi44,i46 _
membered ring, 2-substituted cyclic imines has been developed that utilises N- 
(trimethylsilyl)lactams 343 and a nucleophilic alkylating agent e.g. organolithiums to 
produce an adduct that then loses trimethylsilanol to form the cyclic imines.
An example, detailed below in Scheme 98, shows use of this chemistry in the synthesis of 
polonicumtoxins, that have ecological interest. The cyclic imine core of the structure 
was synthesised by alkyllithium addition to A^-TMS-lactam 343. The alkylating agent was 
synthesised from a bromide 344. THP protection of the alcohol was followed by 
Finkelstein conversion to the iodide 345. Lithium-halogen exchange was carried out using 
LDBB (lithium 4,4'-di-t^At-butylbiphenylide) as previous attempts with butyllithiums were 
unsuccessful. Nucleophilic addition of the alkyllithium to A-TMS-Ô-valerolactam gave an 
adduct that is said to undergo a Peterson-type elimination to leave a cyclic imine 346.
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Removal of the THP protecting group is carried out giving the product, polonicumtoxin C
347, in low overall yield. 147
344
a. DHP, cat. T sO H , DOM 0°C 1 h
"OH -------------------------------------------------------► r
b. N al, a c e to n e , reflux 3 h
6 7 %
LDBB, THF, -78°C , 1 5 m in
'O T H P -------------
3 4 5  then
T H P O .
343
LDBB: lithium 4,4'-d i-/ert-butylbiphenylide 
THP: tetrahydropyran  
DHP: dihyd ropy ran
TMS
THF, -78°C , 3 0  min 
-40°C , 4 0  min
Scheme 98.
MgBrj,
ether,
r.t.
4  h
H O .
N
347
6%
from N-TMS lactam
A more recent development in this chemistry has led to the development of a one-pot 
silylation and alkylation of the A-TMS-lactam, preventing the need for isolation of the 
highly labile silylated product.
6.1.5 Grignard Addition to Nitriies
Another reaction which utilizes organometallic nucleophiles, employs a Grignard reagent. 
Addition of a Grignard reagent to a nitrile group 348 and subsequent intramolecular 
cyclisation via Sn2 displacement of a halide in 348 provides access to a range of 5 and 6  
membered cyclic imines 338, 336, '^*  ^(Scheme 99).
Scheme 99.
348
n = 1 
n = 2
RMgX
CgHs/EtgO, FIT 
(add TH F if n=2)
R = s-butyl 
n-butyl 
phenyl 
benzyl 
m ethyl 
n-propyl
n=1: 338 
n=2; 336
Cyclic imine yield
n = 1 : 5 5 % , n = 2 : 5 8 %  
n = 1: 8 4  %, n = 2: 7 5  % 
n = 1: 9 0  %, n = 2: 8 5  % 
n =  1: 7 2  %, n = 2: 6 4  % 
n = 1 :3 3 % , n = 2: 3 4 %  
n = 1 : N /A n = 2: 8 4  %
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6.1.6 Functionalised Enamines as Starting Materiais
Cyclic imines 336 can be prepared from cyclic enamidine 350, by turning the cyclic 
enamidine into an organolithium reagent 351,^ "^  ^ (Scheme 100). This synthetic 
intermediate is produced by a-lithiation of formamidine derived heterocycles 352 
followed by selenation with diphenyl diselenide 353. Elimination of phenylselenide with 
bicarbonate yields enamidate 350 in 70 -  90% yield. Cyclic enamidines 350 can then 
undergo a-lithiation, again, and alkylation 354 to give 2-substituted enamines 355. 
Removal of the formamidine group follows, leaving 2-substituted cyclic imines 336. 
These can be reduced directly to piperidines 356. In the seven membered ring series the 
sequence was only taken to as far as to form the seven membered enamidine. The 
chemistry has also been extended to give 2 ,6 -disubstituted cyclic imines by repeating the 
lithiation / alkylation process.
f-BuLi hgÆ
[‘ 3 5 2  (P h S e )2
J k
N S e P h  ^353 
N
n or / BuLi
3 5 4
R-X
I 3 5 0  -7 8 “'=
85%JjV
N Li R
3 5 5
R = n-C , 1H23 90  % 
R = PhC H 2 76  %
N2H4-ACOH
25°C
LiAIH^
N R H356  ^ 33^
R = C i ,H 23 9 2 %  
R = P h C H , 7 6  %
Scheme 100.
6.1.7 Aza-Wittig Reaction
The aza-Wittig is similar to the Wittig alkenation but with the a-anion on nitrogen instead 
of carbon. The result is an imine bond, and when the reaction is carried out 
intramolecularly on ketones, 2-substituted cylic imines are produced, (e.g. Scheme 101). 
Thus simple halo ketone 357 was converted into imine 358 in 2 steps via azide 359,^^^’^ °^ 
and also in a one pot p r o c e s s . T h e  yield of imine 358 via this one pot reaction was 
superior to that of the aza-Wittig reaction using preformed azide 359.
M eO  OM e
P h ,P
35 7
M eO O M e 
80%
MWI
3 5 9
NaNa, PPhg, MWI
Scheme 101.
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N
3 5 8
M eO O M e
a: 73%  
b: 98%
Synthesis from alcohols is also possible. Thus a one pot synthesis of the cyclic imine 346 
from a primary alcohol 360 combined Mitsunobu conditions and Staudinger aza-Wittig 
conditions to give an in situ conversion of the alcohol 360 to azide followed by the
intramolecular aza-Wittig r e ac t i on . ( Sc he me  102)
Scheme 102.
O TH P
Zn(Ng)2 .2 Pyr 
'-P r02C N =N C 02'-Pr. PhgP
to lu en e, r.t., 24  ti
O THP
4 0 %
6.1.8 Other Reductive Cyclisations of Azides
Related reductive cyclisations of azides are also possible using other reducing agents. One 
example is a route to pyridines and pyrroles that avoid harsh conditions^^^ by employing a 
dehydrohalogenation reaction, (Scheme 103). The halogenated cyclic imines 361 required 
for this reaction were synthesised from a-haloketimines 362. Regioselective alkylation a  
to the imine with co-iodo-alkyl azides was carried out to give azides 363. The resultant 
a,Y" and a,0- difunctionalised ketimines 363 were then subjected to chemoselective 
reduction and cyclisation using tin(ll) chloride, forming 5 and 6  membered halogenated 
cyclic imines 361 c l e a n l y . T h e  imines were then treated to base conditions to yield the 
desired pyridines 364 and 365 or pyrroles 366/^^
'N
R \ R2 
X  3 6 2
X = CI, Br
Scheme 103.
LDA
HMPA
T H F
-78°C
93
n= 1, 2  
- 7 8 ° C - > 0 “ C
R! R"
6 2 - 1 0 0  %
4 -5  h r.t.
n=1
N aO M e p i
SnC lg
M eOH
M eOH, h eat
R  7 8 - 9 8 %  
3 6 6
H a l o g e n /KO-'Bu
R I  .N
p i  \ v 3 5 - 9 0  %
X  3 6 1
n=2  
R^= H alogen  
N aO M e  
M eOH  
H eat
p i '  3 6 5
7 3 - 8 0  %
3 6 4 9 1  %
In a similar method to the tin(II) chloride reductive cyclisation, a tetrathiomolybdate 
complex 367 was used to reduce the azide 368 and form the cyclic imine 369 in one step^^  ^
(Scheme 104). This procedure was useful for 5, 6  and 7 (benzene fused) cyclic imines 
(e.q. Scheme 105).
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Scheme 104.
Scheme 105.
n= 1. 2  
R= H, M e
OHO
3 6 7
N3 [PhCHgNEtaJgMoS.^ 
C H g C N
[PhCHgNEtglzMoS^
C H 3C N
n= 1, 2 
R=H, M e  
7 9 - 8 2  %
3 6 9
6 7 %
6.1.9 Transition Metal Catalysed Cyclisation of Alkenes and Alkynes
Transition metal promoted intramolecular amination of alkenes or alkynes is also a method 
for cyclic imine formation (e.g. Scheme 106). The use of an alkyne as the potential 
electrophile is superior to an alkene, as the substrate does not suffer the lack of 
regioselectivity that occurs with the alkene. The reaction can be carried out with the 
catalytic action of gold(lll)^^^ or with a palladium(ll) source.
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In the examples shown palladium chloride is used, coordinating to a 7t bond of the alkynes 
370, 371, 372. This draws electron density to the electrophilic palladium(II) and allows 
nucleophilic attack, intramolecularly in this case, by the nitrogen nucleophile. Protonolysis 
of the resulting C-Pd bond is required, and this is encouraged with the addition of catalytic 
water. In the work carried out by Utimoto et 3-alkynylamines 370 were treated to 
palladium chloride (5%) and water (3%). The favoured 5-Endo-Dig product 373 was 
obtained in 31-70% yield. 4-alkynylamines 371 were treated to the same conditions and 
the result was a mixture of 5-exo-dig product 374 and 6-endo-dig 375 product in a ratio of 
80:20-83:17. 5-Alkynylamines 372 cyclise exclusively to the 6-exo-dig 376 product, 
although the 1-endo-dig 377 product is allowed by Baldwin’s rules, it was not observed, 
(Scheme 106). In all cases, the initial products of addition to the alkynes were enamines. 
The exo-dig additions gave exocyclic enamines and the endo-dig additions endocyclic, 
however, the enamines rearranged to give the more stable cyclic imines 373, 374, 376.^ "^^ .
3 -a lk y n y  la m in e s
R/ 370 r2
5 %  P d (ll)C l2
3  %  H2O , M eC N . 
5 -10  h, reflux 
R =n-C gH ,y, /7-C 7 H 15, n-C^Hg, P h , H 
R2=H, CHg, n -C gH ir
. . .  R" 
"  N 3 7 3
5-Endo-Dig 
3 1 -7 0  %
4 - a lk y n y la m in e s  
R 2  371
a : R ’= n-CyHi 
r 2= H 
R ’= n-(
R2= C H ,
5 %  P d (ll)C l2
3  %  H 2O . M eC N . 
5 -1 0  h, reflux
N ■■ R ’'  ' N '  R"
5-Exo-Dig 3 7 4  6-Endo-Dig 3 7 g
a: 8 3  %  
b: 8 0  %
a: 1 7 %  
b: 2 0  %
Scheme 1 1 .
5 - a lk y n y la m in e s
RL. R2
5 %  P d (ll)C l2
37 2 3  %  HgO, M eC N , 
5 -1 0  h, reflux 
R —r?-CgH,g, n-CgH^^, C 2 H5 , PH , H 
R2=H, CHg, n-C gH , 3
Rl
N '  R  
6-Exo-Dig 
15-71 %  3 7 6
R ’ N '  p i ;
7-Endo-Dig 
0 %  3 7 7
Similar cyclisations are possible using other transition metal catalysts.^^^’^ ^^
The hydroamination of aliénés has also been investigated. Organolanthanide complexes of 
La, Sm, Y, and Lu, (Cp'2LnCH(TMS)2, Cp'=r|^Me5C5) have been used in the formation of 
cyclic imines 378 from amino aliénés 380. Alkene and alkyne moieties bearing an amine
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functionality can insert into the a  metal-ligand bond once the amine coordinates to the 
metal centre in bis(cyclopentadienyl)lanthanide complexes.'^* There are two possible 
outcomes of aminoallene reaction with the organolanthanide complexes. The first is 
formation of vinyl pyrrolidines or piperidines 381 or 382 though pathway (a), and the 
second is formation of cyclic imines 378 via pathway (b), (Scheme 107). 1,3-disubstituted 
aminoallenes = alkyl, always gave cyclic allylamines, so a range of 2 ,6  substituted 
cyclic imines cannot be accessed through this route.
The only substrate to give exclusively six membered cyclic imine 378 was unsubstituted 
aminoallene (n=2), R^=Me, with other substrates providing mixtures.
Pathw ay a Path w ay b
R’= H .M e H R ’ N ,
3 8 2  R^=Me, Et  ^ ^  3 7 9  ^  3 7 8
n=2 3 8 0  n= 1 ,2 .
Path w ay  a 
R ’=H, Me 
R2=M e, Et 
n=1
381
Scheme 107.
Aminoallenes have also been investigated as substrates for cyclic imine synthesis using 
titanium and zirconium complexes. The choice of substrate was dictated by the authors 
requirement of a suitably challenging reaction to test the catalytic activity of the complexes 
synthesised. The study examined a range of catalysts starting from CpTiMc2 and 
CpTi(NHAr)(NAr)py, (Ar = 2,6-dimethylphenyl), catalysts that both produced acceptable 
intermolecular hydroamination products, but proved less reactive for intramolecular 
reactions. A tosyl-substituted complex 382 gave increased reactivity and 
regioselectivity reacting with amino allene 383 to form sixmembered cyclic imines 384 
only, over allylamines 385, table 4. The chemistry was extended to an aminoallene 
substrate 386 which gave rise to a 2,7-substituted cyclic imine 387 using the same tosyl 
substituted catalyst 382. In this case the product did contain some allylamine 388 but the 
yield of cyclic imine 387 was excellent, table 4.^^^
Table 4
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e .g . iso la ted  yield
entry su b strate major product cat. t/h im ine ; aliylam ine
1
^  T
3 8 3  I ^ J
F
^ 3 8 4
38 2
10 9 3  % 0  % 
H
3 8 5
2
J 3 8 6 3 8 7
3 8 2
3 9 3  % 7 % 
“
3 8 8
Steric congestion around the metal centre was investigated using mesitylene sulfonyl rather 
than tosyl ligands. The result was increased reactivity of the catalyst, giving better yields 
with the same catalyst loading and reaction time. The more sterically hindered mesityl 
ligand complex 389, (figure 30) is also capable of reacting with 1,3-disubstituted aliénés 
392 giving greater yields than that of the tosyl-ligand, and of producing 2,6-disubstituted 
cyclic imines 393, table 5.^ ^^
Figure 30.
?
l\l NMg2 
T s 38 2 N M e,
38 9
M esityl-substitu ted  cata lyst
Table 5.
entry su b strate m ajor product cat. T °G t/h yield
1
39 0
391
MSG 3 8 9  
T S C  3 8 3
75
7 5
2
2
9 6 %
7 0 %
2 N H 2 
3 9 2  p-Tol
M SG  3 8 9 10 5 2 1 0 0 %
97
Zirconium analogues of the titanium catalysts were synthesised. The mesityl-sulfonyl 
analogue showed improved reactivity compared to Zr(NMe2)4 but increased the production
of the allylamine side product in comparison to the titanium catalyst. 156
6.1.10 Decarboxylation Reactions
The decarboxylation of cyclic p-enaminoesters 394 using boric acid, followed by 
hydrolysis of the boron complex 395, yields cyclic imines 396, (Scheme 108).^^^ P- 
Enaminoesters, synthesised from lactams, first undergo a boric acid catalysed conversion 
of tautomers giving imines 397 suitable for thermal rearrangement. Transestérification 
with boric acid occurs and a thermal rearrangement takes place with the correct tautomer 
398. The boron complex 395 is then hydrolysed using aqueous hydrochloric acid and the 
resultant compound is a 5, 6, or 7 membered cyclic imine 396 depending on the structure 
of the starting P-enaminoester.^^^
COzMe 
H 3 9 4
' f V <
COgMe
39 7
H 3 B O 3
R
C2H5
C2H5
CHg-CgHg
C2H5
CK-CpHp
Yield
7 0 %  
6 5 %  
7 0  % 
3 0  % 
3 9  %
H O - B - O  
" O  3 9 8
CO2
J L N
B-
HO
OH
N R 
3 9 6
3 9 5  -
H3(f
:
Scheme 108.
The methodology was subsequently expanded by the authors to form a route to geminal -  
di substituted cyclic P-enaminoester compounds.
6.1.11 Rearrangement Reactions
Rearrangements comprise a significant portion of the routes available to cyclic imines. 
The rearrangement of A^-acyllactams provides a realatively short route to 6 membered 
cyclic imines, (Scheme 109).^^  ^ In one example simple acylation of 2-piperidinone with an 
acid chloride provided the substrate 399 for the rearrangement. The AT-acyllactam was then 
heated under reflux in benzene with calcium oxide to give the cyclic imine product 400. 
The yield however, was low.^^^
98
C aO , reflux, b e n z e n e
<400
3 9 %
Scheme 109.
Beckmann rearrangement of oxime sulfonates 401 and 402 have also been used to produce 
cyclic imines. Maruoka et al used the derivatised oximes 401 and 402 with an 
organoaluminium reagent 403 to effect the Beckmann rearrangement and also provide a 
nucleophile to add to the intermediate iminocarbocation, (Scheme 110). In this manner 
six, and seven membered cyclic imines 404 and 405 were produced regioselectively 
depending on the geometry of the oxime used. This discrimination comes from the 
selective migration of the group anti to the oxime sulfonate.
H O .
a ) MsCI-NEta
----------------------------------------------L /  4 0 4
401
b) 'BugAISMe 4 0 3
6 4 %
.OH
a) MsCI-NEta
b) 'BugAISMe 4 0 3 40 5
4 0 2 6 7  %
Scheme 110
Palladium catalysed intramolecular reaction of oximes, with an alkenes has also been 
reported, (e.g. Scheme 111). This amino-Heck method of ring closure has been used to 
access bicyclic compounds and spirocyclic compounds. An example of its use is in the 
synthesis of pyrroles 407 via oximes 407, shown below.
OCO C eFs
Scheme 111.
Pd (PR 113)4 10 mol%  
Et3H
DMF 
80°C , 1 h
O C O C pF
Ph
MeaSiCI
DOM 
r.t., 3 0  min
Ph
6 0
from E ox im e 85  % 
from Z  ox im e 82  %
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Chapter 7: Diversity Orientated Synthesis of Cyciic 
Imines
7.1 Proposed Route to Seven Membered Cyclic Imine Library
In chapter 5, I discussed the unsuccessful attempts at the asymmetric synthesis of 
azepanes, which concluded, with a successful synthesis of racemic azepanes by reduction 
of imines produced from amino ketones. A phenethyl group derived from enantiopure 
phenylethylamine had been employed but its removal had proved capricious and the use of 
an enantiopure protecting group seemed strange in a racemic synthesis. Consequently 
alternative protecting groups were considered that might allow access to the key imine 
intermediates. Not only are imines useful targets in themselves but asymmetric reduction 
would allow enantioselective access to chiral azepanes.
The route towards cyclic imines required a new protecting group strategy. Previously the 
silyl carbamate group, (Figure 30), had been employed to protect amines during the 
Takeda reaction and deprotection was facile. However this protecting group was unstable 
and required formation immediately prior to use. A new protecting group that could 
withstand the Takeda conditions was needed. In addition, we wanted to keep the benefits 
of previous protecting groups: ease of removal, preferably under cleavage conditions, was 
highly desirable so as to avoid the need for post cleavage modification and ease 
purification of the products without use of chromatography. The a-phenylethylamine 
auxiliary had provided insight into the protection strategy as it showed that sterically 
hindered amines were tolerated in the titanium reagent.
SiMea
Silyl carbam ate protecting group a lp h a-p henyleth ylam in e auxiliary
Figure 30.
The protecting group chosen was the bulky trityl protecting group, (Figure 32), as it is 
easily cleaved under mildly acidic conditions like those used for cleavage of the enol ether 
from resin.
Y100
Ph
Ph
Figure 32.
A m ine p roteced  with a 
trityi protecting group
7.1.1 Seven Membered Imine Route
Two routes to a suitable thioacetal substrate were investigated with a view to forming 
seven membered cyclic imines, (Scheme 112). Formation of the alcohol 282 by ring 
opening of 2,3 dihydropyran 275 was followed by Swem oxidation to give the aldehyde 
283. This could then be treated in two ways: firstly, a direct reductive amination of the 
aldehyde with tritylamine provided the tritylated substrate 409 for the Takeda reaction; 
secondly formation of the oxime 410 using hydroxylamine hydrochloride, sodium acetate, 
water and ethanol worked well (40%), providing a naixture of E  and Z isomers visible in 
the NMR spectrum. Reduction of the oxime 410 to the amine 411 was carried out using 
lithium aluminium hydride. The alternative of using sodium borohydride with
molybdenum trioxide gave a lower yield. Tritylation of the amine 411 using
tritylchloride, which is considerably cheaper than tritylamine, was carried out under two 
conditions, with little difference between the yields (see below) to form the substrate 409, 
(see appendix la), for the Takeda reaction. The route via oximes 410 was initially 
preferred as tritylamine is expensive and the relative cost of materials via the oxime 410 in 
spite of the extra steps, was cheaper. Formation of the o x i m e w a s  facile and the reaction 
produced an easily managed crystalline compound. This was advantageous as the Swem 
oxidation used prior to the oxime formation produced a number of impurities and the 
aldehyde was not suitable for purification. Crystallisation of the oxime removed these 
without the need for column chromatography.
SH  SH  
BFa.OEtg, DOM
1 . ( P h 3)CNH 2 2 . NaBHgCN
M olecular s ie v e s  
M eOH, reflux
Py.SO g. EtjN  
DM s o ,  DOM
M ethod  A:
CiC (Ph)3 , pyridinePh Ph LiAiH., THF, 0°C
NHzOH.HCi
N aO A c
HgO
Eton
4 0 9
M eth od  B;
C iC (Ph)3 , DMAP 
EtgN, DOM
18% via reductive am ination (2 s te p s  form ROH) 
T rity lation  m e th o d  A: 31%  over  2 s te p s  from oxim e  
T rity lation  m e th o d  B: 32%  o v er  2 s te p s  from oxim e
Scheme 112.
or M0 O 3 , NaBH^I 4 1 0  40%  o v er  2  s te p s  
THF
101
However, although large scale production of the oxime 410 was simple, large scale 
reduction of the oxime to the primary amine 411 proved problematic. The time taken to 
quench large quantities of lithium aluminium hydride and the subsequent task of isolating 
the product amine from large amounts of aluminium salts was frustrating. At this time it 
was important to produce a large quantity of the substrate in a short time and a literature 
search revealed a method for converting trityl chloride 412 into tritylamine 413 by 
refluxing in liquid ammonia, (Scheme 113).^^  ^A large quantity of tritylamine 413 was then 
produced from the inexpensive trityl chloride 412 making the one step reductive amination
reaction more attractive. 166
I
4 1 2
NHg, liquid -6 0 ° C
6 h
NHz
9 5 %
41 3
Scheme 113.
Having obtained a reasonable quantity of substrate 409, a test Takeda reaction was carried 
out, (Scheme 114). Subjecting the substrate to low valent titanium complex 40 produced 
the titanium alkylidene 414 that then reacted with a resin-bound ester 30d to form an enol 
ether 415d. Cleavage of the enol ether using 10% TFA in DCM solution gave the TFA salt 
of the primary amine 416d. Treatment of the salt under concentrated basic conditions (4 M 
NaOH), provided the free base and dehydrated in one step, cyclising the primary amine 
416d to a cyclic imine 339d (for sample ^HNMR see appendix 2a) completely in good 
yield. Following prolonged exposure to air the imine ring opened again to form the amine 
416d, so it was important to treat all subsequent imines under anhydrous and inert gas 
conditions.
N Ph
40
Cp2Ti[P(OEt)3]2
CpaTi '
4 0 9 THF, 15  min
Ph
4 1 4
3 0 d Ph
10% TFA /D C M  
4M NaO H
After tim e....
air and  w ater
4 1 6 d
Scheme 114.
This first test reaction allowed access to synthetically valuable cyclic imines, and showed 
the use of the trityl group under Takeda conditions was possible. This was a relief as
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investigation into the trityl group showed that one method of deprotection used for it, 
developed for chemoselectivity reasons, was the use of low valent titanium reagents/^^
7.1.2 Investigation Into Substrate Synthesis
Diphenyldithioacetals are more easily reduced than dithianes so the thioacetal functionality 
was switched from dithiane to dithiophenyl functionality to aid alkylidene formation, 
(Scheme 115). Ring opening of the 2,3-dihydropyran 275 to form the alcohol 276, was 
followed by Swem oxidation to the aldehyde 277 that was used without purification in a 
reductive amination r e a c t i o n t o  produce the tritylated substrate 417, (see appendix lb).
H SPh
O
275
BFa.OEta. DCM Ph S
78%
Py.SO a, EtgN 
2 7 ^ ^  DM S O , DCM P h S '
5Ph
2 7 7
1. PhgCNHj 
M olecular s ie v e s
MeOH, reflux
2 . NaBHqCN  
h _ .
P h S K
34  % over  2  s te p s  
41 7
Scheme 115.
7.1.3 Seven-Membered Imine Library Synthesis
The production of a large quantity of substrate facilitated the production of a small library 
of diverse cyclic imines, (Scheme 116). The titanium alkylidene 414 was formed by 
reduction of the thioacetal 417 with the low valent titanium complex 40 and used to 
alkylidenate resin-bound esters 30 to form enol ethers 415. The enol ether moiety was 
cleaved selectively using a trifluoroacetic acid, triethylsilane, DCM mixture to give the 
free alkylammonium salts 418.
The trityl derived side products were removed by washing with non-polar solvents. The 
addition of triethylsilane to the cleavage m i x t u r e w a s  necessary as without it the cleaved 
trityl cation picked up water and produced trityl alcohol 419. This side product was 
considerably more difficult to remove by washing from the TFA salt 418 than 
triphenylmethane 420, produced when the triethylsilane additive was used, that could be 
washed away in hexane. Conversion to the HCl salts prior to cyclisation was achieved by 
washing the trifluoroacetic acid with saturated ethereal HCl and was carried out to increase 
the purity and because the HCl salt was a solid and easier to handle than the TFA salt.
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which was an oil. The HCl salt also provided a characterisation possibility, should the 
imine fail to form. Following removal of the trityl side products the mixture was treated to 
a 4 M NaOH wash, producing mainly ring closed imines 339. In some cases it was 
necessary to gently warm the imine under a flow of argon if there was a small proportion 
of ring opened primary amine present. This produced only ring closed product.
5Ph
P h S
^Ph
N Ph  
417 H
40
Cp2Ti[P(O Et)3 l2
Cp2Ti N Ph
4  % TFA  
1 % EUSiH
+ Trityl by-products 0  ^
DCM
1) H C l.ether w a sh
2 ) 4  M NaOH (aq)
3) h eat, if n eed ed , 
u nder argon
N '
339
Trityl by-products
OH H
P h ^ P h P h ^ P h
Ph Ph
419 420
Scheme 116.
The library below was produced using the above method, table 6.
Table 6.
30
X 415 H
T?Ph
^P h
Ester Used
30f 30k30d
PhImine
Produced 4 8 %2 4 % ,27 %339f 339k
339j
Yields for the propyl substituted imine 339j were taken at the HCl salt phase 418j to avoid 
an artificially low yield due to the volatility of the imine product.
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The following compounds were prepared partially closed, complete formation of the imine 
was not possible. The ratio was determined by ^HNMR spectroscopy. Determination of 
the ratios for the diethylamino substituted imine were not possible as the ^HNMR spectrum 
was not clean. The ^^CNMR spectrum did show signals for both the imine 3391 (167.85 
ppm) and the ketone 416j (195.14 ppm), table 6.
Table 6.
E s te r  U s e d A m in o  k e t o n e  R a t io  im in e
0
3 0 g  0
4 1 6 8  N H . ° - ^  3 3 9 o
1
/  4 1 6i NHa /  3 3 9 i
One reason for the complicated signals in the NMR and the impurity of the compounds 
3391 and 4161 is that treatment of this compound under basic conditions, e.g. the sodium 
hydroxide wash needed for cyclisation, causes elimination to occur, (Scheme 117).
NaO H  4M . aq
Scheme 117.
Evidence supporting this process comes from the treatment of (S)-l-diethylamino-S-(l- 
phenylethylamino)octan-3-one 2981 to hydrogenation conditions in an attempt to synthesis 
the racemic azepane 3391. It was hopped that hydrogenation conditions detailed earlier, in 
the presence of hydrochloric acid^^ would remove the auxiliary and form the azepane. 
However the first hydrogenation reaction was unsuccessful and to neutralise the HCl salt 
formed, sodium hydroxide solution was used. The resultant mixture was subjected to a 
second set of hydrogenation conditions before ketone 2981(b) was isolated assuming from 
hydrogenation of the intermediate alkene, (Scheme 118).
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1. HCl 6 M, Pd/(O H )2/G 20%  
atm  psi, Hg 
C onditions a
1. C onditions a
2 . NaOH w ash
3 . Ha, P d (0H )2 ,/C  20%  
45  psi
3391
2981(b)
Scheme 118.
This process, combined with the failure to fully close and form the ring, can then lead to a 
wide range of products present in the final mixture, (Figure 33).
4 2 2
N-
423
Figure 33.
7.2 Six~Membered Cyclic Imines
In order to fully demonstrate the versatility of the methodology, we had investigated 
preparation of six-membered cyclic imines in parallel. Examples have been shown of the 
pharmaceutical value of seven-membered cyclic i m i n e s , h o w e v e r  their six-membered 
counterparts are of equal value as potential therapeutic l e a d s . O n e  of the more notorious 
compounds is coniceine 391, synthesised by our methodology (detailed later) along with 
coniine 424, figure 34, they are the active ingredients in the hemlock drink used to execute 
the Greek philosopher Socrates.
391
N ' 
424H
Figure 34.
Other examples include the ecotoxic compound 425, figure 35, an antifungal compound 
that has activity against barley and wheat mildews.
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425
Figure 35.
7.2.1 Synthetic Route
The synthetic route was analogous to that for the seven membered series, (Scheme 119). 
As before, initially the dithiane substrate was synthesised. Dihydrofuran 196 was treated 
with propanedithiol to give the alcohol 197. Oxidation of this product under Swem 
oxidation conditions gave the aldehyde 198 which was converted into the oxime 426 using 
hydroxylamine hydrochloride and sodium acetate. Reduction of the oxime 426 with 
lithium aluminium hydride gave the primary amine 427 which was then tritylated using 
trityl chloride and DMAP conditions to give substrate 428.
0
1 9 6
SH  SH
B F 3 . O B 2 , DCM
Ph
4 2 8
2 6  % from 4 2 6
Ph
197 5 0 %
CIC(Ph)3 , DMAP 
Et3 N, DCM
OH
Py.SO g, EtgN 
D M SG , DCM
NH,
THF, LiAIH,0°C
5 0 %
4 2 7
19 8
NHgOH.HCI 
NaOAc 
Eton, HgO
OH
40%  o v er  2  s te p s  
mix of E and  Z  
4 2 6
Scheme 119.
The dithiophenyl substrate was then made for the library production, (Scheme 120). Ring 
opening of dihydrofuran 196 gave thioacetal 182. Swem oxidation of the resulting alcohol 
182 gave the aldehyde 183, and reductive amination with triylamine then yielded the trityl- 
protected substrate 429, (see appendix Ic). In this manner, large quantities of substrate for 
the Takeda reaction were produced in three simple steps. The oximes 430 were also made 
but their conversion to trityl derivatives 429 not investigated.
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P h
83%  18 2
BFg.OEtg, DCM PhS"O
1 9 6
Ph SD M SO , DCM
1 8 3
1. PhaCNHa 2. NaBHgON  
M olecular s ie v e s  
M eOH, reflux ^ —
S P h S P h
H
Ph
Ph
Ph S P h S OH
Ph4 2 9 36%  o v er  2 s te p s
31% 4 3 0
Scheme 120.
7.2.2 Library Production of Six-Membered Series
The substrate 429 was then treated with low valent titanium complex 40 to form the 
alkylidene, which was reacted with resin-bound esters 30 to form enol ethers 431, (Scheme 
121). The enol ethers were then selectively cleaved from resin using a TFA and triethyl 
silane mixture to ensure the by-product of deprotection was triphenylmethane. After 
washing away side products, sodium hydroxide solution neutralised and cyclised the TFA 
salt products to form cyclic imines 336.
S P h
P h S
4 0
1 ) C p 2 T I [ P ( O E t ) 3 ] 2
2) O
Q T o^ r
^  30
431
Ph
Ph
1 ) 4 %  TFA, 1 % EtgSiH 
in DCM 
2 ) H ex a n e  w ash  
3) 4  M NaOH w ash
Scheme 121.
R N 
3 3 6
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Using this procedure the following library of six-membered cyclic imines were produced, 
(for sample ^HNMR of 336g see appendix 2b) table 7.
Table 7.
Ester UsedEster Used Imine ProducedImine Produced
Ph
30d 89% 336d67%
336g
Ph30g
12%
336f
30m 336n46%30t
73%
336k30k 301
Imine 336e was also produced under these conditions but the purity was not as good as 
those in table 7.
from
Figure 36.
quant. 336e 30e
Coniceine was also prepared and its yield was based on isolation of the ketone 434 as the 
imine is volatile. An interesting observation was the deuterium incorporation into the HCl 
salt 434 that gives coniceine upon cyclisation, (Scheme 122). Exposure for a prolonged 
time, one month, to deuterated methanol caused exchange in the CH2 groups a  to the 
carbonyl position of the ketone 434. This conversion was complete when the salt was left 
in deuterated methanol for 2 more months to provide the fully deuterated compound 435, 
with notable absence of the triplet for the a  protons (CH2C=OCH2) in the NMR 
spectrum and near complete loss of the CH2 signal in the ^^ C NMR. Attempts to convert 
the deuterated compound back to the unlabelled form using MeOH and aqueous HCl 
stirring for two weeks, failed. This method of incorporation is perhaps unsurprising as a 
favourite method of labelling metabolites synthesis is stirring the compound to be labelled 
with deuterated trifluoroacetic acid.
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-------- -H3N"
c P  7 0  % 4 3 4  3  m on ths q P  D D d  D
2) 4  % TFA 1 % Et3 SiH DCM ^ 3 5
3) H exan e w ash  then  ether.HCI w a sh
Scheme 122.
N
336j/391
Anabaseine 436 is a six membered cyclic imine that has been isolated from a pheromone 
cocktail of ants belonging to the aphaenogaster g e n u s . I t  is an ant recruitment 
pheromone used to lead ants from the same colony to a food source. Biological testing of 
the compound has shown it increases levels of the neurotransmitter dopamine in the brain. 
It is an agonist with selective binding for the nicotinic r e c e p t o r s . W i t h  this efficacy it is 
a potential lead for treatment of Alzheimer’s d i s e a s e a n d  so a good synthetic target for 
testing the methodology.
43 6
Figure 37.
The synthesis of this compound was attempted using resin-bound nicotinic acid 30m, 
prepared by coupling 3-nicotinic acid 437 with hydroxymethylpolystyrene resin, (Scheme 
123).
Scheme 123.
OH  
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THF  
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QIC; 1 ,3-diisopropylcarbodiim ide  
DMAP: 4-d im ethylam ino pyridine
O
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Unfortunately when this resin was treated under the above conditions, it failed to give the 
desired anabaseine product. The lone pair of the pyridine nitrogen atom may coordinate 
with the titanium alkylidene 438 preventing reaction with the carbonyl group of the resin- 
bound ester, figure 38.
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Figure 38.
7.2.3 Reduction of the Imine Bond
Time constraints only allowed a brief investigation of the reduction of the imines 336 
produced using the route detailed above, to give piperidines 439 and 440, (Scheme 124). 
Lithium aluminium hydride gave poor un-optimised yields, but a wide range of 
manipulations including asymmetric reduction would have been possible.
LiAlH.
R ’ N Ri N '
H
R = C H jC H jPh 3 3 6 d
R = CHzCHjCHa 336j R = CHgCHgPh 2 0  % 4 3 9
R = CH 2 CH2 CH3 9  % (HCl sa lt) 4 4 0
Scheme 124.
7.3 Utility of Cyciic imines: Future Work and Applications
The imines produced using this methodology could have been functionalised in a variety of 
ways. The simplest is asymmetric hydrogenation of the imine bond 339 to produce 2- 
substituted heterocycles 441 selectively, (Scheme 125). This can be carried out with many 
catalysts, one example is Buchwald’s titanium catalyst the precursor 442 being converted 
into an active titanium hydride species before coordination of the imine bond of 339 to the 
metal centre occurs.
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1-5%  m ol 
■j^ X = 1,1 '-b lnaphth-2,2'-diolate
C O
1. n-BuLI
2. PhSiHa
4 4 3  v j i
R N 3 3 9 N'
H 441
71-85%  yield  
95 -9 9 %  e e
Scheme 125.
Examples of hydrogenation of five, six and seven-membered imines to their corresponding 
nitrogen heterocycles using Buchwald’s catalyst have been demonstrated. In all cases 
however, a high pressure of hydrogen is required, (Scheme 126), table 8.
4 4 3
5 mol%
cat.
Scheme 126.
Table 8.
Time Psi t t Yield ee
24 h 500 45 71 98
30 h 80 65 74 97
Other manipulations can also be carried out using the imine bond. Grignard or alkyl 
lithium additions can form a new chiral centre and provide greater diversity as shown by
Basile et al}^^ (Scheme 127).
Y
R ' N COgR^
Scheme 127.
X  Y
R ' N COzR" 
H
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Grignard reagents and organolithiums would also add to iminium ions and use of a chiral 
auxiliary attached to the nitrogen atom might provide selectivity but is only useful if the 
auxiliary chosen can be removed eas i l y . ( S cheme  128).
 R^MgX or R^Li R^
Aux
Scheme 128.
 Aux
Aza-Diels Alder reactions could provide a route to bicyclic systems. There are examples 
of aza-Diels Alder reactions using Danishefsky’s diene 444 and tosylated 
benzylideneimides e.g. 445. Cz chiral BINAP-derived copper catalyst can be used to 
obtain a small degree of control over the chiral centre formed in the r eac t ion , ( Scheme  
129).
O M e
Scheme 129.
Ph t M S O ^  C uC IO ,.4M eC N
4 4 4  10 mol % cat. g g  %
e e :  4 6  %
Ar = p-tolyl
Applied to our substrates, the following compounds could be accessed, (Scheme 130), 
though conditions would need to be harsher as there is no electron withdrawing group 
activating the imine.
O M e
• 1 . ----------------   c a .
Scheme 130.
In summary, a general route for the high throughput synthesis of diverse imines has been 
successfully demonstrated. These intermediates should be of great utility in the synthesis 
of alkaloids and may have interesting biological properties themselves.
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Chapter 8: Experimental
All reactions were carried out under an atmosphere of nitrogen or argon, using oven-dried 
glassware. All solutions were added via syringe unless otherwise stated. THF was freshly 
distilled from sodium and benzophenone. Dichloromethane, triethyl phosphite and 
pyridine were distilled from CaH2 prior to use. DMF was distilled from calcium hydride 
and stored over 4Â molecular sieves. Reagents were obtained from commercial suppliers 
and used without further purification unless otherwise stated. Purification by column 
chromatography was carried out using Fisher Matrix TM silica gel, mesh size 35-70pm, 
the stationary phase. Melting points are uncorrected. IR spectra were recorded using a 
JASCO FT-IR 410 or a Nicolet Impact 410 FTIR spectometer and Golden gate apparatus 
where indicated and NMR spectra were recorded using a Bruker DPX-400 spectrometer. 
Chemical shifts are given in ppm relative to tetramethylsilane using residual C H C I 3  as an 
internal standard (7.26ppm). J values are given in Hz. The multiplicities of C nuclei were 
determined using the DEPT pulse sequence. Mass spectra were recorded on a JEOL 
JMS700 spectrometer. Combustion analysis was carried out using a Carlo-Erba 1106 
elemental analyser.
Solid-phase Takeda reaction -  General Method A
Titanocene dichloride (1.00 g, 4.02 mmol, 12 eq), magnesium turnings (108 mg, 4.42 
nunol, 13.2 eq) and 4Â molecular sieves (200 mg) were heated briefly under vacuum. 
Following cooling, the reaction flask was flushed with argon, and THF (4 mL) and 
triethylphosphite (1.38 mL, 8,04 mmol) were added and the reaction mixture was stirred, 
with cooling using a water bath for 30 min. After stirring for a further 2-2.5 h, a THF (10 
mL) solution of the thioacetal (286 mg, 1.01 mmol) was added, and the solution was stirred 
for 15 min. The reaction mixture was added via syringe into a flask containing 1 kan of 
resin-bound ester (0.280-0.335 meq equal to 1 equivalent). The mixture was stirred under 
argon for 15-18 h. After this time, the kan was removed and then washed with THF (x 5), 
alternately with MeOH and DCM (x 5), then MeOH and finally with diethyl ether. The 
resin was then dried under vacuum.
Solid Phase Takeda reaction -  General Method B
Titanocene dichloride (981 mg, 3.936 mmol), magnesium turnings (105 mg, 4.33 mmol) 
and 4Â molecular sieves (200 mg) were heated briefly under vacuum. Following cooling.
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the reaction flask was flushed with argon, and THF (4 mL) and triethyl phosphite (1.35 
mL, 7.87 mmol) were added and the reaction mixture was stirred for 3 h. At this time a 
THF (10 mL) solution of the thioacetal or dithiophenyl compound (0.984 mmol) was 
added, and the solution stirred for 15 min. The reaction mixture was added via syringe into 
a flask containing one of resin-bound ester (0.328 meq). The mixture was stirred under 
argon for 15-18 h. After this time, the kan was removed and then washed with THF (x 5), 
alternately with MeOH and DCM (x 5), then MeOH and finally with diethyl ether. The 
resin was then dried under vacuum.
Solid Phase Takeda reaction -  General Method C
Titanocene dichloride (981 mg, 3.94 mmol) was added to a flask cooled under high 
vacuum containing magnesium turnings (105 mg, 4.33 mmol) and 4Â molecular sieves 
(200 mg) that had been placed in the oven overnight. The mixture was then heated briefly 
under vacuum. Following cooling, the reaction flask was flushed with argon 3 times, and 
THF (4 mL) and triethylphosphite (1.35 mL, 7.87 mmol) were added and the reaction 
mixture was stirred for 3h. At this time a THF (6 mL) solution of the thioacetal (0.984 
mmol) was added, and the solution stirred for 15 min. The kan containing resin-bound 
ester (0.328 meq) flushed with argon was quickly added to the reaction mixture under a 
flow of argon. The mixture was stirred under argon for 15-18 h. After this time, the kan 
was removed and then washed with THF (x 5), alternately with MeOH and DCM (x 5), 
then MeOH and finally with diethyl ether. The resin was then dried under vacuum.
Cleavage from resin -  General Method A
A solution of TFA in DCM (1%, 5 mL) was added to a tube containing 1 kan of Menifield 
resin-bound ester, which had been subjected to the Takeda reaction conditions. This was 
then shaken for 1-2 h before the contents were removed and the kan washed with DCM (x 
4). The combined organics were then neutralised with potassium carbonate and 
concentrated under reduced pressure.
Cleavage from resin -  General Method B
A solution of TFA in DCM (10%, 5 mL) was added to a tube containing 1 kan of 
Merrifield resin-bound ester, which had been subjected to the Takeda reaction conditions. 
This was then shaken for 1-2 h before the contents were removed and the kan washed with
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DCM (x 4). The combined organics were then washed with NaOH (IM), water (x 1) and 
brine (x 1), dried over sodium sulfate, filtered and concentrated under reduced pressure.
Cleavage from resin -  General Method C
A solution of TFA in DCM (4%, 5 mL) was added to a tube containing 1 kan of Merrifield 
resin-bound ester, which had been subjected to the Takeda reaction conditions. This was 
then shaken for 1-2 h before the contents were removed and the kan washed with DCM (x 
4). The combined organics were then washed with NaOH (IM), water (x 1) and brine (x 
1), dried over sodium sulfate, filtered and concentrated under reduced pressure.
Cleavage from resin -  General Method D
A solution of TFA (4%) and EtsSiH (1%) in DCM (5 mL), was added to a tube containing 
1 kan of Merrifield resin-bound ester, which had been subjected to the Takeda reaction 
conditions. This was then shaken for 1-2 h before the contents were removed and the kan 
washed with DCM (x 4). The combined organics were then concentrated under reduced 
pressure, washed with cold hexane then treated to a NaOH (4 M) wash and extracted with 
DCM. The combined organics were then dried over sodium sulfate, filtered and 
concentrated under reduced pressure.
kan loading 
General Method A : Resin bound ester
IRORI mackrokans® (kans) containing a known quantity of chloromethylpolystyrene 
polymer (Merrifield resin), were treated with a solution of 3 eq caesium carbonate, 2 eq of 
corresponding carboxylic acid and 0.5 eq potassium iodide in dry DMF (0.08 Mol L'^), 
based on the loading of the resin chosen. The reaction mixture was heated to 80 °C under 
argon overnight.
Work-up: the kans were washed with 3 x DMF: water (9:1), 2 x THF, 2 x MeOH and 
DCM alternately, 1 x MeOH and 1 x Ether. The kans containing resin-bound ester are then 
dried under high vacuum.
General Method B : Carboxylate salt immobilisation
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kans containing 1 equivalent of chloromethylpolystyrene polymer, based on polymer 
loading, were treated in dry DMF with 2 equivalents carboxylate salt (sodium acetate) and 
11% 15-crown-5 at 80 °C overnight under argon. The kans were then treated to the same 
work up as general method A.
Resin-bound ^^0-labeiied acetic acid 30a
Following resin loading, general method A, using ^^O-labelled acetic acid (110 mg, 1.56 
mmol) and stratosphere® resin plugs of chloromethylpolystyrene with resin loading 0.15 
mmol/plug, 4 kans of resin-bound^^O-labelled acetic acid 30a were prepared.
Resin-bound acetic acid 30b
o A
3 0 b
Method A
Following resin loading, general method A, using acetic acid (0.075 mL, 1.31 mmol) and 
Merrifield resin (chloromethylpolystyrene), 0.328 meq/kan, 1 kan of resin-bound acetic 
acid 30b was prepared.
Method B
Following resin loading general method B, using sodium acetate (59 mg, 0.719 mmol) and 
chloromethylpolystyrene resin (170 mg/kan, 0.328 meq/kan), 2 kans of resin-bound acetate 
30b were prepared.
Vmax (swollen with DCM on NaCl plate)/cm’ :^ 3027 (CH), 2985 (CHz, CH3),
1731 (C=0).
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Resin-bound radiolabelled sodium acetate 30c
o
*=
3 0 c
Sodium acetate (53.93 mg, 145.63 MBq, 0.656 mmol) was placed in a round bottom 
flask from the vial used for accurate measurement, with 2 kans containing Merrifield resin 
(170 mg/kan, 0.328meq/ kan), DMF was used to wash out radioactive starting material (5 
mL), and an air condenser, connected two 2 sodium hydroxide traps attached. To this 
DMF (15 mL) and solution of 15-crown-5 (1 mL, 0.722 Mol/L'^) in dry DMF was added. 
This was heated to 80°C over 3 nights. The kans were then worked-up as for resin loading 
general method A giving 30c and all washings and the reaction mixture kept separate for 
scintillation counting. From the counts of these and the sodium hydroxide traps it was 
taken that the resin was 89.7% loaded with radiolabelled sodium acetate. The kans were 
then treated to sodium acetate (27 mg, 0.329 mmol) and 15-crown-5 (0.5 mL, 0.722 Mol/L' 
)^ in dry DMF, under exactly the same conditions. Following the counting of all washings, 
the reaction mixture and the NaOH traps, 0.36 MBq of activity was obtained showing no 
transestérification taking place
Resin-bound 3-phenyl propionic acid 30d
3 0 d
Following resin loading general method A, 3-phenylpropionic acid (990 mg, 6.56 mmol) 
was loaded onto 10 kans containing chloromethylpolystyrene resin (170 mg each) giving a 
loading of 0.328 meq / kan. 10 kans containing Stratosphere ® plugs (0.15 mmol/kan) 
were also loaded separately using general method A with 3-phenyl propionic acid (316 mg, 
3.00 mmol). The resin-bound ester 30d was also prepared under the same conditions using 
loose chloromethylpolystyrene resin of loading 1.93 meq/g (170 mg, 0.328 meq/kan).
Vmax (swollen with DCM on NaCl plate)/cm'^ 3053 (CH), 2986 ( C H i ,  C H 3 ) ,
1731 (C=0).
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Resin-bound dimethyl acrylic acid 30e
o
3 0 e
Dimethyl acrylic acid (0.47 g, 3.10 mmol), caesium carbonate (5.04 g, 15.5 mmol) and 
potassium iodide (0.26 g, 1.55 mmol) were placed in a dry flask with 10 kans containing 
chloromethylpolystyrene resin (0.170 g, 0.311 meq/kan) in DMF (100 mL). The reaction 
mixture was then stirred at 80 °C under argon overnight. The reaction mix was decanted 
and the kans washed as follows, DMFrwater 9:1 (x 3), THF (x 5), MeOH and DCM 
alternately (x 3), MeOH and finally diethyl ether. The kans 30e were then dried on the 
high vacuum.
Vmax (swollen with DCM on NaCl plate)/cm'^ 2989 (CHg), 1650 (C=0).
Resin-bound 4-fluorobenzoic acid 30f
3 0 f
Following resin loading general method A, 4-fluorobenzoic acid (919 mg, 3.28 mmol) was 
loaded onto 10 kans (170 mg/kan, 0.328 meq/kan), giving 30f, using 
chloromethylpolystyrene resin (0.170 g / kan).
Vmax (swollen with DCM on NaCl plate)/cm'^: 3050 (CH), 1711 (C=0).
Resin-bound furan-3-carboxylic acid 30g
O'
o
3 0 g
3-Furoic acid (520 mg, 4.67 mmol), caesium carbonate (5.04 g, 15.5 mmol) and potassium 
iodide (260 mg, 1.55 mmol) were placed in a dry flask with 10 kans containing 
chloromethylpolystyrene resin (170 mg/kan, 0.311 meq/kan) in DMF (100 mL). The 
reaction mixture was then stirred at 80 °C under argon overnight. The reaction mix was
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decanted and the kans washed as follows, DMF:water 9:1 (x 3), THF (x 5), MeOH and 
DCM alternately (x 3), MeOH and finally diethyl ether. The kans, 30g, were then dried 
on the high vacuum.
Vmax (swollen with DCM on NaCl plate)/cm ^ 3055 (CH), 1675 (C=0).
Resin-bound 3-(3,4-dimethoxy)(phenyl)propionic acid 30h
o
3 0 h  ^  O
Following kan loading general method A, using resin of loading 1.93 meq/g, 10 kans 
containing (170 mg/kan, 0.328 meq/kan). Chloromethylpolystyrene resin was loaded with 
3-(3,4-dimethoxy)(phenyl)propionic acid (1.38 g, 6.56 mmol) using caesium carbonate 
(3.21g, 9.84 mmol) and potassium iodide (270 mg, 1.64 mmol) in DMF, giving 30h.
Vmax (swollen with DCM on NaCl plate)/cm'^: 2988 (CH), 1719 (C=0).
Resin-bound 3-(diethylamino)-propionic acid 30i
Q r^ O - — N' 
301
Following kan loading general method A using resin of loading 1.93 meq/g, 10 kans of 
Merrifield resin (170 mg/kan, 0.328 meq/kan) were loaded with the 3-(diethylamino)- 
propionic acid hydrochloride (715 mg, 3.94 mmol). Using caesium carbonate (3.21g, 9.84 
mmol, 5 eq) in a larger excess to neutralise the starting acid, and potassium iodide (163 
mg, 0.984 mmol), in DMF, the kans 30i were successfully loaded.
Vmax (swollen with DCM on NaCl plate)/cm'^: 2990 (CH), 1744 (C=0).
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Resin-bound butyric acid 30]
o
o
30j
Following resin loading general method A using resin of loading 1.93 meq/g, butyric acid 
(0.36 mL, 3.93 mmol) was loaded onto 6  kans containing chloromethylpolystyrene resin 
(170 mg/kan, 0.328 meq/kan), giving kans 30j.
Vmax (swollen with DCM on NaCl plate)/cm'*: 3062 (CH), 1730 (C=0).
Resin-bound cyclohex-3-enecarboxylic acid 30k
O
0 ^ 0  
30k
Following resin loading general method A, 3-cyclohexene carboxylic acid (0.72 mL, 3.10 
mmol) was loaded onto chloromethylpolystyrene resin. 10 kans loading (170 mg/kan, 
0.310 meq/kan), 30k were synthesised.
Vmax (swollen with DCM on NaCl plate)/cm'^ 2988 (CH2), 1719 (C=0), 1602
(C=C).
Resin-bound (R)-(-)-2-phenylpropionic acid 30m
o
30m
Following resin loading general method A using resin of loading 1.93 meq/g, 
phenylpropionic acid (493 mg, 3.28 mmol) was loaded onto 10 kans loading (170 mg/kan 
resin giving 0.328 meq/ kan of 30m, using chloromethylpolystyrene resin.
Vmax (swollen with DCM on NaCl plate)/cm'^: 3053 (CH), 2 9 8 6  (C H 2 , CH3),
1735 (C=0).
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Resin-bound 3-nicotinic acid 30n
O
' O '  
3 0 n
Hydroxy-Merrifield resin with a loading of 2.0 meq / g was weighed out into 6 IRORI 
macrokans (170 mg/kan, 0.340 meq/kan). The kans were placed in a dry flask and 
nicotinic acid (3.01 g, 24.5 mmol), DMAP (76.0 mg, 0.623 mmol) and THF (40 mL) 
added. To this DIG (3.80 mL, 24.5 mmol) was added and the reaction mixture was stirred 
overnight. The resin was subjected to the work-up before being re-treated with the same 
conditions. Work-up: the kans were washed with THF (x 3), MeOH and DCM alternately 
(x 4), MeOH and diethyl ether, then placed under high vacuum to dry giving kans 30n.
Vmax (swollen with DCM on NaCl plate)/cm'\ 1713 (C=0), 1601 (pyridine).
6,7-Methylenedioxy-2-(2'-methylpropenyl)quinoline 55ce'
< - j  .
N
5 5 c e '
2-[2'-(A^-f^rr-Butoxycarboxyamino)-4',5'-methylenedioxybenzyl]-l ,3-dithiane 127c (340 
mg, 0.93 mmol) was dissolved in THF (7 mL) and TMSCl (0.14 mL, 1.12 mmol) was 
added. To this LDA (0.56 mL, 1.12 mmol, 2M) was added drop-wise at -78 °C. The 
mixture was allowed to warm slowly over 1 h to room temperature and then stirred for a 
further 45 min. The THF was then removed and diethyl ether (7 mL) was added. The 
reaction mix was then filtered and concentrated under reduced pressure, and used without 
further purification to form the corresponding titanium alkylidene under standard Takeda 
reaction conditions B. When reacted with the corresponding resin-bound ester 30e the enol 
ether was produced. Subsequent cleavage using 10% TFA/DCM (5 mL) solution gave the 
TFA salt (73.8 mg, 68%). The salt was then subjected to manganese dioxide (90 mg) with 
DCM (10 mL) as the solvent. After 2 h heating under reflux in air, solid sodium carbonate 
was added and the solution filtered though wet-packed celite, washing with ethyl acetate. 
The solvent was removed under reduced pressure to give the quinoline 55ce'^^^ (73.8 mg, 
62%). The quinoline was insoluble in a number of solvents however deuterated benzene 
was successful as an NMR solvent.
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Vmax (GG)/cm'^: 1650 (CH=CH), 1573+1502 (benzene/pyridine C=C)
ÔH (400 MHz: CgDe): 1.92 (3H, d, J  1.2, CCH3), 2.45 (3H, d, J  1 .1 ,CCH3), 5.30 (2H, s, 
OCH2O), 6.58 (IH, d, J  1.4, H-1’), 6.82 (IH, s, H -8 ), 7.02 (IH, d, J  8.4, H-3), 7.50 (IH, d, 
7 8.4, H-4), 7.70 (IH, s, H-5).
ÔH (400 MHz: C D C I 3 ) :  1.98 (3H, s, C C H 3 ) ,  2.12 (3H, s, C C H 3 ) ,  6.08 (2H, s,
OCH2O), 7.01 (IH, s, H-8 ), 7.18 (IH, d, J  8.4, H-3)*, 7.34 (IH, s, H-5),7.87 (IH, d, J  8.4, 
H-4)*, 7.87 (IH, s, H-4)*.
*= signals affected by D-H exchange.
ÔC (100 MHz: CôDô): 19.0 ( C H 3 ) ,  26.4 ( C H 3 ) ,  99.9 ( C H 2 ) ,  101.4 (CH), 105.1 (CH), 119.8 
(CH), 121.8 (C), 124.3 (CH), 133.0 (CH), 139.9 (C), 145.5 (C), 146.0 (C), 149.5 (C), 154.5 
(C).
m/z, (Cl): 228 [(M+H)^, 100%], 85 (27%). HRMS: 228.1024. C 14H 16NO2 requires
(M+H) 228.1025.
2-(3'-furyl)benzofuran 60
2-(2'-Trimethylsiloxyphenyl)-l,3-dithiane (265 mg, 0.93 mmol), prepared by a literature 
procedure^ ^ was reacted under general Takeda reaction conditions B using resin-bound 3- 
furanoate 30g. The resin-bound enol ether was cleaved using 1% TFA/DCM (5 ml) and 
the benzofuran neutralised onto solid potassium carbonate, filtered and concentrated in 
under reduced pressure to give benzofuran 60 (15.2 mg, 26%).
Vmaj (NaCiycm ' : 3118 (CH), 2960 (CH).
8 h (400 MHz: CDCl,): 6.58 (IH, dd, J  2.0, 0.8, H-4'/H-5'), 7.07-7.17 (IH, m, H-
4 ’/H-5'), 7.21 (IH, td, J  7.2, 1.3, H-5/H-6), 7.26 (IH, td, J  7.2, 1.6, H-5/H-6), 7.47 (IH , m, 
H-4), 7.49 (IH, d, 72.0, H-2'), 7.54 (IH, ddd, 70.8, 1.6, 7.4, H-7), 7.91 (IH, s, H-3).
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5c (100 MHz: CHCI3): 101.4 (CH), 108.0 (CH), 110.9 (CH), 117.6 (C), 120.5 (CH)
122.9 (CH), 124.0 (CH), 138.1 (C), 139.8 (CH), 143.8 (CH), 150.1 (C), 154.5 (C).
m/z, (El): 184 (M'+, 100%), 155 (30%). HRMS: 184.0522. CnHjO requires
184.0524.
2-[2'-(teit-Butyldimethylsilyloxy)phenyl]-1,3-dithiane 68
VO
Y
68 ~5i—
Following a literature procedure^^ 2-(2'-hydroxyphenyl)-l,3-dithiane was prepared. 
TBDMSCl (2.55 g 16.9 mmol) was added to a solution of 2-(2'-hydroxyphenyl)-l,3- 
dithiane (2.99 g 14.23 mmol) and imidazole (2.12 g, 31.1 mmol) in anhydrous DMF (30 
mL). This was left stirring overnight. The DMF was then removed on the rotary 
evaporator and DCM (30 mL) and water (30 mL) added. The aqueous layer was extracted 
with DCM and the combined organic extracts washed with water (x 2) and brine (x 1) and 
then dried over sodium sulfate, filtered and concentrated under reduced pressure. A 
portion of the resultant mixture (1.85 g) was purified using silica gel chromatography 
eluting with ethyl acetate and hexane (1:8). This gave 2-[T-{tert- 
butyldimethylsilyloxy)phenyl-l,3-dithiane^^ 68 (1.75 g, 83%) as an oil. Rf ( A I 2 O 3 ,  1:8 
EtOAc:hexane): 0.68
5h (400 MHz: C D C I 3 ) :  0.26 [6H, s, S i ( C H 3 ) 2 ] ,  1.06 [9H, s, S i C ( C H 3 ) 3 ] ,  1.87-1.99
(IH, m, C H S C H z C H a x ) ,  2.13-2.19 (IH, m, C H S C H 2 C H e q ) ,  2.87-2.03 [2H, m, C H S C H 2 ] ,  
3.00-3.07 [2H, m, C H S C H 2 ] ,  5.60 (IH, s, C H S 2 ) ,  6.79 (IH, dd, J  8.2 Hz, 1.1 Hz, H-3'), 
6.96 (IH, td, J  7.7 Hz, 1.1 Hz, H-5'), 7.15 (IH, m, H-4'), 7.54 (IH, dd, J  7.7 Hz, 1.8 Hz, 
H-6').
ÔC (100 MHz: C D C I 3 ) :  -4.30 ( C H 3 ) ,  18.30 (C), 25.32 ( C H 2 ) ,  25.80 ( C H 3 ) ,  32.54
( C H 2 ) ,  44.78 ( C H ) ,  118.83 ( C H ) ,  121.69 ( C H ) ,  129.05 ( C H ) ,  129.13 (CH), 129.76 (C), 
151.78 (C).
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1 -[2’-(fe/t-Butyldimethylsilyloxy)phenyl]propan-2-one®^ 65
1 -[2'-(feit-Butyldimethylsilyloxy)phenyl]propan-2-ol 72
65 —Sr
0 °
72 — S i -
Following solid phase Takeda reaction general method A, using 2-[T-{tert- 
butyldimethylsilyloxy)phenyl]-l,3-dithiane (643 mg, 1.97 mmol) 6 8  and 2 kans (loading 
0.15 meq/kan), containing resin-bound acetic acid and ^^O-labelled resin-bound acetic acid 
30a individually, were reacted to form resin-bound enol ether. The unlabelled enol ether 
was stirred in dry DCM (10 mL) for 1.5 h in dry glassware. At this point TFA (0.1 mL) 
was added and the reaction mixture left for 1.5 h under argon, at which time 5 mL of the 
cleavage solution was removed and treated with triethylsilane (13 pL, 1.1 eq) in an attempt 
to reduce the ketone. After water addition and the organic layer washed with water (x 2), 
brine (x 1), dried over sodium sulfate and concentrated under reduced pressure to give 1- 
[2'-(fgrr-butyldimethylsilyloxy)phenyl]propan-2-one^^ 65 (18 mg 42%) as yellow oil. The 
remaining cleavage mixture transferred to another dry flask and the TFA/DCM removed 
under high vacuum. Dry MeOH (5 mL) was then added followed by sodium borohydride 
(6  mg, 0.16 mmol) and the reaction left stirring for 2 h. This was then quenched with 
water and DCM was added. The water was extracted with DCM and the organics washed 
with water (x 2 ), brine (x 1), dried over sodium sulfate, filtered and concentrated under 
reduced pressure. This gave l-[2'-(tert-butyl-dimethylsilyloxy)-phenyl]propan-2-ol 72 
(20.4 mg, 47% over 2 steps) as an oil.
l-[2'-(^^rt-ButyIdimethylsilyloxy)phenyI]propan-2-one 65
Vmax (NaCiycm ': 2929 (CHj, CH;), 1713 (C=0),1253 (Si-CHj).
8 h (400 MHz: CDCI3): 0.24 [6 H, s, Si(CH3h], 0.99 [9H, s, SiC(CH3)3], 2.11 [3H, s,
C(0 )CH3], 3.66 [2H, s, CH2C(0 )], 6.84 (IH, dd, J  7.8 Hz, 1.1 Hz, H-3'), 6.92 (IH, td, J
7.6 Hz, 1.1 Hz, H-5'), 7.12 (IH, dd, 77.6  Hz, 1.6 Hz, H-6 '), 7.16 (IH, td, 77.8 Hz, 1.6 Hz, 
H-4').
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ÔC (100 MHz: CDCls): -4.18 (CH3), 18.22 (C), 25.75 (CH3), 29.04 (CH3), 45.87
(CH2), 118.41 (CH), 121.24 (CH), 125.67 (C), 128.30 (CH), 131.33 (CH), 153.76 (C), 
206.76 (C).
m/z, (CI): 265 [(M+H)"", 100%]. HRMS: 265.1627. Ci5H2 5 0 2Si
requires 265.1624.
l-[2'-(/e/t-ButyldimethyIsilyloxy)phenyl]propan-2-ol 72
Vmax (GG)/cm'^: 2955 (CH2, CH3), 1489 (CH), 1250 (SiCH3).
ÔH (400 MHz: CDCI3): 0.14 [3H, s, Si(CH3)2], 0.15 [3H, s, Si(CH3)2], 1.03 [9H, s,
SiC(CH3)3], 1.24 [3H, d, J  6.4 Hz, CH(0 H)CH3], 2.66 [IH, dd, J  13.3 Hz, 8.2 Hz, 
CH2C(0 H)], 2.86 [IH, dd, J  13.3 Hz, 4.3 Hz, CH2C(0 H)], 4.03-4.08, (IH, m, CHOH), 
6.83 (IH, d, J  8.0 Hz, H-3'), 6.92 (IH, td, J  7.4 Hz, 1.0 Hz, H-5'), 7.11-7.17 (2H, m, H-4', 
H-6 ').
ÔC (100 MHz: CDCI3): -4.10 (CH3), 18.23 (C), 22.98 (CH3), 25.80 (CH3), 40.64
(CH2), 68.05 (CH), 118.59 (CH), 121.24 (CH), 127.61 (CH), 129.23 (C), 131.54 (CH), 
153.87 (C).
m/z, (CI): 267 [(M+H)\ 95%], 249 (55%), 135 (100%). HRMS:
267.1779. Ci5H2 7 0 2Si requires 267.1780.
1 -[2-(fe/t-Butyl-dimethyl-silanyloxy)-phenyl]-propan-2-ol ^°0-labeiled 73
Resin-bound enol ether derived from ^^0-labelled acetic acid 30a, contained in an IRORI 
macrokan® was stirred under argon for 1 h in dry DCM (10 mL). DCM (5 mL) was then 
added followed by TFA (0.15 mL). This was left to cleave for 1 h. At this time the 
contents were removed and placed in a dry 100 mL flask. This was then attached to a 
vacuum pump and cooled with a water bath. The DCM and TFA were removed using the 
pump and the compound left on the pump for a further hour to remove all TFA residues. 
At this time the flask was placed under argon and dry MeOH (4 mL) was added, followed 
by sodium borohydride (248 mg, 0.656 mmol). This was left stirring overnight. Water
126
was added to reaction mixture to quench, the mixture was then extracted with DCM (x 3), 
and the combined organics washed with water (x 3) and brine (x 1), dried over sodium 
sulfate, filtered and concentrated under reduced pressure. This gave alcohol 73 (17.4 mg, 
19.9%) as an oil.
GCMS was used to compare the samples of alcohols and the analyse the % of ^^0-labelled 
alcohol.
Methoxymethyl triphenylphosphonium chloride 125
©
P h g P ^ a ^
Cl
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MOMCl (8.35 mL, 110 mmol) was added to a stirred solution of triphenylphosphine 
(26.23 g, 100 mmol) in DCM (150 mL). The mixture was stirred under reflux for 40 h. 
after which time the MOMCl was removed under reduced pressure and the resultant white 
powder dried by azeotropic distillation with toluene to give salt 125 (33.66 g, 98%).^"^
ÔH (400 MHz: CDCI3) 3.72 (3H, d, J  0.6, OCH3), 5.92 (2H, d, J  3.9, CH3OCH2), 
7.65-7.73 (6 H, m, Ar-H), 7.78-7.85 (9H, m, Ar-H).
Data agrees with literature. 
2-(2-Nltrophenylmethyl)-1,3-dithiane 127a
S s
N O ,
127a
rerf-Butyllithium (27 mL of a 1.7 M solution) was added drop-wise to phosphonium salt 
125 over 7 min.at -78 C. The reaction mixture was stirred for a further 15 min at this 
temperature, then allowed to warm to -40 °C over 30 min. The mixture was cooled again 
to -78 °C for 15 min before a solution of 2-nitrobenzaldehyde (5.0 g, 33 mmol) in THF 
(27.5 mL) was added. The reaction mixture was allowed to warm to room temperature and 
left stirring under argon overnight. After the reaction was completed, a small amount of 
water was added to the reaction flask and some of the THF removed under reduced
127
pressure. The reaction mixture had water (275 mL) added to it and was then extracted with 
DCM (3x140 mL). The combined organic extracts were then washed with water (3 x 200 
mL) and brine (200 mL), dried over sodium sulphate filtered, and concentrated under 
reduced pressure to yield crude enol ether product (18.12 g) as a mixture of Z and E  
isomers 126a. Sh (400MHz: CDCI3) 3.74 (3 H ^ s, OCH3), 3.80 (3H^, s, OCH3), 5.70 
( i t f ,  d, J  7.2, CH=CH0CH3), 6.31 (IH^, d, J  7.2, CH=CH0CH3), 6.39 (IH ^  d, J  12.8, 
CHCHOCH3), 7.01 (IH^, d, J  12.8, CHCHOCH3). This product was taken on without 
further purification. The enol ether was dissolved in toluene (55 mL) and acetic acid (33 
mL) and 1,3-propanedithiol (3.65 mL, 36.3 mmol) was added. Boron trifluoride diethyl 
etherate (12.55 mL, 99 mmol) was added drop-wise and the reaction left stirring overnight. 
The triphenylphosphine oxide residues were then filtered off and the eluent poured into 
water (110 mL) and extracted into ethyl acetate (2 x 55 mL). The combined organic 
extracts were then washed with water (55 mL), aqueous NaOH (2x55 mL, 2M), water (110 
mL) and then brine (110 mL), dried over magnesium sulfate and concentrated under 
reduced pressure. The product was recrystallised from toluene to give the thioacetal 127a 
(1.04 g, 14%), as yellow prisms.
mp: 77-81 °C.
Vmax (KBr)/cm'‘: 1517 (NO2), 1340 (NO2).
6 h (400 MHz: CDCI3) 1.83-1.94 (IH, m, SCH2CHax), 2.07-2.17 (IH, m,
SCHzCHeq) 2.83-2.85 (4H, m, SCH2), 3.40 (2H, d, J  7.5, CH2CHS) 4.36 (IH, t, J  7.5, 
CHS) 7.42-7.45 (2H, m, Ar-H), 7.56 (IH, td, J  7.6 and 1.2 Hz Ar-H) 8.00-8.02 (IH, m, 
Ar-H).
8 c (lOOMHz: CDCI3) 26.03 (CH2), 30.49 (CH2), 39.31 (CH;), 47.09 (CH), 125.55
(CH), 128.70 (CH), 128.70 (C), 132.78 (C), 133.20 (CH), 133.94 (CH).
m/z, (Cl): 256 [(M-rH)*, 100%], 226 (40%), 119 (72%).
Microanalysis:- C, 51.8; H, 5.12; N, 5.43%. C11H 13NO2S2 requires C,51.74; H, 5.13;
N, 5.49%.
Data agrees with literature. 174
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2-(2-Aminophenylmethyl)-1,3-dithiane 128a
A mixture of 2-(2-nitrophenylmethyl)-l,3-dithiane 127a (530 mg, 2.1 mmol), iron powder 
(350 mg, 6.3 mmol), and ammonium chloride (560 mg, 10.5 mmol), in ethanol (14 mL) 
and water (7 mL) were heated under reflux. After 2 h 15 min, the mixture was filtered 
through Celite and concentrated under reduced pressure. The amine was taken up in ethyl 
acetate and the solution washed with water (25 mL) and brine (2 x 25 mL), dried over 
magnesium sulfate and concentrated under reduced pressure to give dithiane 128a as a 
pure yellow/orange oil (410 mg,
Vmax (NaCl)/cm'^: 1623 (Ar C=C), 752 (A,r C-H, bending)
5h (400MHz: C D C I 3 )  1.81-1.92 (IH, m, SCHiCH^x), 2.05-2.17 (IH, m, 
S C H s C H e q ) ,  2.79-2.84 (4H, m, S C H 2 ) ,  2.94 (2H, d, J  7.2, C H 2 C H S ) ,  4.33 (IH, t, /  7.2, 
C H S ) ,  6.70 (IH, d, J  8.1, H-3), 6.75 (IH, t, 77.4, H-5), 7.07-7.10 (2H, m, Ar-H).
ÔC (lOOMHz: C D C I 3 )  26.1 (CH2), 31.02 (CH2), 38.06 (CH2), 47.12 (CH), 116.60 
(CH), 119.21 (CH), 123.80 (C), 128.68 (CH), 131.51 (CH), 145.0 (C),
m/z, (El): 225 (M"", 5%), 119 (M“"-C3H6S2, 20%), 83.0 (100%). HRMS: 225.0646.
C11H 15NS2 requires 225.0646.
2-[2-(A/-ferf-Butyloxycarboxyamino)phenylmethyl]-1,3-dithiane 129a
s.
s.
N H
°^ 0 -* B u
129a
2-(2'-Aminobenzyl)-l,3-dithiane 128a (580 mg, 2.58 mmol), di-r^rr-butyl dicarbonate (620 
mg, 2.84 mmol) and THF (3.3 mL), were heated under reflux under nitrogen overnight. 
Water (10 mL) and DCM (6  mL) were added. The mixture was extracted with DCM (6  
mL) and all the organic extracts combined and washed with water (2 x 10 mL), dried over
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sodium sulfate and concentrated under reduced pressure. Crystallisation from cyclohexane 
gave the thioacetal 129a as fine needles (630 mg, 75%).
mp: 130-133 “C.
Vmax (KBr)/cm'\ 3400 (N-H), 2927 (CH), 1677 (CO)
ÔH (400 MHz: C D C I 3 )  1.54 [9H, s, ( C H 3 ) 3 ] ,  1.87-1.95 (IH, m, S C H z C H a x ) ,  2.11- 
2.16 (IH, m, SCHzCHeq), 2.86-2.89 (4H, m, S C H 2 ) ,  3.05 (2H, d ,  J  7.1, C H 2 C H S ) ,  4.23 
(IH, t ,  77.1, C H S ) ,  6.53 (IH, br s, N H ) ,  7.25-7.29 (4H, m, Ar-H)
5c ( 1 0 0  MHz: CDCI3) 25.92 (CH2), 28.75 (CH3), 30.77 (CH2), 37.78 (CH2), 48.20 
(CH), 80.88 (C), 124.36 (CH), 125.04 (CH), 127.9 (CH), 128.28 (C), 130.97 (C), 136.47 
(CH), 153.94 (C).
m/z, (El): 325 (M* -^, 10%), 268 (M'+-C4H9, 12%), 119 (100%). HRMS: 325.1175.
C16H23NO2S2 requires 325.1170.
Microanalysis:- C, 59.14; H, 7.12; N, 4.31%. C16H23NO2S2 requires C, 59.05; H,
7.12; N, 4.30%.
Data agrees with literature. 174
2-[2-(A^fe/t-Butyloxycarboxyamido)-3-methoxyphenylmethyl]-1,3-dithiane 
129b
2-(3'-Methoxy-2'-nitrophenylmethyl)-l,3-dithiane 127b was formed by adding ‘BuLi 
(12.8mL, 21.7 mmol) drop-wise to a suspension of methoxymethyltriphenylphosphonium 
chloride 125 (8.13 g, 23.76 mmol) in THF (40 mL) at -78 °C. After stirring for 15 min at - 
78 °C, the reaction mixture was allowed to warm to -40  °C over 30 min. The reaction was 
cooled again to -78 °C for 15 min and then 3-methoxy-2-nitrobenzaldehyde (2.87g, 15.84 
mmol) in THF (13 mL), was added drop-wise. After stirring at room temperature
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overnight, the reaction was quenched with water (130 mL) and the compound extracted 
with DCM (2 X 70 mL). The organic extracts were washed with water (3 x 100 mL) and 
brine (100 mL), dried using sodium sulphate, filtered, and concentrated under reduced 
pressure to give enol ether 126b, which was taken on without further purification. The 
^HNMR spectrum showed a 1:1 mixture of Z and E  isomers Ôh (400 MHz: CDCI3): 3.45 
(3 tf , s, OCH3), 3 .6 6  (3H^,s, OCH3), 5.04 (IH^, d, J  7.2, CHCHOCH3), 5.62 (IH^, d, J  
12.8, CHCHOCH3), 6.26 ( i t f ,  d, J  7.2, CHCHOCH3), 7.08 (IH^, d, J  12.8, 
CHCHOCH3). The enol ether was dissolved in toluene (26 mL), acetic acid (16 mL) and
1,3-propanedithiol (1.75 mL, 17.42 mmol) was added. Borontrifluoride diethyletherate 
(6.02 mL, 47.5 mmol) was added drop-wise and the reaction mixture left stirring under 
argon overnight. The precipitate was filtered off, the solution poured into water (55 mL) 
and the organic layers extracted with ethyl acetate (2 x 30 mL). The organic extracts were 
then washed with water (30 mL), aqueous sodium hydroxide (2 x 30 mL, 2M), water (55 
mL), and brine (55 mL) dried over magnesium sulfate and concentrated under reduced 
pressure. ’HNMR analysis confirmed that this was the desired thioacetal, 2-(3'-Methoxy- 
2'-nitrobenzyl)-l,3-dithiane 127b (3.92 g) and was taken on directly to the next step 
without further purification. 5h (400 MHz, CDCI3): 1.81-1.92 ( I H ,  m, C H a x ) ,  2.07-
2.12 ( I H ,  m, C H e q ) ,  2.82-2.84 (4H, m, C H 2 S ) ,  3.03 (2H, d, J  7.7, C H 2 C H S ) ,  3.88 (3H, s, 
OCH3), 4.23 ( I H ,  t, J  7.7, CHS), 6.95 ( I H ,  d, J  7.8, H-4'), 7.16-7.18 ( I H ,  m, H-6 '), 7.36 
( I H ,  t, 7 8.1, H-5'). Data agrees with l i te r a tu re .I ro n  powder (2.30 g, 41.23 mmol) was 
added to a solution of 2-(3'-Methoxy-2'-nitrobenzyl)-l,3-dithiane (3.92g) in ethanol (59 
mL) and water (29 mL) with ammonium chloride (3.68 g, 68.73 mmol) and the mixture 
was heated under reflux for 2 h. After this time the reaction mixture was filtered through 
celite and washed with ethyl acetate. The ethanol was removed under reduced pressure 
and the compound dissolved in ethyl acetate (170 mL) and washed with water (170 mL), 
then brine (2 x 170 mL). The organic extracts were then dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. ^HNMR analysis confirmed the amine 
128b. The compound was taken up in THF (22 mL) and di-tert-butyl dicarbonate (3.67 g, 
16.8 mmol) was added. The reaction was then refluxed overnight under nitrogen. Column 
chromatography (Si0 2 ) eluted with hexane-ethyl acetate (1 :1), gave dithiane 129b (1.07g, 
34% over 4 steps). Rp [Si0 2  hexane-ethyl acetate (1:1)] = 0.39.
ÔH (400 MHz: CDCI3): 1.53 [9H, s, (CH3)3], 1.84-1.90 (IH, m, CHax), 2.06-2.11
(IH, m, CHeq), 2.80-2.83 (4H, m, CH2S), 3.13 (2H, d, 7 7.4, CH2CHS), 3.81 (3H, s, 
OCH3), 4.30 (IH, t, 7 7.4, CHS), 6.00 (IH, s, NH), 6.81 (IH, dd, 7 8.2, 1.1, H-4'), 6.89- 
6.90 (IH, m, H-6 '), 7.17 (IH, t, 7 8.0, H-5').
Data agrees with literature.
1 3 1
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2-[2'-(A/-fe/t-Butyloxycarboxyamino)-4',5'-methylenedioxyphenylmethyl]-1,3- 
dithiane 129c
cca':
129c
2-(4',5'-Methylenedioxy-2'-nitrophenylmethyl)-l,3-dithiane 127c was formed by adding 
‘BuLi (28.21 mL, 47.95 mmol, 1.7 M) drop-wise to a suspension of 
(methoxymethyl)triphenyl phosphine chloride 125 (17.97 g, 52.5 mmol) in THF (87 mL) 
at -78 °C. After stirring for 15 min at -78 °C, the reaction was allowed to warm to -40 °C 
over 30 min before being cooled again to -78 °C for 15 min. 6 -Nitropiperonal (6.83 g, 35 
mmol) in THF (30 mL) was then added drop-wise. This was left stirring at room 
temperature overnight. The reaction was quenched with water (290 mL) and the 
compound extracted with DCM (2 x 160 mL). The organics were washed with water (3 x 
290 mL) and brine (290 mL). The compound 126c was then dried using sodium sulphate, 
filtered, and concentrated under reduced pressure. The ^HNMR spectrum shows a 1:1 
mixture of Z and E. 5» 3.73 s, OCH3), 3.79 (3H^°'^,s, OCH3), 5.83 (IH^, d, J  7.3,
CHCHOCH3), 6.07 (2H ^V  s. OCH2O) 6.07 s, OCH2O) 6.23 ( i t f ,  d, J  7.3.
CHCHOCH3), 6.52 (IH^, d, J  12.8, CHCHOCH3), 6.93 (IH^, d, J  12.8, CHCHOCH3). 
The crude enol ether was dissolved in toluene (58 mL), acetic acid (35 mL) and 
propanedithiol (3.83 mL) was added. To this boron trifluoride diethyletherate (13.30 mL) 
was added drop-wise and the mixture left stirring under argon overnight. The precipitate 
was filtered off, the solution poured into water (130 mL) and the organic layers extracted 
with ethyl acetate (2 x 65 mL). The organic extracts were then washed with water (65 
mL), aqueous sodium hydroxide (2 x 130 mL, 2 M), water (130 mL), and brine (130 mL), 
dried over magnesium sulfate and concentrated under reduced pressure to give thioacetal 
127c 2-(4,5-Methylenedioxy-2-nitrophenylmethyl)-1,3-dithiane (4.00 g, 38%) as the major 
product, which was used without further purification.^"^ Ôh (400 MHz: C D C I3): 1.92-1.88 
(IH , m, C H a x ) , 2.83-2.86 (IH , m, CHeq), 2.83-2.86 (4H, m, CH2S), 3.34 (2H, d, J  7.5, 
C H 2C H S), 4.37 (IH , t, 7 7.7, CHS), 6.12 (2H . s, OCH2O) 6 .8  (IH , s, Ar-H), 7.56, (IH , s, 
Ar-H). 2-(4',5'-Methylenedioxy-2'-nitrobenzyl)-l,3-dithiane 127c was dissolved in 
Ethanol (58 mL) and water (28 mL) and treated to iron powder (2.24 g) ammonium 
chloride (3.58 g) and heated under reflux for 2 h. The reaction mixture was filtered though
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celite and the ethanol removed under reduced pressure. The resulting mixture was 
dissolved in ethyl acetate and (165 mL) and washed with water (2 x 165 mL) and brine 
(165 mL). The organic layers were dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. The resultant amine 128c was solvated in THF (15 
mL) and di-tert-dibutyl dicarbonate was added (2.4 g, 11 mmol) and the reaction refluxed 
under nitrogen overnight. Sodium hydroxide (100 mL, 1 M) was added to the reaction 
flask along with DCM (25 mL). The layers were separated and the organics washed with 
water (3 x 40 mL) and brine (40 mL), dried over sodium sulfate, filtered and concentrated 
under reduced pressure. This gave a brown solid, which was re-crystallisation twice from 
cyclohexane to isopropanol (4:1) to give dithiane 129c (1.58 g, 12% over 4 steps) as an 
olive green solid.
5h (400 MHz: C D C I 3 ) :  1.50 [9H, s, ( C H 3 ) 3 l ,  1.84-1.93 (IH, m, C H a x ) ,  2.09-2.14
(IH, m, CHeq), 2.81-2.86 (4H, m, S C H 2 ) ,  2.94 (2H, d, 7 7.1, C H 2 C H S ) ,  4.16 (IH, t, 7 7.1, 
C H S ) ,  5.93 (2H, s, O C H 2 O ) ,  6.32 (IH, s, N H ) ,  6.70 (IH, s, H - 6 ' ) ,  7.04 (IH, s, H - 3 ' )
Data agrees with literature.
2-[1 '-(2'-Nitrophenyl)ethyl]-1,3-dithiane 139
139
Phosphonium salt 125 (30.4 g, 90 mmol) in THF (150 ml) under argon was cooled to -78 
°C and ^BuLi (49 ml, 82 mmol, 1.7 M) was added drop-wise by canula over 15 min. The 
reaction was stirred for a further 15 min at this temperature, then allowed to warm to -40 
°C over 30 min. The mixture was cooled again to -78 °C for 15 min before a solution of 2- 
nitrophenyl acetophenone (10 g, 60 mmol) in THF (50 ml) was added. After stirring at 
room temperature the reaction was completed, a small amount of water was added to the 
reaction flask and some of the THF removed under reduced pressure. Water (275 ml) was 
added to the reaction mixture and the organic mixture extracted with DCM (3 x 280 ml). 
The combined organic extracts were then washed with water (3 x 400 ml) and brine (400 
ml), then dried over sodium sulphate filtered and concentrated under reduced pressure to 
give impure enol ether 138 product as a 2:1 mixture of E  and Z isomers (31.76 g). 5h 
(400MHz: CDCI3) 1.89, (3H^ d, J  1.3, CHCH3,), 1.95 (3H^, d, J  1.4, CHCH3,) 3.49 (3H^
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S, OCH3), 3.69 (3H^ s, OCH3), 5.98 d, J  1.4, CCHOCH3), 6.05 (IH ^ d, J  1.3, 
CCHOCH3). This product was taken on without further purification. Toluene (100 mL) 
was added to the crude enol ether, along with acetic acid (60 mL) and propane dithiol (6.63 
mL, 6 6  mmol). Boron trifluoride diethyl etherate (22.81 mL, 180 mmol), was added drop- 
wise and the mixture left stirring overnight. The triphenylphosphine oxide residues were 
then filtered off and the filtrate poured into water (220 mL) and extracted with ethyl 
acetate (2 x 110 mL). The combined organic layers were then washed with water (110 
mL), NaOH (2 x 110 mL 2M), water (220 mL) and brine (220 mL), dried over magnesium 
sulfate and concentrated under reduced pressure. Column chromatography (SiOz) eluting 
with hexane - ethyl acetate (2:1) gave thioacetal 139 as a yellow oil (6.89 g, 43%). Rp 
[(SiOz) hexane :ethyl acetate (2 :1)] = 0.53.
Vmax (NaCl)/cm ': 3066 (CH), 2900 (CH), 1523 (ArNOz), 1353 (NO2).
6 h (400 MHz: C D C I 3 )  1.55 (3H, d, J  7.0, C H C H 3 ) ,  1.81-1.91 (IH, m, S C H z C H a x ) ,  
2.02-2.09 (IH, m, S C H z C H e q ) ,  2.78-2.90 (4H, m, S C H z ) ,  3.79 (IH, quin, J  7.1, C H C H 3 ) ,  
4.27 (IH, d, J  7.9, C H S ) ,  7.38 (IH, td, J  7.0 and l .8  H - 4 ' ) ,  7.52-7.59 (2H, m, Ar-H), 7.77 
(lH ,dd , 7 8.2 and 1.2, H-3’)
ÔC (100 MHz: CDCI3) 18.80 (CH3), 25.61 (CHz), 29.65 (CHz), 30.24 (CHz), 38.54 
(CH), 52.98 (CH) 124.15 (CH), 127.62 (CH), 129.06 (CH), 132.30 (CH), 137.57 (C), 
150.24 (C).
m/z, (Cl): 270 [(M+H)", 100%], 240 (20%). HRMS: 270.0619. C12H 16S2NO2
requires (M+H) 270.0622.
Microanalysis:- C, 53.54; H, 5.49; N, 5.09% C 12H15NO2S2 requires C, 53.50; H,
5.61; N, 5.20%.
2-[1 '-(2'-Aminophenyl)ethyl]-1,3-dithiane 140
...0
140
134
2-[r-(2'-Nitrophenylmethyl)ethyl-l,3-dithiane 139 (413 mg,1.53mmol) was dissolved in 
ethanol (6.5 mL) and water (3.25 mL). Iron powder (257 mg, 4.59mmol) was added, 
followed by ammonium chloride (410 mg, 7.67mmol). The reaction was then heated under 
reflux under nitrogen for 3 h. After this time the reaction mixture was filtered through 
celite to remove the iron residues, washing with ethyl acetate. The combined filtrate was 
concentrated under reduced pressure. The mixture was then dissolved in ethyl acetate and 
washed with water (1 x 19 mL), and brine (2 x 19 mL), dried over magnesium sulfate, 
filtered and concentrated under reduced pressure to give aniline 140 (310 mg 84 %)as an 
orange oil.
Vmax (NaCl)/cm-' : 3345 (NH), 2894 (CH), 1619.
5h (400MHz: CDCI3) 1.48 (3H, d, J  7.0, CHCH3), 1.76-1.87 (IH, m, SCHzCHax),
2.04-2.11 (IH, m, SCH^CHaq), 3.16 (IH, quin, 76.9, CHCH3), 4.35 (IH, d, 76.8, CHS),
6.7 (IH, dd, 7 7.9 and 1.2, H-3’), 6.81 (IH, td, 7 7.6 and 1.2, H-5’), 7.07 (IH, td, 7 7.8 and 
.1.5, H-4’), 7.17 (IH, dd, 77.7 and 1.5, H-6 ’).
m/z, (El): 239 (MV 20%), 119 (100%), 83 (80%). HRMS: 239.0801. C 12H 17NS2
requires 239.0802.
2'-(1-1,3-Dithian-2-yl-ethyI)-phenyI]-carbamic acid tert-butyl ester 141
0 ^ 0
2-[ 1 '-(2'-Aminophenyl)ethyl]-l ,3-dithiane 140 was dissolved in THF (15 mL), di-tert- 
dibutyl dicarbonate was added (2.4 g, 11 mmol) and the reaction mixture was heated under 
reflux under nitrogen overnight. Aqueous sodium hydroxide (100 mL, 1 M) was added to 
the reaction flask along with DCM (25 mL). The organic layer was then washed with 
water (3 x 40 mL) and brine (40 mL), dried over sodium sulfate, filtered and concentrated 
under reduced pressure. This gave an 8:1.8 mixture of dithiane 141 (324 mg, 8 8 %), as a 
yellow solid to Boc anhydride.
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V m a x  (GG)/cm-' ; 3338 (CONH), 2967 (CH).
8 h (400 MHz: CDClj) 1.46 (3H, d, J  7.0, CHCH3), 1.51 (9H, s, CCH3), 1.52 (18H, 
s, Boc anhyd.)*, 1.79-1.86 (IH, m, SCHjCHax), 2.05-2.10 (IH, m, SCHzCHe,), 3.31 (IH, 
quin, J  7.4, CHCH3), 4.21 (IH, d, J  8.1, CHS), 6.45 (IH, bs, NH), 7.16 (IH, td, J  7.6 and 
1.3, Ar-H), 7.23 (IH, dd, J  7.8 and .1.5, Ar-H), 7.30 (IH, dd, J  7.7 and 1.6, Ar-H), 7.56- 
7.58 (IH, m, Ar-H).
8 c (100 MHz: CDCI3) 18.83 (CH3), 25.64 (CH2), 27.41 (CH3)*, 28.36 (CH3), 30.46 
(CH2), 30.77(CHz), 38.32 (CH), 54.14 (CH), 125.24 (CH), 126.99 (CH), 127.33 (CH), 
153.01 (C).
*=Boc anhydride signals in NMR.
3-(1,3-Dithian-2-yl)propan-1-ol 197
OHS
197
Boron trifluoride diethyletherate (35.9 mL, 285 mmol) was added drop-wise to a solution 
of 2,3-dihydrofuran (10.8 mL, 143 mmol) and 1,3 propane dithiol (14.3 mL, 143 mmol) in 
DCM (127 mL) stirring at 0 ®C. This was then stirred overnight. The reaction was 
quenched with water (100 mL) and the aqueous layer extracted with DCM (3 x 40 mL). 
The organics were then combined and washed with water (3 x 90 mL), brine (1 x 90 mL), 
dried over sodium sulfate, filtered and concentrated under reduced pressure. This gave 
alcohol 197^  ^ (19.3 g, 76%) as an oil, taken on without further purification.
ÔH (400 MHz: C D C I3 ): 1.65 (IH, s, O H ) ,  1.75-1.95 [5H, m, CH(CH2)2CH2 0 H and
C H axH eq C H 2S ], 2.09-2.16 (IH, m, CHaxHeqCH2S), 2.81-2.93 [4H, m, C H S (C H 2 ) ] ,  3.68 
(2H, t, J  6.2 Hz, C H 2 O H ) 4.08 ( IH, t, J  6 .8  Hz, C H S 2 ).
ÔC (100 MHz: C D C I3 ): 25.9 (CH2), 29.6 (C H 2 ), 30.3 (C H 2 ), 31.8 (C H 2 ), 47.2 (C H ) ,
62.2 (C H 2 ).
Data in agreement with literature.
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4-(1,3-Dithian-2-yl)butan-2-one 199
Ç‘
1 9 9
Pyridine sulphur trioxide (33.9 g, 213 mmol) was added to a solution of 3-(l,3-Dithian-2- 
yl)propan-l-ol 197 (10.00 g, 178 mmol), triethylamine (51.5 mL, 370 mmol), and DMSO 
(37.2 mL, 560 mmol) in DCM (187 mL) and the solution stirred overnight. The reaction 
was quenched with water (270 mL) and the aqueous layer extracted with DCM (3 x 350 
mL). The organic phases were combined, washed with brine, dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. This gave the 3-(l,3-dithian-2- 
yl)propionaldehyde 198 (17.7 g), though large amounts of DMSO and triethylamine salts 
were present. This compound was taken on without further purification. 5h (400 MHz: 
CDCI3): 1.82-1.96 (IH, m, CHaxHeqCHaS) 2.08-2.16 (3H, m, CHaxHeqCHzS and
CHCH2) 2.72 (2H, td, J  7.2 Hz, 1.0 Hz, CH2CHO) 2.84-2.87 [4H, m, CHS(CH2)] 4.05 
(IH, t, J  7.0 Hz, CHS2) 9.81 (IH, s, CHO). Methyllithium (17.5 mL, 28.0 mmol) was 
added drop-wise to a solution of crude 4-(l,3-dithian-2-yl)-propionaldehyde 198 (4.43 g) 
in THF at -78 °C and left stirring to warm to room temperature overnight. The reaction 
mix was cooled to 0 °C before quenching with aqueous saturated sodium hydrogen 
carbonate. This reaction yielded 4-(l,3-dithian-2-yl)butan-2-ol (3.41 g) however there was 
also staring material present in the mixture, which gave a complicated proton 'HNMR 
spectrum. This was taken on directly for oxidation. Selected product signals: 6 h (400 
MHz: CDCI3): 1.21 (3H, d, J  6.2 Hz, CH3CHOH), 3.83 (IH, q, J  6.1 Hz, 
CH3CH(0 H)CH2). Pyridine sulphur trioxide (8.47 g, 159 mmol) was added to a solution 
of 4-( 1,3-dithian-2-yl)butan-1 -ol (3.41 g), triethylamine (12.9 mL, 92.4 mmol), and DMSO 
(9.90 mL, 140 mmol) in DCM (47 mL) and the solution stirred overnight. The reaction 
was quenched with water (70 mL) and the aqueous layer extracted with DCM (3 x 50 mL). 
The organic phases were combined, washed with brine, dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. Column chromatography (silica) eluting 
with hexane and ethyl acetate (2 :1 ) gave 4-(l,3-dithian-2-yl)butan-2-one 199 as a pale 
yellow oil (1.058 g, 40% over 3 steps). Rp ( Si0 2 , 2:1 hexane:ethyl acetate): 0.47
Vmax (GG)/cm ‘: 2896 (CH), 1710 (C=0).
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Ôh (400 MHz: CDCls): 1.81-1.92 (IH, m, CHaxHeqCHzS), 2.05-2.15 [3H, m,
C H axH eqC H 2S and C H C H 2 ], 2.17 (3H, s, C H 3 ), 2.68 [2H, t, J  7.2 Hz, CH2C(0 )], 2.83-2.86 
[4H, m, C H S (C H 2 ) ] ,  4.05 (IH, t, 77.0 Hz, C H S 2 ).
ÔC (100 MHz: C D C I3 ): 25.8 (C H 2 ), 29.0 (C H 2 ), 29.9 (C H 2 ), 30.0 (C H ) , 40.1 (C H 2 ),
46.4 (CH3), 207.4 (C).
m/z, (El): 190 (M^\ 8 %), 132 (30%), 84 TCsHgO, 100%]. HRMS: 190.0487.
C8H14OS2 requires 190.0486.
Microanalysis: C 50.61%, H 7.51%; Theoretical C8H 14OS2: C 50.48%, H 7.51%
3 (1 ,3-Dithian-2-yl)-1-methyl-propyl-(1-phenylethyl)-amine 200
R, R- d ia stereom er S , R - d ia stereom er
200
Sodium triacetoxyborohydride (970 mg, 4.58 mmol) was added to a solution of 4-(l,3- 
dithia-2-yl)butan-2-one 199 (851 mg, 4.47 mmol), (R)-(+)-a-phenylethyl amine (1.06 mL, 
8.32 mmol) and molecular sieves (210 mg) in DCM (15 mL). This was left stirring 
overnight. The reaction mixture was cooled to 0 °C before water (17 mL) was added and 
the organics separated from the aqueous, washed with water (3 x 30 mL), brine (2 x 15 
mL). The organics were then dried over magnesium sulfate, filtered and concentrated 
under reduced pressure, to give diastereoisomers 200 (126 mg, 100%) as a 3:5 mixture of 
the two isomers A:B as an orange oil. Separation attempts were unsuccessful.
V m a x  (NaCl)/cm'' : 2956 (CH2, CH3)
5h (400 MHz: CDCI3): 1.16-1.27 [6 H*"". m, NCH(CH3)CH2], 1.61-2.17 [9H''"®, m,
CHsCPh, S2CH(CH2)2], CHaxHeqCH2S], 2.57 (IH*, bs/m, NCHCH2), 2.72 (IH®, bs/m, 
NCHCH2), 2.75-2.80 (4H*, m, CHSCH2), 2.83-2.86 (4H®, m, CHSCH2), 3.84 (IH*, t, J
6 .8  Hz, CHS2), 3.92 (IH®, t, 76 .6  Hz, CHS2), 4.12 (IH*, bs/m, NCHPh), 4.18 (IH®, bs/m, 
NCHPh), 7.28-7.54 <5H*"®, m, Ar-H).
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ÔC (100 MHz: CDCI3): 25.95 (CH2), 30.31 (CH2), 31.36 (CH2), 31.74 (CH2), 47.32
(CH3), 47.40 (CH), 50.04 (CH3), 55.09 (CH), 55.28 (CH), 126.90 (CH), 127.38 (C), 127.64 
(CH).
m/z, (El): 269 (M'"", 100%), 280 (30%), 173 (65%), 148 (90%), 105 (83%).
HRMS: 295.1427. C16H25NS2 requires 295.1428.
5,5-Bis(phenylsulfanyl)pentan-1 -ol 276
S P h
Following a literature procedure boron trifluoro diethyletherate (13.1 mL, 105 mmol) 
was added drop-wise to a solution of 2,3 dihydro-2H-pyran (8.00 g, 95.1 mmol) and 
thiophenol (19.5 mL, 190 mmol) in DCM (85 mL) stirring at 0 °C . This was then stirred 
overnight. The reaction was quenched with water (75 mL) and the aqueous layer extracted 
with DCM (3 X  40 mL). The organic phases were then combined and washed with water 
(3 X  90 mL), brine (1 x 90 mL), dried over sodium sulfate, filtered and concentrated under 
reduced pressure to give alcohol 276^^ (24.6 g, 85%) as an oil, which was taken on without 
further purification.
ÔH (400 MHz: C D C I3 ): 1.31 (IH, s, OH) 1.50-1.57 [2 H, m, (CH2)3CH2 0 H] 1.64-
1.72 [2H, m, (CH2)3CH2 0 H] 1.85-1.90 [2H, m, (CH2)3CH2 0 H] 3.60 (2H, t, J  6.5 Hz, 
CH2OH) 4.40 (IH, t, J  6 .6  Hz, CHS) 7.25-7.33 (6 H, m, Ar-H) 7.44-7.47 (4H, m, Ar-H).
ÔC ( 1 0 0  MHz: C D C I3 ): 23.27 (CH2), 32.05 (C H 2 ), 35.51 (C H 2 ), 58.35 (C H ) , 62.56
(C H 2 ), 127.69 (C H ) , 128.88 (C H ) , 132.72 (C H ) , 134.18 (C).
Data agrees with literature.
4-(1,3-Dithian-2-yl)butanol 282
OH  
282
139
Boron trifluoride diethyletherate (35.1 mL, 279 mmol) was added drop-wise to a solution 
of 2,3 dihydro-2H-pyran (11.8 mL, 140 mmol) and 1,3-propane dithiol (14.0 mL, 140 
mmol) in DCM (125 mL) stirring at 0 °C. This was then stirred overnight. The reaction 
was quenched with water (100 mL) and the aqueous layer extracted with DCM (3 x 40 
mL). The organics were then combined and washed with water (3 x 90 mL), brine (1 x 9 0  
mL), dried over sodium sulfate, filtered and concentrated under reduced pressure. This 
gave 4-( 1,3-dithian-2-yl)butanol 282/^^ (22.4 g, 83%) as an oil , which was taken on 
without further purification.
ÔH (400 MHz: C D C I 3 ) :  1.56-1.63 (4H, m, C H 2 C H 2 C H 2 O H ) ,  1.66 ( I H ,  s, O H ) ,  1.76-
1.81 (2 H, m, C H C H 2 ) ,  1.82-1.91 [ I H ,  m, C H a x H e q ( C H 2 ) 2 S 2 ] ,  2.09-2.16 [IH, m, 
C H a x H e q ( C H 2 ) 2 S 2 ] ,  2.80-2.92 [4H, m, C H S C H 2 ] ,  3.63-3.66 (2 H, m, C H 2 O H ) ,  4.06 [ I H ,  t, J  
6.9 Hz, C H S 2 ] .
ÔC (100 MHz: C D C I 3 ) :  22.81 ( C H 2 ) ,  25.91 ( C H 2 ) ,  30.36 ( C H 2 ) ,  32.13 ( C H 2 ) ,  35.07
( C H 2 ) ,  47.39 ( C H ) ,  62.44 ( C H 2 ) .
Data agrees with literature. ^
(S)-(1,3-Dithian-2-yl-butyl)-A/-(1-phenylethyl)amine 284
2 8 4  *  II
Pyridine sulphur trioxide (84.5 g, 531 mmol) was added to a solution of 4-(l,3-Dithian-2- 
yl)butan-l-ol 282 (140 mmol), triethyl amine (51.5 mL, 370 mmol), and DMSG (37.2 mL, 
560 mmol) in DCM (187 mL) and the solution stirred overnight. The reaction was 
quenched with water (270 mL) and the aqueous layer extracted with DCM (3 x 350 mL). 
The organic phases were combined, washed with brine, dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. This gave 4-(l,3-dithian-2-yl)butanal 
283 (50.8 g), though large amounts of DMSG and triethylamine salts were present. This 
compound was taken on without further purification. 5h (400 MHz: CDCI3): 1.76-
1.97 [5H, m, CHaxHeqCH2S, (CH2)2CH2CHG], 2.09-2.15 [IH, m, CHaxHeqCH2S], 2.48 
[2 H, t, J  6 .6  Hz, CH2CHG], 2.81-2.92 (4H, m, CHSCH2), 4.05 (IH, t, J  6 .6  Hz, CHS2) 
9.77 (IH, s, CHG). Sodium triacetoxyborohydride (16.3 g , 76.8 mmol) was added to a 
solution of 4-(l,3-dithian-2-yl)butanal 283 (69.8 g, 25.4 mmol),(5)-(-)-a-phenyl 
ethylamine (17.9 mL, 140 mmol) and 4Â molecular sieves (33 g) in DCM (200 mL). This
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was left stirring overnight. As before on standing after work up similar crystals of (S)-N- 
(l-Phenylethyl)acetamide formed, chromatography (alumina) using ether and hexane (2:1) 
yielded pure amine 284 (7.00g, 41% over 2 steps) as a yellow oil. Rf ( A I2O 3, 2:1 diethyl 
ether:hexane): 0.5.
Vmax (GG)/cm'^ : 2929 (CH or NH), 2854 (CH).
ÔH (400 MHz: CDCI3): 1.34 [3H, d, J  6 .6  Hz, NCH(CH3)], 1.44-1.53 [4H, m,
NCH2(CH2)2], 1.70-1.75 (2H, m, CHCH2), 1.83-1.89 [IH, m, CHaxHeqCH2S], 2.07-2.13 
[IH, m, CHaxHeqCH2S], 2.13-2.45 (IH, m, NCH2), 2.47-2.51 (IH, m, NCH2), 2.77-2.89 
(4H, m, CHSCH2), 3.74 (IH, q, J  7.0 Hz, NCR), 4.01 (IH, t, J  6.9 Hz, CHS), 7.20-7.25 
(IH, m, Ar-H), 7.26-7.34 (4H, m, Ar-H).
ÔC ( 1 0 0  MHz: C D C I3 ): 24.29 (C H 3 ), 24.37 (CH2), 25.97 (C H 2 ), 29.82 (C H 2 ), 30.41
(C H 2 ), 35.25 (C H 2 ), 47.47 (C H ) , 47.48 (C H 2 ), 58.34 (C H ) , 126.47 (C H ) , 126.77 (C H ) ,
128.35 ( C H ) , 145.77 (C).
m/z, (El): 295 (M'"", 32%), 105 (34%), 82 (100%). HRMS: 295.1427.
C16H25NS2: requires 295.1428.
Microanalysis: C, 65.05; H, 8.49; N, 4.82%. C16H25NS2 requires C, 65.02;
H, 8.52; N, 4.76%.
Optical Rotation: [a]o -3.79 concentration : 0.1 dm'^ taken at 22 in DCM
(S)-(1,3-Dithian-2-yl-butyl)-/V-(1 -phenylethyl)amine 285
Following the above procedure sodium triacetoxyborohydride (16.3 g , 76.8 mmol) was 
added to a stirred solution of 4 (1,3-dithian-2-yl)butanal (25.4 g), (R)-(+)-a- 
phenylethylamine (17.9 mL, 140 mmol) and 4 molecular sieves (33.0 g) in DCM (200 
mL). This was left stirring overnight. The reaction mixture was cooled to 0 °C before 
water (200 mL) was added, the organic phases were then separated from the aqueous, and 
washed with water (3 x 150 mL) and brine (1 x 150 mL). The organic phases were then
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dried over magnesium sulfate, filtered and concentrated under reduced pressure. On 
standing large clear colourless crystals formed, further purification and spectroscopic 
investigation lead to the side product determined as N-( 1 -phenylethyl)acetamide 286. 
The majority was crystallised out (4:1 cyclohexane, isopropanol), and chromatography 
(alumina) using diethyl ether and hexane (2:1 solvent system) gave the amine 285 (7.29 g, 
35% over 2 steps) as a yellow oil. Rf ( AI2O3, 2:1 diethyl ether:hexane): 0.4.
Vmax (GG)/cm ': 2929 (CH), 2855 (CH or NH), 1601 (NH),
8 h (400 MHz: CDCI3): 1.34 [3H, d, J  6 .6  Hz, NCH(CH3)], 1.38-1.52 [4H, m,
NCH2(CH2)2],1.69-1.75 (2H, m, SCHCH2), 1.81-1.88 [IH, m, CHaxHe,CH2S], 2.06-2.12 
[IH, m, CHaxHeqCH2S], 2.40-2.44 (IH, m, NCH2), 2.47-2.57 (IH, m, NCH2), 2.78-2.85 
[4H, m, CHSCH2], 3.47 (IH, q, J  7.0 Hz, NCR), 4.01 (IH, t, J  6.9 Hz, CHS), 7.20-7.22 
(IH, m, Ar-H), 7.24-7.36 (4H, m, Ar-H).
5c ( 1 0 0  MHz: CDCI3): 24.3 (CH3), 24.3 (CH2), 25.9 (CH;), 29.8 (CH2), 30.4 (CH2),
35.2 (CH2), 47.4 (CH), 47.4 (CH2), 58.3 (CH), 126.4 (CH), 126.7 (CH), 128.3 (CH), 145.7 
(C).
m/z, (El): 295 (M"*, 32%), 105 (100%). HRMS: 295.1426. C 16H25NS2:
requires 295.1428.
Microanalysis: C, 64.51; H, 8.48; N, 4.72%. C16H25NS2 requires C, 65.02; H, 8.52;
N, 4.76%.
Optical Rotation: [a]o 5.02 concentration : 0.1 dm^ taken at 22 °C in DCM
/V-(1 -Phenylethyl)acetamide^^® 286
WN 
286
ÔH (400 MHz: C D C I3 ): 1.49 (3H, d, J  6.9 Hz, N C H )  1.99 [3H, s, CH3C(0 )] 5.14
[IH, q, H N C H (C H 3 ) ]  5.65 (IH, bs, N H )  7.28-7.37 (5H, m, Ar-H)
m/z, (El): 163 (M""', 6 8 %), 106 [C6H5CH2(CH3)’  ^ 100%].
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(/?)-A/-[5,5-Bis(phenyIsuIfanyl)pentyl]-/V-(1-phenyIethyl)amine 295
5Ph
P h S  —  N
295 H
Pyridine sulphur trioxide (47.3 g, 297 mmol) was added to a solution of 5,5- 
Bis(phenylsulfanyl)pentanol 276 (23.8 g, 78.3 mmol), triethylamine (72.0 mL, 517 mmol), 
and DMSO (56.0 mL, 783 mmol) in DCM (260 mL) and the solution stirred overnight. 
The reaction was quenched with water (200 mL) followed by aqueous sodium hydrogen 
carbonate solution and the aqueous layer extracted with DCM (3 x 100 mL). The organics 
were combined, washed with brine, dried over magnesium sulfate, filtered and 
concentrated under reduced pressure. This gave 5,5-Bis(phenylsulfanyl)pentanal 277 (31.7 
g), containing large amounts of DMSO and triethylamine salts. This compound was taken 
on without further purification . 5h (400 MHz: CDCI3): 1.83-1.89 [2H, m, CH(CH2)2],
1.91-1.98 [2H, m, CH(CH2)2l, 2.41 (2H, td, 77.1 Hz, 1.4 Hz, CH2CHO), 4.38 (IH, t, 76.4 
Hz, CHS2), 7.28-7.35 (6 H, m, Ar-H), 7.44-7.47 (4H, m, Ar-H), 9.71 (IH, t, 7 1.5 Hz, 
CHG). Sodium triacetoxyborohydride (9.12 g , 43.0 mmol) was added to a solution of 5,5- 
Bis(phenylsulfanyl)pentanal (11.8 g) at 0 °C, (i?)-(+)-a -phenylethylamine (10 mL, 78.3 
mmol) and molecular sieves (18.5 g) in DCM (200 mL). The reaction was left stirring 
overnight. The reaction mixture was cooled to 0 °C before water (200 mL) was added and 
the organic phases separated from the aqueous, washed with water (3 x 150 mL), then 
brine (1 x 150 mL). The organic phases were then dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. Chromatography (silica) eluting with DCM and 
hexane (4:1) followed by EtOAc elution gave (2.54 g, 16% over 2 steps) (R)-N-[5,5- 
Bis(phenylsulfanyl)penty]-N-(l-phenylethyl)amine 295 as an orange oil. Rp (Si0 2 , 4:1 
DCM:hexane): 0.41.
Vmax (NaCl)/cm ‘: 3316 (NH), 2931 (CH3, CH2).
Sh (400 MHz: CDCI3): 1.33 (3H, d, /  6 .6  Hz, NCHCH3) 1.36-1.46 [2H, m,
NCH2(CH2)2] 1.55-1.63 [2H, m, NCH2(CH2)2] 1.79-1.84 (2H, m, CHCH2) 2.32-2.40 (IH, 
m, CH2N) 2.42-2.48 (IH, m, CH2N) 3.71 (IH, q, J  6 .6  Hz, NCHCH3) 4.37 (IH, t, J  6.7 
Hz, SCH) 7.21-7.33 (IIH , m, Ar-H) 7.42-7.46 (4H, m, Ar-H).
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ÔC (100 MHz: C D C I3 ): 24.31 (C H 3 ), 24.71 (C H 2 ), 29.61 (C H 2 ), 35.57 (C H 2 ), 47.45
(C H 2 ), 58.19 (C H ) , 58.32 (C H ) , 126.46 (C H ) , 126.79 (C H ) , 127.58 (C H ) , 128.35 (C H ) ,
128.81 (C H ) , 132.60 (C H ) , 134.18 (C), 145.68 (C).
m/z, (FAB+/NOBA): 408 [(M+H)\ 100%], 298 (70%), 106 (98%). HRMS:
408.1825. C25H30NS2: requires 408.1820.
Microanalysis: C, 73.44; H, 6.95; N, 3.38%. C 25H 29N S2 requires C, 73.66;
H, 7.17; N, 3.44%.
Optical Rotation: [a]o 2.23 concentration : 0.1 dm‘^  taken at 22 °C in DCM
(S)-A/-[5,5-Bis(phenylsulfanyl)pentyl]-A/-(1-phenylethyl)amlne 296
S P h  i
S P h
. ..L  N
2 96  ^
Following the above procedures and employing L-(-)-a-phenyl ethylamine (10.0 mL, 78.3 
mmol), (S)-[5,5-Bis-phenylsulfanyl-pentyl]-(l-phenylethyl)amine was prepared and 
purified as follows: Chromatography (silica) DCM and hexane (4:1) solvent elution
followed by EtOAc elution. This gave amine 296 in (6.38 g 40% over 2 steps) as an 
orange oil. Rp ( Si0 2 , 4:1 DCM:hexane): 0.12
Vmax (GG)/cm-‘; 2926 (CH;, CHz).
5h (400 MHz: CDCI3): 1.34 (3H, d, J  6.4 Hz, NCHCH3), 1.38-1.47 [2H, m,
NCH2(CH2)2], 1.54-1.63 [2H, m, NCH2(CH2)2], 1.79-1.84 (2H, m, CHCH2), 2.35-2.41 
(IH, m, CH2N), 2.43-2.49 (IH, m, CH2N), 3.72 (IH, q, J  6 .6  Hz, NCHCH3), 4.37 (IH, t, J 
6 .6  Hz, SCH), 7.21-7.34 (IIH , m, Ar-H), 7.42-7.44 (4H, m, Ar-H).
8 c (100 MHz: CDCI3): 24.26 (CH3), 24.75 (CH2), 29.59 (CH2), 35.61 (CH2), 47.47
(CH2), 58.24 (CH), 58.37 (CH), 126.51 (CH), 126.87 (CH), 127.63 (CH), 128.41 (CH),
128.85 (CH), 132.5 (CH), 134.22 (C), 145.60 (C).
m/z, (El): 407 (M '\  20%), 298 (M'+-SPh, 90%), 105 (CH3CHPh'*,1 0 0 %).
HRMS: 4071739. C25H29NS2: requires 407.1741.
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Microanalysis: C, 73.40; H, 7.17; N, 3.48%. C25H29NS2 requires C, 73.66; H, 7.17;
N, 3.44%.
Optical Rotation: [a]o -2.23 concentration : 0.1 dm'^ taken at 22 °C in DCM
1 -Phenyl-8-(1 -phenylethylamino)octan-3-one 297
Titanocene dichloride (930mg, 3.72 mmol), magnesium turnings (90 mg, 4.09 mmol) and 
4Â molecular sieves (200 mg) were heated briefly under vacuum. Following cooling, the 
reaction flask was flushed with argon, and THF (4 mL) and triethylphosphite (1.28 mL, 
7.20 mmol) were added and the reaction mixture was stirred for 3h. At this time a THF 
(10 mL) solution of (S)-A-{4-(l,3-dithian-2-yl)-butyl}-iV-(l-phenylethyl)amine 284 (0.900 
mmol) was added, and the solution stirred for 15 min. The reaction mixture was added via 
syringe into a flask containing 1 kan of resin-bound ester (0.150 mmol). The mixture was 
stirred under argon for 15-18 h. After this time, the kan was removed and then washed with 
THF (x 5), alternately with MeOH and DCM (x 5), then MeOH and finally with diethyl 
ether. The resin was then dried under vacuum. Following cleavage from resin using 
general method B, {S)-l-Phenyl-8-(l-phenylethylamino)octan-3-one 297 was obtained 
cleanly (37.3 mg, 37%yield. The enantiomer of this compound was also prepared using 
(R)-7/-[4-(l,3-dithian-2-yl)-butyl]-A-(l-phenylethyl)amine 285 and solid phase Takeda 
reaction: general method B with a kan of resin-bound ester containing 0.310 meq. Again 
following the general cleavage procedure B, {R)-l-Phenyl-8-(l-phenylethylamino)octan-3- 
one 290 was produced (18.8 mg, 19%) as a yellow oil.
(S)-l-PhenyI-8-(l-phenylethylamino)octan-3-one 297
V m a x  (NaCiycm-' : 2924 (CH or NH), 2854 (CH or NH), 1713 (C=0), 1603 (NH).
8 h (400 MHz: CDCI3): 1.19-1.24 [2H, m, NCH2(CH2)3], 1.35 [3H, d, J  6 .6  Hz,
NCH(CH3)], 1.40-1.49 [2H, m, NCH2(CH2)3], 1.48-1.55 [2H, m, NCH2(CH2)3], 2.35 (2H, 
t, /  7.4 Hz, PhCH2), 2.38-2.43 (IH, m, NCH2), 2.46-2.52 (IH, m, NCH2), 2.70 [2H, t, J  7.6 
Hz, C(0 )CH2], 2.88 (2H, t, J  7.6 Hz, C(0 )CH2], 3.76 [IH, q, J  6 .6  Hz, NCH], 7.15-7.20 
(2H, m, Ar-H), 7.22-7.34 (8H, m, Ar-H).
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6 c (100 MHz: CDCI3): 23.49 (CH2), 24.02 (CH3), 29.69 (CH2), 29.74 (CH2), 31.90
(CH2), 42.81 (CH2), 44.22 (CH2), 47.44 (CH2), 58.41 (CH), 126.04 (CH), 126.56 (CH), 
126.98 (CH), 128.28 (CH), 128.44 (CH), 140.09 (C), 145.10 (C), 210.13 (C).
m/z, (El): 323 (M '\  8 %), 308 (78%), 105 (100%). HRMS: 323.2252. C22H29NO
requires 323.2249.
(/?)-1 -Phenyl-8- ( 1 -pheny Iethylamino)octan-3-one 290
ÔH (400 MHz: CDCI3): 1.14-1.23 [2H, m, NCH2(CH2)3], 1.28 [3H, d, J  6.4 Hz,
NCH(CH3)], 1.32-1.39 [2H, m, NCH2(CH2)3], 1.41-1.48 [2H, m, NCH2(CH2)3], 2.23 (2H, 
t, /7 .4  Hz, PhCH]), 2.31-2.43 (IH, m, NCH2), 2.37-2.41 (IH, m, NCH2), 2.62 [2H, t, 77.6 
Hz, C(0 )CH2], 2.81 (2H, t, J  7.6 Hz, C(0 )CH2], 3.67 [IH, q, J  6 .6  Hz, NCH], 7.05-7.12 
(2H, m, Ar-H), 7.19-7.26 (8H, m, Ar-H).
6 c ( 1 0 0  MHz: CDCI3): 23.56 (CH2), 24.23 (CH3), 26.86 (CH2), 29.68 (CH2), 29.93
(CH2), 42.86 (CH2), 44.23 (CH2), 47.51 (CH2), 58.37 (CH), 126.05 (CH), 126.52 (CH),
126.86 (CH), 128.29 (CH), 128.40 (CH), 141.11 (C), 145.63 (C), 210.13 (C).
(S)-7-(1 -Phenylethylamino)heptan-2-one 298b
Following solid phase Takeda reaction general method C, using resin-bound acetic acid, 
and general cleavage procedure B, gave 7-(l'-Phenylethylamino)heptan-2-one 298b was 
prepared as an orange oil (26 mg 43%) as a yellow oil.
Vmax (NaCiycm"' : 2926 (CH;, CH3), 1715 (C=0).
Sh (400 MHz: CDCI3): 1.24-1.31 [2H, m, (CH2)3CH2N] 1.35 (3H, d, J  6 .6  Hz,
NCHCH3) 1.40-1.49 [2H, m, (CHz)3CH2N] 1.50-1.58 [2H, m, (CH2)3CHzN] 2.14 (3H, s, 
CH3CO) 2.37-2.43 (3H, m, CH2N and CH3COCH2) 2.46-2.52 (IH, m, CH2N) 3.74 (IH, q,
76.8 Hz, NCHCH3) 7.22-7.27 (IH, m, Ar-H) 7.29-7.36 (4H, m, Ar-H).
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ÔC (100 MHz: CDCI3): 23.58 (CH2), 24.31 (CH3), 26.81 (CH2), 29.86 (CH3), 29.97
(CH2), 43.58 (CH2), 47.58 (CH2), 58.38 (CH), 126.49 (CH), 126.81 (CH), 128.37 (CH), 
145.67 (C), 209.15 (C).
m/z, (CI): 324 [(M +H)\ 100%), 81 (29%). HRMS: 234.1856. C15H24NO
requires (M+H)^, 234.1858.
(S)-1 -(Furan-3'-yl)-6-(1 "-phenyleth-1 "-ylamino)hexan-1 -one 298g
M
Following solid phase Takeda reaction general method C using resin-bound ester and 
general cleavage procedure B, gave (S)-l(-Furan-3'-yl)-6-(l"-phenyleth-y'- 
ylamino)hexan-l-one 298g (38 mg, 43%) as a yellow oil.
Vmax (NaCl)/cm-': 2929 (CH;, CH;), 1677 (C=0), 1562 (NH).
Sh (400 MHz: CDCI3): 1.23-1.31 [5H, m, (CH;)3CH;N and NCHCH3] 1.34-1.48
[2H, m, (CH;)3CH;N] 1.57 -1.65 [2H, m, (CH;)3CH;N] 2.25-2.37 (IH, m, CH;N) 2.40-
2.46 (IH, m, CH;N) 2.60 (2H, t, J  7.5 Hz, COCH;) 3.67 (IH, q, J  6.5 Hz, NCHCH3) 6 .6 8  ( 
IH, d, J  1.3 Hz, H-4') 7.14-7.18 (IH, m, Ar-H) 7.21-7.27 (4H, m, Ar-H) 7.35 (IH, d, J  1.6 
Hz, H 5 ) 7.92 (IH, s, H-2').
Sc (100 MHz, CDCI3): 24.12 (CH;), 24.31 (CH3), 26.95 (CH;), 30.00 (CH;), 40.26
(CH;), 47.58 (CH;), 58.38 (CH), 108.59 (CH), 126.50 (CH), 126.81 (CH), 128.03 (CH), 
144.11 (CH), 145.67 (C), 146.99 (CH), 195.14 (C).
m/z, (El): 285 (M**, 7%), 270 (35%), 105 (75%), 83 (100%). HRMS:
285.1731. C18H23NO2: requires 285.1729.
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(S)-1 -(3',4'-Dimethoxyphenyl)-8-(1 "-phenylethylamino)octan-3-one 298h
Following solid phase Takeda reaction general method C using resin-bound 3-(3,4- 
dimethoxy)phenyl)propionic acid and general cleavage procedure B, gave (S)-l-(3',4^- 
Dimethoxyphenyl)-8-(y'-phenylethylamino)octan-3-one 298h (0.013 g 11%) as a yellow 
oil.
Vmax (GG)/cm ': 2930 (CH;, CH3), 1709 (C=0), 1514 (NH).
8 h (400 MHz: CDCI3): 1.19-1.30 [2H, m, (CH;)3CH;N] 1.34 (3H, d, J  6 .6  Hz,
NCHCH3) 1.38-1.48 [2H, m, (CH2)3CH;N] 1.49-1.57 [2H, m, (CH;)3CH;N] 2.36 [2H, t, J
7.4 Hz, C0 CH;(CH;)3] 2.38-2.42 (IH, m, CHaHyN) 2.44-2.51 (IH, m, CHaHyN) 2.68 [2H, 
t, J  7.5 Hz, Ar(CH;);CO] 2.83 [2H, t, J  7.5 Hz, Ar(CH;)2CO] 3.85 (3H, s, OCH3) 3.86 
(3H, s, OCH3) 6.71 (IH, d, J  7.4 Hz, H-5') 6.71 (IH, d, J  3.6 Hz, H-2') 6.77-6.79 (IH, m, 
H-6 ') 7.21-7.25 (IH, m, Ar-H") 7.28-7.34 (4H, m, Ar-H").
8 c (100 MHz: CDCI3): 23.54 (CH;), 24.32 (CH3), 26.87 (CH;), 29.40 (CH;), 29.98
(CH;), 42.92 (CH;), 44.52 (CH;), 47.58 (CH;), 55.79 (CH3), 55.88 (CH3), 58.41 (CH), 
111.17 (CH), 111.61 (CH), 120.02 (CH), 126.51 (CH), 126.84 (CH), 128.39 (CH), 133.72 
(C), 147.27 (C), 148.78 (C), 210.32 (C).
m/z, (El): 383 (M '\ 10%), 368 (25%), 151 (22%), 105 (43%), 83 (100%), 47
(25%). HRMS: 383.2459. C24H33NO 3 :  requires 383.2460.
(5)-1 -Diethylamino-8-(1 '-phenylethylamino)octan-3-one 298i
,xH
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Following solid phase Takeda reaction general method C using resin-bound 3- 
(diethylamino)-propionic acid and general cleavage procedure B, gave l-Diethylamino-8- 
(l-phenylethylamino)octan-3-one 298i (59 mg 56%) as a yellow oil.
Vmax (GG)/cm ': 2929 (CH;, CH;), 1708 (C=0).
8h  (400 MHz: CDCl;): 1.01 [6 H, t, J  7.2 Hz, C H ; C H ; N ]  1.23-1.31 [2H, m,
( C H 2 ) ; C H ; N ]  1.35 (3H, d, J  6 .6  Hz, N C H C H ; )  1.40-1.48 [2H, m, ( C H ; ) ; C H ; N ]  1.50-1.61 
[2H, m, ( C H ; ) ; C H ; N ]  2.37-2.43 [3H, m, N ( C H ; ) ; C O C H ;  and C H a H y N C H C H ; ]  2.45-2.55 
[7H, m, 2 X C H 3 C H 2 N ,  C H a H y N C H C H s  and N C H ; C H ; C O ]  2.73 [2H, t, J  7.0 Hz, 
N C H 2 C H 2 C O ]  3.74 (IH, q, J  6 .6  Hz, N C H C H 3 )  7.21-7.25 (IH, m, Ar-H) 7.27-7.34 (4H, 
m, Ar-H).
8 c (100 MHz: C D C I 3 ) :  11.64 (CH;), 23.47 (CH;), 24.31 (CH;), 26.85 (CH;), 30.00
(CH;), 40.35 (CH;), 43.03 (CH;), 46.76 (CH;), 47.28 (CH;), 47.57 (CH;), 58.35 (CH),
126.46 (CH), 126.76 (CH), 128.33 (CH), 145.71 (C), 210.52 (C).
m/z, (FAB-i-NOBA): 319 [(M+H)+, 28%], 246 (20%), 87 (100%). HRMS: 319.2746. 
Ca)H;;N;0 requires (M+H)*, 319.2749.
(S)-8-(1 -Phenylethylamino)octan-3-one 2981(b)
This compound was obtained by treatment of (l'S)-l-Diethylamino-8 -(l-phenyleth-l- 
ylamino)octan-3-one 298: (51 mg, 0.16 mmol) to hydrogenation conditions of Pd/(OH)2 
10% (12 mg) 145 psi, at 40 °C in EtOH (3 mL) with a basic work-up. This gave the 
unexpected result of (S)-8-(l-Phenylethylamino-octan-3-one 298i(b) as a dark orange oil 
(23 mg).
Vmax (GG)/cm ‘: 2930 (CH;, CH3), 1714 (C=0), 1452 (CH).
8h  (400 MHz: CDCl;): 1.04 (3H, t, J  7.3 Hz, CH;CH;CO) 1.18-1.31 (2H, m,
(CH;)3CH;N] 1.35 (3H, d, 76 .6  Hz, NCHCH3) 1.41-1.51 [2H, m, (CH;)3CH;N] 1.52-1.61
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[2H, m, (CH2)3CH;N] 2.35-2.43 (5H, m, C H a H y N  and C H 2 C O C H 2 )  2.45-2.54 (IH, m, 
C H a H b N ) 3.75 (IH, q, J  6 .6  Hz, N C H )  7.21-7.25 (IH, m, Ar-H) 7.28-7.35 (4H, m, Ar-H).
ÔC ( 1 0 0  MHz: CDCI3): 7.79 (CH3), 23.69 (CH3), 24.33 (CH;), 26.98 (CH;), 29.85
(CH;), 35.83 (CH;), 42.21 (CH;), 47.60 (CH;), 58.37 (CH), 126.47 (CH), 126.78 (CH),
128.35 (CH), 145.75 (C), 211.78 (C).
m/z, (CI): 248.2 [(M+H)*, 100%]. HRMS: 248.2012. CieH^NO requires
(M-t-H)*, 248.2014.
(S)-9-(1 -Phenylethylamino)nonan-4-one 298j
298j
M ethod A
Following solid phase Takeda reaction general method C  using resin-bound 3- 
(diethylamino)-propionic acid and general cleavage procedure B, gave (S)-9-(l- 
Phenylethylamino)nonan-4-one 298j (62 mg, 72%) as a yellow oil.
M ethod B
(5)-(-)-a-phenylethylamine (1.52 mL, 11.9 mmol) was added to a solution of 9-Iodo- 
nonan-4-one 320 (11.88 mmol) in dry MeOH (23 mL). This was left stirring for 30 min 
before triethylamine (1.66 nL , 11.9 mmol) was added and the solution left stirring for 30 h 
before being refluxed for a further 18 h. At this time the solvent was removed and aqueous 
HCl (IM) added until the reaction mixture dissolved and was at pH l. This solution was 
then extracted with ether (x 3), then chloroform (x 3). The aqueous was treated with 
aqueous NaOH (IM) to pH 12 and then extracted with DCM (x 3). The chloroform layer 
was neutralised with NaOH solution (IM) and all individual organic extracts were dried 
separately over sodium sulfate, filtered and concentrated under reduced pressure. The 
ether layer gave un-reacted 9-Iodo-nonan-4-one (137 mg), the DCM layer gave un-reacted 
(5)-(-)-a-phenylethylamine (836 mg), and the chloroform layer gave 9-('- 
phenylethylamino-nonan-4-one 298j (978 mg, 32%) as a yellow oil. This compound was 
also prepared in 6 % yield using 9-bromo-nonan-4-one (1.16 g, 5.27 mmol) as a starting 
material in place of 9-Iodononan-4-one.
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Vmax (GG)/cm‘‘; 2928 (CH3, CH2), 1707 (C=0).
5h (400 MHz; CDCI3): 0.81 (3H, t, 7 7.4 Hz, CH3CH2), 1.14-1.20 (2H, m, CH3CH2),
1.25 (3H, d, J  6.4 Hz, CHCH3), 1.33-1.38 [2H, m, C(0 )CH2(CH2)3], 1.39-1.54 [4H, m, 
C(0 )CH2(CH2)3], 2.24-2.27 [4H, m, CH2C(0 )CH2], 2.28-2.42 (2H, m, CH2N), 3.65 (IH, 
q, 76.8, NCHCH3), 7.11-7.16 (IH, m, Ar-H), 7.21-7.30 (4H, m, Ar-H).
5c (100 MHz; CDCI3); 13.68 (CH3), 17.02 (CH2), 23.58 (CH2), 24.16 (CH3), 26.50 
(CH2), 29.46 (CH2), 42.38 (CH2), 44.42 (CH;), 47.18 (CH2), 58.16 (CH), 126.27 (CH), 
126.56 (CH), 128.13 (CH), 145.28 (C), 210.77 (C).
m/z, (El); 261 (M” , 22%), 246 [M'^-'CHs, 100%], 105 (CH3CHPh'", 100%).
HRMS; 261.2090. C 17H27NO requites 261.2093.
Microanalysis: C, 77.67; H, 10.49; N, 5.36%. C17H27NO requires C, 78.11; H, 10.41; N, 
5.36%.
4-([l,3]-dithian-2-yl-butyl)-3-phenyl-N-(l-phenylethyl)propionainide 
^/7^-A/-4-(1,3-dithian-2-yl-butyl)-3-phenyl-A^(1-phenylethyl)propionamide 304
^  R o to m e r  1 3 0 4 R o to m e r  2
3-PhenyIpropionic acid (5.00 g, 33.3 mmol) was treated with thionyl chloride (24.3 mL, 
333 mmol) under anhydrous conditions and heated under refluxed for 3h. At this time the 
thionyl chloride was removed on the rotary evaporator and the acid chloride used directly 
in the formation of f/?)-A-4-(l,3-dithian-2-yl-butyl)-3-phenyl-A-(l- 
phenylethyl)propionamide 304. Triethylamine (2.45 mL, 17.6 mmol) was added to a 
solution of (/?)-(l,3-dithian-2-yl-butyl)-N-(l-phenylethyl)amine 285 (2.63 g, 15.6 mmol) 
stirring dry DCM (10 mL). After 15 min 3-phenylpropionyl chloride was added in dry 
DCM (5 mL). The reaction was left stirring overnight. Water was added to the reaction 
upon completion and the mixture extracted with DCM. The combinded organic phases 
were then washed with water ( x 5), NaOH (2M x 2), water (x 2) and brine ( x 1). The
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organic phases were then dried over sodium sulfate, filtered and concentrated under 
reduced pressure. Column chromatography (silica) eluting with pet ether / ethyl acetate 
(2:1) solvent system, gave (R)-N-{4-(l,3-dithian-2-yl-butyl)-3-phenyl-N-(l-phenyl- 
ethyl)propionamide 304 as a thick yellow oil, (2.12 g, 73%). The HNMR is particularly 
complicated due to the presence of rotamers A.and B in a 3:2 ratio. Rp ( SiOz, 2:1 Pet 
ether:ethyl acetate): 0.39.
Vmax (GG)/cm-' : 2932 (CH), 1633 [R2NC(0 )R].
8 h (400 MHz, CDCI3): 0.93 (IH^, m, C H 2N ) 1.13-1.23 [4H'''"®, m, SC H C H 2C H 2],
1.30 [3H'', d, 7 7.6 Hz, N C H (C H 3)], 1.41 (3H®, d, 77.1 Hz, N C H C H 3), 1.56-1.60 (2H®, m, 
C H 2CH 2N), 1.74-1.81 [IH^*®, m, CHaxHeq(CH2)2S2], 2.00-2.05 [IH"'*®, m, 
CHaxHeq(CH2)2S2], 2.60 [2H*, t, 7 7.4 Hz, C H 2 C (0 )N ], 2,67 [2H®, t, 7 7.5 Hz, C H  
2 C (0 )N )], 2.71-2.74 (4H**®, m, C H SC H 2), 2.77-2.95 (2H*. m, C H 2C H 2N ), 2.93-3.00 
[2H**®, m, C H 2Ph], 3.14-3.19 (IH®, m, C H 2N ) 3.80 (IH* t, 7 6.9 Hz, C H S ), 3.87 (IH®, t, 
7 6.9 Hz, C H S ), 4.99 (IH®, q, 7  6.9 Hz, N C H ), 5.96 (IH*, q, 7 7.0 Hz, N C H ), 7.08-7.26 
(lOH**®, m, Ar-H).
5c (100 MHz: CDCI3): 16.63 (CH3), 18.31 (CH3), 23.94 (CH 2), 24.30 (CH2), 25.80
(CH2), 25.89 (C H 2), 28.34 (CH2), 30.20 (CH2), 30.24 (CH2), 31.56 (CH;), 31.80 (CH2), 
34.51 (CH2), 34.82 (CH2), 35.35 (CH2), 35.50 (CH2), 43.08 (C H ;), 43.46 (CH2), 46.99 
(C H ), 47.24 (C H ), 55.00 (CH), 50.85 (C H ), 126.02 (C H ), 126.58 (C H ), 127.22 (C H ), 
127.43 (C H ), 127.48 (C H ), 128.26 (C H ), 128.38 (C H ), 128.43 (C H ), 128.53 (C H ), 140.43 
(C), 140.88 (C), 171.77 (C), 172.09 (C).
m/z, (El): 427 (M"", 70%), 105 (C6H5CHCH3*, 100%.), 322 [(CH2>3S2CH(CH2)
4NC(0 )(CH2) 2Ph+, 32%]. HRMS: 427.2003. C25H33NOS2: requires 427.2004.
Microanalysis: C, 69.70; H, 7.74; N, 3.41%. C23H33NOS2 requires C, 70.21; H,
7.77; N, 3.28%.
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8-Bromo-1-phenyl-octan-3-one 318
Following a literature p roced u rep h en y le th y l bromide (4.17 mL, 30.5 mmol) was added 
drop-wise, via a pressure equalizing dropping funnel, in dry ether (8  mL) to magnesium 
turnings (690 mg, 28.4 mmol) under argon. The 3 neck flask also had a water condenser 
attached. A couple of crystals of iodine were added and the reaction left till there was no 
more magnesium (1 h). At this point 6 -Bromohexane nitrile (5.00 g, 28.4 mmol) was 
added drop-wise in 20 mL dry ether and the reaction left stirring for 48 h. The reaction 
was cooled to 0 °C and ice was added to quench, followed by aqueous HCl (IM). The 
reaction mixture was then extracted with ether (x 5) and the combined organic phases dried 
over sodium sulfate, filtered and concentrated under reduced pressure. The resulting 
ketone was purified using silica gel column chromatography eluting with hexane and ether 
(3:1). The impure ketone was then purified further using kugelrorh distillation 170 °C at 
0.6 mmHg removing all impurities from the product leaving pure 8 -Bromo-l-phenyl- 
octan-3-one 318^^^ (825 mg, 1 0 %) as orange oil. Rf ( SiOz, 2 :1 , hexane:diethyl ether): 0 .6
Vmax (GG)/cm ': 2935 (CH;. CH;), 1711 (C=0), 1452 (C-H).
8 h (400 MHz: CDCI3): 1.19-2.25 [2 H, m, (CH2)3CH2Br] 1.36-1.43 [2 H, m,
(CH2)3CH2Br] 1.54-1.62 [2H, m, (CH2)3CH2Br] 2.40 (2H, t, J  7.4 Hz, CH2(CH2)4Br 2.73 
[2H, t, J  7.6 Hz, Ph(CH2)2] 2.90 [2H, t, J  7.6 Hz, P^C H ;);] 3.90 (2H, t, J  6 .8  Hz, 
CH2CH2Br) 7.14-7.21 (3H, m, Ar-H) 7.26-7.30 (2H, m, Ar-H).
8 c (100 MHz: CDCI3): 22.70 (CH2), 27.64 (CH;), 29.75 (CH;), 32.48 (CH;), 33.60
(CH;), 42.67 (CH;), 44.29 (CH;), 126.09 (CH), 128.50 (CH), 128.47 (CH), 141.03 (C), 
209.84 (C).
m/z, (El): 284 (M"", ®'Br, 18%), 282 (M"+, ’^ r ,  20%), 203 [M'*-Br", 25%], 179
rC ( 0 )(CH;)5, ®'Br, 13%], 177 rC(0)(C H ;);, ^ ^ r ,  15%], 91 (PhCH;+, 5%). HRMS: 
282.0619 (100%), 284.0602 (91%). Ci4Hi9™BrO requires 282.0619, C iA g ^B rO  requires 
284.0600.
Microanalysis: C, 60.12; H, 6.82%. CuHigBrO requires C, 59.37; H, 6.76%.
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9-Bromononan-4-one 319
319
Following a literature procedure, 6 -bromohexane nitrile (3.98 mL, 30 mmol), was 
added to an n-propylmagnesium chloride (2M) solution in ether (15.0 mL, 30 mmol). This 
was left stirring at 40 °C for 48 h. The reaction was then cooled to 0 °C and ice was added 
to quench, followed by aqueous HCl (IM), water was added and the reaction mixture 
extracted with ether (x 5). The combined organic phases were then dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. Chromatography (silica), eluting 
with hexane and EtOAc (3:1) gave 9-Bromo-nonan-4-one 319 in (3.55 g, 54%), as a 
yellow oil. Rf ( Si0 2 , 10:1 hexane: diethyl ether): 0.32
Vmax (GG)/cm ' : 2928 (C H ,, C H ;), 1709 (C =0 ).
5h(400MHz:CDCI3): 0.91 (3H, t, J  7.2 Hz, CH,) 1.39-1.47 (2H, m, CH3CH2)
1.53-1.63 [4H, m, C(0 )CH;(CH2)2] 1.81-1.90 (2H, m, CH2CH;Br) 2.38 [2H, t, J  7.6 Hz, 
CH3CH2CH;C(0 )] 2.42 (2H, t, J  7.2 Hz, CH3CH2CH2C(0 )CH2) 3.41 (2H, t, J  6 .6  Hz, 
CHzBr).
5c (100 MHz; C D C I3 ): 13.74 (C H 3 ), 17.27 (CH,), 22.79 (CH;), 27.71 (CH;), 32.52
(CH;), 33.63 (CH;), 42.41 (CH;), 44.76 (CH;), 211.00 (C).
m/z, (Cl): 221 [(M+H)" ,^ 100%], 223 [(M+H)" ,^ 98%], 141
[C H 3(C H ; ) ; C (0 ) ( C H ; )5" ,  15%]. HRMS: 221.0541 (1 0 0 %), 223.0522 (90%). C g H is ’^ B r O  
requires 221.0541, CçHig^'BrO 223.0521.
Microanalysis: C, 49.13; H, 7.90%. CgH^Br requires C , 48.88; H, 7.75%.
Data agrees with literature.
9-lodononan-4-one 320
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9-Bromononan-4-one 319 (2.63 g, 11.9 mmol) was added to a solution of sodium iodide 
(2.23 g, 14.9 mmol) in dry acetone (24 mL). The reaction mixture was left stirring for 1 h 
under argon, then heated under reflux for 30 min. The precipitate was then filtered off and 
washed with acetone. The acetone layer was then concentrated under reduced pressure to 
give iodide 320 (3.22 g, quantitative)
ÔH (400 MHz: MeOD): 0.94 (3H, t, J  7.4 Hz, CH3) 1.38-1.47 (2H, m, CH3CH2)
1.56-1.64 [4H, m, C(0 )CH2(CH2)2] 1.80-1.87 (2H, m, CH2CH2I) 2.45-2.60 [4H, m, 
CH2C(0 )CH2] 3.26 (2H, t, /  6 .8  Hz, CH2I)
ÔC (100 MHz: MeOD): 6.82 (CH2I), 14.10 (CH3), 18.27 (CH2), 23.72 (CH2), 31.09
(CH2), 34.58 (CH2), 43.23 (CH2), 45.45 (CH2), 213.82 (C).
Data agrees with literature.
(S)-6-(1 '-Phenylethylamino)hexanenitrile 321
(5)-(-)-a-Phenylethylamine (2.56 mL, 20.0 mmol) was added to a stirred solution of 6 - 
bromohexane nitrile (1.33 mL, 10.0 mmol) in dry MeOH (15 mL). This was left stirring 
under argon overnight. The reaction mixture was concentrated under reduced pressure and 
aqueous HCl (IM) was added and the mixture was extracted with ether (x 3), then 
chloroform (x 3). The chloroform layer was washed with NaOH (IM), then water and 
brine sequentially. The organic phase was dried over sodium sulfate, filtered and 
concentrated under reduced pressure. This gave 6-(ï-Phenylethylamino)hexanenitrile 321 
(1.36 g, 63%) as an oil.
Vmax (GG)/cm-' : 2928 (CHj, CH;), 2244 (CN).
Sh (400 MHz: CDCI3): 1.35 (3H, d, J  6.4 Hz, CH3), 1.39-1.53 [4H, m,
(CH;);CH;N], 1.63 (2H, quin, J  7.2 Hz, NCCH;CH;), 2.31 (2H, t, J  7.2 Hz, NCCH;),
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2.38-2.45 (IH, m, C H 2 N ) ,  2.48-2.54 (IH, m, C H 2 N ) , 3.74 (IH, q ,  J  6.5 Hz, N C H C H 3 ) ,  
7.22-7.26 (IH, m, Ar-H), 7.301-7.380 (4H, m, Ar-H).
ÔC (100 MHz: CDCI3): 17.10 (CH2), 24.41 (CH3), 25.26 (CH2), 26.43 (CH2), 25.68
(CH2), 29.50 (CH2), 47.36 (CH2), 58.44 (CH), 119.74 (C), 126.51 (CH), 126.91 (CH), 
128.40 (CH), 145.69 (C).
m/z, (CI): 217 [(M+H)"", 100%], 201 [NC(CH2)5NHCPh^, 18%). HRMS: 217.1709.
Ci4H2]N2 requires (M+H)^, 217.1705.
9-[1 (S)-Phenylethylamino]nonan-4(S)-ol and 
9-[1(S)-Phenylethylamino]nonan-4(R)-ol : mixture of diastereomers 326
Method A
(S)-l-Phenyl-8-(l-phenylethylamino)octan-3-one 298j (100 mg, 0.383 mmol) was 
dissolved in dry DCM (1 mL) and stirred with TMSCl (0.24 mL, 1.9 mmol) overnight 
under argon. At which time sodium triacetoxyborohydride (487 mg, 2.30 mmol) was 
added followed by dry DCM (1 mL) and the reaction left stirring overnight. Water was 
added to quench the reaction and the mixture was extracted with DCM. The organics were 
washed with IM  NaOH, water and then brine. The solution was dried over sodium sulfate, 
filtered and concentrated under reduced pressure. The reaction was incomplete so the 
residue was dissolved in dry DCM (2 mL) and treated to TMSCl (0.49 mL, 3.8 mmol) 
followed by sodium triacetoxyborohydride (975 mg, 4.6 mmol) and dry DCM (2 mL). 
Column chromatography on deactivated alumina eluted with hexane : DCM : MeOH 
(67:33:2) alcohol 9-(l-Phenyl-ethylamino)-nonan-4-ol 326 (35 mg, 35% ) as a pale yellow 
oil. Rf (AI2O3, 66:32:2 hexane: DCM:MeOH): 0.47
Method B
Sodium borohydride (26 mg, 0.694 mmol) was added to a solution of l-Phenyl-8 -(l- 
phenylethylamino)octan-3-one 298j (0.0907 g, 0.347 mmol) in MeOH (0.50 mL) and the 
reaction left stirring under nitrogen overnight. Water was added to quench the reaction.
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followed by aqueous HCl (IM). The reaction mixture was then extracted with chloroform 
and the organic layer washed with, sodium bicarbonate solution (x 2 ), water (x 2 ), brine (x 
1) and then dried over sodium sulfate, filtered and concentrated under reduced pressure. 
This gave alcohol 326 (63 mg 69%) as a pale yellow oil.
Vmax (GG)/cm ‘: 3305 (OH), 2926 (CH;, CH3), 1492 (Ar).
Sh (400 MHz: CDCI3): 0.83 (3H, t, J  6 .8  Hz, CH3CH;), 1.20-1.25 (2H, m,
CH3CH;), 1.28 (3H, d, J  6 .8  Hz, NCHCH3), 1.31-1.44 [lOH, m, CH0 H(CH;)4  
CH3CH;CH; ], 2.23-2.39 (IH, m, CH;N), 2.41-2.49 (IH, m, CH;N), 3.50-3.51 (IH, bs/m, 
CHOH), 3.68 (IH, q, 76.8 Hz, NCHCH3), 7.14-7.19 (IH, m, Ar-H), 7.20-7.27 (4H, m, Ar- 
H)
Sc (100 MHz: CDCI3): 14.08 (CH3), 18.78 (CH;), 24.42 (CH3), 25.43 (CH;), 27.29
(CH;), 30.09 (CH;), 37.29 (CH;), 39.61 (CH;), 47.68 (CH;), 58.35 (CH), 71.43 (CH), 
126.48 (CH), 126.79 (CH), 126.35 (CH), 145.65 (C).
m/z, (El): 248 (M^-CH;, 40%), 158 (M'+-CHCH3Ph, 8 %), 105 [CHsCHPh*,
80%] 84 (100%) HRMS: 263.2249. CnH;9NO requires 263.2249.
2-Phenethylazepane 330d
330d
(S)-l-Phenyl-8-(l-phenylethylamino)octan-3-one 298d ( 1 0 2  mg, 0.316 mmol) was placed 
into a glass vessel with EtOH (5 mL) and 20% palladium hydroxide on carbon (25 mg). 
The glass container was placed inside a bomb and the contents were hydrogenated at 70 psi 
H2 and 40 °C overnight. The reaction mixture was filtered through a pipette plugged with 
cotton wool and celite, washing through with more EtOH and concentrated under reduced 
pressure. The resultant mixture of starting material and product was separated on 
deactivated alumina eluting with DCM :MeOH (100:1) to give 2-phenethylazepane 330d 
(21.9 mg, 34%), as a yellow oil. Rp (AI2O3, 99:1 DCM:MeOH): 0.06
Vmax (GG)/cm-' : 2918 (CH;, CHj), 1494 (Ar).
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S h  (400 MHz: CDCb): 1.35-1.44 (IH, m, NCHCH;) 1.46-1.56 [IH, m,
NCHCH;(CH;)4] 1.57-1.68 [4H, m, NCHCH;(CH;)3] 1.70-1.74 (3H, m, NCHCH;(CH;)3, 
NCH;) 1.78-1.86 (IH. m, NCH;) 2.61-2.75 [4H, m, N(CH;);Ph] 3.00-3.05 (IH, m, NCH) 
7.13-7.22 (3H, m, Ar-H), 7.25-7.32 (2H, m, Ar-H).
Sc (100 MHz: CDCI3): 25.51 (CH;), 27.17 (CH;), 30.72 (CH;), 32.87 (CH;), 36.04
(CH;), 39.23 (CH;), 47.16 (CH;), 58.47 (CH), 125.67 (CH), 128.29 (CH), 128.33 (CH), 
142.22 (C).
m/z, (Cl): 204 [(M+H)\ 100%]. HRMS: 204.1751. Ci4H;;N requires (M+H)+
204.1752.
2-Propyl-azepanlum chloride 330]
V  CpH H
(S)-9-(l-Phenylethylamino)nonan-4-one 298j (74.1 g, 0.284 mmol) in EtOH (5 mL) was 
put into a glass vessel followed by 20% palladium hydroxide on carbon (36 mg), the 
vessel was placed in a bomb and the contents were hydrogenated at 90 psi Hi and 42°C 
overnight. The reaction mixture was filtered through a pipette plugged with cotton wool 
and celite, washed through with more EtOH and a few drops of ethereal HCl (2M) was 
added. The salt was then concentrated under reduced pressure. This gave 2- 
propylazepanium; chloride 330j (56.8g, quantitatively), as a peach coloured solid.
Vmax (GG)/cm ': 2930 (CH;, CH3), 2596 (-'14H;-),1452 (CH).
S h  (400 MHz: CDCI3): 0.96 (3H, t, J  7.2 Hz, CH3CH;), 1.47 (2H, bs, CH3CH;),
1.55-1.77 [6 H, m, CH3CH;CH;, NCHCH;, N(CH;);CH;], 1.90-1.98 [5H, m, N(CH;)3CH;, 
NCH; N(CH;);CH;], 2.05 (IH, bs, NCH;), 3.21 (2H, bs, NH;), 3.28 (IH, bs, NCH).
Sc (100 MHz: CDCI3): 13.72 (CH3), 19.16 (CH;), 24.74 (CH;), 24.91 (CH;), 26.94
(CH;), 30.47 (CH;), 35.82 (CH;), 44.99 (CH;), 58.72 (CH).
m/z, (Cl): 142 [(M+H)", 100%]. HRMS: 142.1599. C,H;oN requires
142.1596.
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6-Phenethyl-2,3,4,5-tetrahydro-pyridine 336d
3 3 6 d
Following general solid-phase Takeda reaction C, using A-[4,4-Bis(phenylsulfanyl)but-l- 
yl]-/V-tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound 3-phenyl propionoic 
acid 30d containing 0.328 meq the corresponding enol ether was formed. This was 
cleaved from resin using general cleavage method D and the 6-phenethyl-2,3,4,5- 
tetrahydropyridine 336d isolated (53.1 mg 87%) as a yellow oil.
Vmax (NaCl)/cm ‘: 2929 (CH;), 1665 (C=N), 1453 (CH).
8h  ( 4 0 0  MHz: C D C l ; ) :  1 . 5 6 - 1 . 5 8  [2 H, m, N C C H ; C H „ | H a x , N C ( C H ; ) ; C H e q H a x ]  1 . 6 3 -
1 . 6 9  [2 H, m, N C C H ; C H e q H a x , N C ( C H ; ) 2 C H e q H a x ]  2 . 0 8 - 2 . 1 2  [2 H, m, N C C H ; ( C H ; ) 3 ]  2 . 4 2 -  
2 . 4 6  ( 2 H ,  m, N C C H ; C H ; P h )  2 . 8 4 - 2 . 8 8  ( 2 H ,  m, N C C H ; C H ; P h )  3 . 5 7 - 3 . 6 0  ( 2 H ,  m, N C H ; )  
7 . 1 6 - 7 . 2 1  ( 3 H ,  m, Ar-H) 7 . 2 8 - 7 . 2 9  ( 2 H ,  m, Ar-H).
8 c (100 MHz: CDCI3): 19.59 (CH;), 21.93 (CH;), 29.63 (CH;), 32.63 (CH;), 42.45
(CH;), 49.29 (CH;), 125.82 (CH), 128.35 (CH), 142.01 (C), 170.12 (C).
m/z, (El): 187 (M '\  100%), 110 (35%), 91 (75%). HRMS: 187.1362. C 13H 17N
requires 1 8 7 . 1 3 6 1
Data agrees with literature.
6-(2-Methyl-propenyl)-2,3,4,5-tetrahydro-pyridine 336e
N' 
3 3 6 e
Following general solid-phase Takeda reaction C, using iV-[3-(l,3-dithian-2-yl)propyl]-A- 
tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound (N,-N,- 
dimethylamino)acrylic acid 30e containing 0.328 meq the corresponding enol ether was
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formed. This was cleaved from resin by shaking the kan with TFA (4%) and EtgSiH (1%) 
in 5 mL DCM for 2 h. At this time the cleavage solution was decanted and the kan washed 
with DCM (x 3). The organic phases were combined and concentrated under reduced 
pressure. The HCl salt was formed by addition of saturated ethereal HCl and the salt was 
washed with diethyl ether. 6-(2-Methyl-propenyl)-2,3,4,5-tetrahydro-pyridine 336e was 
isolated on washing with NaOH (aq, 4M) (62.7 mg, quantitative yield with some impurities 
present that could not be removed).
Vmax (NaCl)/cm'^: 2916 (CH z, CH3), 1637 (C=N)
ÔH (400 MHz: CD3O D): 1.82-1.96 [6 H, m, (CHz)3CH2N] 2.09 (3H, s, CH 3) 2.14 (3H,
s, CH3) 3.69 [2H, m, C H 2C =N ] 6.20 [IH, s, C H =C (CH 3)2].
ÔC (100 MHz: CD3O D): 18.08 (CH2), 20.45 (CH2), 22.05 (CH3), 29.22 (CH3), 45.53
(CH2), 121.35 (C H ), 161.45 (C), 182.50 (C).
m/z, (Cl): 138 (M"", 100%). HRMS: 138.1287. C9H 16N requires 138.1283.
6-(4'-Fluoro-phenyl)-2,3,4,5-tetrahydro-pyridine 336f
33 6 f
Following general solid-phase Takeda reaction C, using A-[4,4-bis(phenylsulfanyl)but-l- 
yl]-A-tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound 4-flourobenzoic acid 
30f (0.328 meq) gave the corresponding enol ether. This was cleaved from resin and 
cyclised using general cleavage method D and the 6-(4'-fluoro-phenyl)-2,3,4,5- 
tetrahydropyridine 336f isolated in (11.4 mg, 20%) as a yellow oil.
Vmax (NaCiycm ': 2924 (CH;), 1599 (C=N), 1506 (Aromatic ring).
5h (400 MHz: CDCI3): 1.64-1.70 [2H, m, NCH;(CH;);], 1.81-1.87 [2H, m,
NCH;(CH;);], 2.58-2.62 (2H, m, NCCH;), 3.81-3.83 (2H, m, NCH;), 7.04 (2H, t, J  8.7 
Hz, H 3 and H-4'), 7.76 (2H. dd, J  8 .6  Hz, 5.6 Hz, H-2' and H-6 ').
8c (100 MHz: CDCb): 19.69 (CH;), 21.77 (CH;), 26.91 (CH;), 49.83 (CH;), 114.99
(d, J 22 Hz, CH), 127.74 (d, J  8.0 Hz, CH), 136.38 (d, J  3.0 Hz, C), 163.68 (d, J  247 Hz, 
C), 164.29 (C).
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m/z, (El): 177 (M "\ 100%), 176 (98%), 135 (45%), 121 (98%), 84 (57%).
HRMS: 177.0955. C iiH^NF requires 177.0954.
6-Furan-3'-yl-2,3,4,5-tetrahydropyridine 336g
i r  N
o
3 3 6 g
Following general solid-phase Takeda reaction C, using A-[4,4-bis(phenylsulfanyl)but-l- 
yl]-7/-tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound 3-furoic acid 30g 
(0.311 meq), the corresponding enol ether was formed. This was cleaved from resin and 
cyclised using general cleavage method D and the 6-furan-3-yl-2,3,4,5-tetrahydro-pyridine 
336g isolated in (48.9 mg, 70%) as a yellow oil.
Vmax (NaCl)/cm ‘: 2933 (CH;), 1636 (C=N).
Sh (400 MHz: CDCb): 1.63-1.69 [2 H, m, NCH;(CH;);] 1.76-1.82 [2 H, m,
NCH;(CH;);] 2.45-2.49 (2H, m, NCCH;) 3.74-3.77 (2H, m, NCH;) 6.76 (IH, dd, J  1.8 
Hz, 0.65 Hz, furanyl-H-2') 7.39 (IH, t, 7 1.7 Hz, furanyl-H-4') 7.69 (IH, broad s, furanyl- 
H 5 )
ÔC ( 1 0 0  MHz: CDCI3): 19.36 (CHz), 22.10 (CH2), 27.63 (CH2), 49.46 (CH2), 107.92
(CH), 128.64 (C), 141.72 (CH), 143.46 (CH), 160.18 (C).
m/z, (El): 149 (M"", 45%), 120 (40%), 84 (98%), 49 (100%). HRMS: 149.0840.
C9H 11ON requires 149.0841.
A/,A/-Diethyl-[2-(3,4,5,6-tetrahydro-pyridin-2-yl)-ethyl]-amine 336i
N
3361
Following general solid-phase Takeda reaction C, using A-[4,4-Bis(phenylsulfanyl)but-l- 
yl]-A-tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound 3-(diethylamino)-
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propionic acid 3 0 :  containing 0 . 3 2 8  meq, the corresponding enol ether was formed. This 
was cleaved from resin and cyclised using general cleavage method D  and the N,N-diethyl- 
[2-(3,4,5,6-tetrahydro-pyridin-2'-yl)ethyl]amine 3 3 6 1  isolated in 7 2 %  yield, 0 . 0 4 3 1  g as a 
yellow oil.
Vmax (NaCI)/cm ': 2 9 3 2  (CH;, CH3), 1 7 1 3  [ ( C = 0 )  very weak], 1 6 6 0  (C=N), 1 4 4 4
(CH).
5 h  ( 4 0 0  MHz: C D C I 3 ) :  1 . 0 3  [6 H, t ,  J  7 . 2  Hz, N ( C H ; C H 3 ) ; ] ,  1 . 5 2 - 1 . 5 8  [ 2 H ,  m,
N C C H ; C H e q H a x ,  N C ( C H ; ) ; C H e , H a x ] ,  1 . 6 2 - 1 . 7 0  [ 2 H ,  m, N C C H ; C H e q H a x ,
N C ( C H ; ) ; C H a q H a x ] ,  2 . 1 2 - 2 . 1 8  [ 2 H ,  m, N C C H ; ( C H ; ) 3 ] ,  2 . 3 0  ( 2 H ,  t, J  7 . 9  Hz, 
N C C H ; C H ; P h ) ,  2 . 5 4  [ 4 H ,  q, J  7 . 2  Hz, N ( C H ; C H 3 ) ; ] ,  2 . 6 9  ( 2 H ,  t, J  8 . 0  Hz,
N C C H ; C H ; P h ) ,  3 . 5 4 - 3 . 5 6  ( 2 H ,  m, N C H ; ) .
8 c (100 MHz: CDCb): 11.81 (CH;), 19.57 (CH;), 21.85 (CH;), 29.65 (CH;), 38.14
(CH;), 46.83 (CH;), 49.24 (CH;), 49.66 (CH;), 169.91 (C).
Unstable under all conditions for mass spectrometry El, Cl and FAB.
6-Propyl-2,3,4,5-tetrahydro-pyridine 336j
336j
Following general solid-phase Takeda reaction procedure, using A-[4,4- 
bis(phenylsulfanyl)but-l-yl]-A-tritylamine 4 2 9  (523 mg, 0.984 mmol) and a kan of resin- 
bound butyric acid 3 0 j  containing 0.328 meq, the corresponding enol ether was formed. 
This was cleaved from resin using TFA (4%) and EtsSiH (1%) in DCM (5 mL) by shaking 
for 2  h with the kan containing resin-bound enol ether. The cleavage mixture was decanted 
and the kan washed (x 3) with DCM, than all the washings combined and concentrated 
under reduced pressure. The residue was washed with hexane to remove triphenylmethane. 
Addition of saturated ethereal HCl and a few drops of EtOAc to solvate TFA salt, followed 
by decanting of the solution left the precipitated HCl salt. This was then dried under high 
vacuum and characterised (43.8 mg, 74%). Conversion into the imine 3 3 6 j  was carried out 
by addition of NaOH (4 M) followed by C D C I 3  and the organic layer dried with sodium
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sulfate after the aqueous was removed. The characterisation data given is that of Louis 
Adriaenssens who carried out the synthesis of this compound after partial deuterium 
exchange at the positions indicated occurred in my sample.
5-Oxo-octyI-ammonium chloride: Evidence of D/H exchange 434
Vmax (NaCl)/cm'‘ in CD3OD: 2964 (CH;, CH3) and (-NH;'"), 1690 (C=0).
ÔH (400 MHz: DMSO): 0.94 (3H, t, J  7.4 Hz, CH3CH2), 1.67 (2H, sextet, J  7.5,
CH;CH;NH;), 1.70-1.83 [4H, m, CH3CH;CH;C(0 ), C(0)CH;CH;], 2.68 [2H, t, 77 .6  Hz, 
CH3CH;CH;C(0 )], 2.77 [2H, t, 7 6.0 Hz, C(0 )CH;(CH;)3], 3.56 (2H, m, CH2NH3), 3.70 
(3H, bs, NH3)
Sc (100 MHz: DMSO): 13.31 (CH3), 16.48 (CH;), 18.89 (CH;), 18.95 (CH;), 28.87
(CH;), 38.45 (CH;), 43.57 (CH;), 190.48 (C).
m/z, (Cl): 126 [(M+H)"-H;0, 100%], 97 (12%), 71 (18%). HRMS: 126.1284.
CsHiéN requires [(M+H)*-H;0] 126.1283.
6-Propyl-2,3,4,5-tetrahydro-pyridine 336j
V m a x  (NaCI)/cm ': 2927 (CH;, CH3), 1660 (C=N), 1459 (CH).
S h  (400 MHz: CDCI3): 0.91 [3H, t, 7 7.4 Hz, NC(CH;);CH3] 1.52-1.60 [4H, m,
NCCH;(CH;);] 1.62-1.68 (2H, m, NCCH;CH;CH3), 2.08-2.13 (4H, m, NCCH;)* 3.52- 
3.55 (2H, m, NCH;).
Sc (100 MHz: CDCb): 13.90 (CH;), 19.58 (CH;), 19.77 (CH;)**, 21.91 (CH;),
28.94 (CH;)*, 43.06 (CH;)*, 49.11 (CH;), 171.06 (C).
m/z, (Cl): 126 [(M+H)+, 100%], 71 (10%). HRMS: 126.1282. CgHisN requires
126.1283.
*= positions where D/H exchange has occurred.
**= positions that D/H exchange affects in the NMR.
Data unlabelled agrees with literature. 141
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6-Cyclohex-3-enyl-2,3,4,5-tetrahydro-pyridine 336k
336k
Following general solid-phase Takeda reaction C, using A-[4,4-bis(phenylsulfanyl)but-l- 
yl]-A-tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound 3-cyclohexene-l- 
carboxylic acid 30k containing 0.310 meq, the corresponding enol ether was formed. This 
was cleaved from resin and cyclised using general cleavage method D and the 6-Cyclohex-
3-enyl-2,3,4,5-tetrahydro-pyridine 336k isolated in (38.8 mg 77%) as a yellow oil.
Vmax (NaCiycm"': 2929 (CH;), 1662 (C=N) (C=C),
8 h (400 MHz: C D C b ) :  1.47-1.59 [3H, m, N C ( C H 2 ) ; C H ; ,  N C C H s C H e q H a x ]  1.64-
1.70 [2 H, m, NCCHzCHcqHax, N C C H C H « q H a x ]  1.85-1.89 ( I H ,  m, N C C H C H e q H a x )  2.07- 
2.18 (6 H, m, N C C H ; ,  N C C H C H ; C H ; ,  N C C H C H ; C H C H )  2.25-2.32 ( I H ,  m, N C C H )
3.56-3.59 ( 2 H ,  m, N C H ; )  5.66-5.73 ( 2 H ,  m, N C C H C H ; C H C H ) .
S c  ( 1 0 0  MHz: CDCb): 1 9 . 6 3  (CH;), 2 2 . 0 8  (CH;), 2 5 . 5 5  (CH;), 2 6 . 3 2  (CH;), 2 7 . 2 9
(CH;), 2 8 . 8 7  (CH;), 4 4 . 5 1  (CH), 4 9 . 2 1  (CH;), 1 2 6 . 3 0  (CH), 1 2 6 . 6 6  (CH), 1 7 3 . 8 5  (C).
m/z, (Cl): 164 [(M+H)", 100%], 163 (10%). HRMS: 164.1428. CnH,sN requires
(M+H)*, 164.1439.
6-((S)-1 -Phenyl-ethyl)-2,3,4,5-tetrahydro-pyridine 336m
336 m
Following general solid-phase Takeda reaction C, using N-[4,4-bis(phenylsulfanyl)but-l- 
yl]-A-tritylamine 429 (523 mg, 0.984 mmol) and a kan of resin-bound (R)-(-)-2-phenyl 
propionic acid 30m containing 0.328 meq, the corresponding enol ether was formed. This
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was cleaved from resin and cyclised using general cleavage method D and the 6 -((S)-l- 
Phenyl-ethyl)-2,3>4,5-tetrahydro-pyridine 336m isolated (28.2 mg, 46%) as a yellow oil.
Vmax (NaCl)/cm‘‘ : 2929 (C% . CH3), 1662 (C=N), 1448 (CH).
ÔH (400 MHz: CDCI3): 1.40 (3H, d, 7 7.1 Hz, CH3) 1.51-1.58 (4H, m, NCCH2CH2)
1.87-1.92 (IH, m, NCHzCH^H»,) 1.93-2.05 (IH, m, NCHzCH«,H,J 3.51 [IH, q, 77.1 Hz, 
NCCH(CH>3] 3.61-3.70 (2H, m, NCHj) 7.20-7.32 (5H, m, Ar-H).
5c (100 MHz: CDCI3): 18.56 (CH3), 19.58 (CH2), 22.06 (CH2), 27.58 (CH2), 49.39
(CH2), 49.86 (CH), 126.39 (CH), 127.57 (CH), 128.46 (CH), 143.75 (C), 172.44 (C).
m/z, (Cl): 188 [(M+H)*, 100%], 100 (20%). HRMS: 188.1436. CjsHisN requires
(M+H)*, 188.1439.
7-Phenethyl-3,4,5,6-tetrahydro-2H-azepine 339d
3 3 9 d
7-Phenethyl-3,4,5,6-tetrahydro-2//-azepine 339d was obtained as a yellow oil (40 mg, 
60%) via solid phase Takeda reaction general method C, using titanocene dichloride (980 
mg, 3.94 mmol), magnesium (105 mg, 4.33 mmol), triethyl phosphite (1.35 mL, 7.87 
mmol), 4-([l,3]dithian-2-yl-butyl-tritylamine (0.427 g, 0.984 mmol) and one kan of resin- 
bound 3-phenyl propionic acid 30d (0.328 meq). The resultant enol ether was cleaved 
using general cleavage method C. The trifluoroacetic acid salt obtained from resin was 
dissolved in aqueous HCl (1 M) and washed with ether. The aqueous phase was then 
basified with NaOH (4 M) and extracted with DCM (x 3). The DCM washings were 
combined washed with brine, dried over sodium sulphate, filtered and concentrated under 
reduced pressure to give (39.7 mg, 60%) of 7-Phenethyl-3,4,5,6-tetrahydro-2//-azepine 
339d as a yellow oil.
Vmax (NaCl)/cm ‘ : 2922 (CH2, CH;), 1663 (C=N).
8 h (400 MHz: C D C I 3 ) :  1.41-1.47 [2 H, m, ( C H 2 ) 3 C H 2 N ] ,  1.51-1.57 [2 H, m,
( C H 2 ) ; C H 2 N ] ,  1.76-1.81 [2H, m, ( C H 2 ) ; C H 2 N ] ,  2.38-2.40 (2H, m, C H 2 C N ) ,  2.56-2.60
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(2H, m, CHzCHzPh), 2.84-2.88 (2H, m, CHzCHzPh), 3.59-3.62 (2H, m, CH2N), 7.20-7.23 
(IH, m, Ar-H), 7.26-7.29 (4H, m, Ar-H).
ôc (100 MHz: CDCI3): 23.38 (CH2), 26.39 (CH2), 31.53 (CH2), 32.40 (CH2), 33.62
(CH2), 44.28 (CH2), 51.84 (CH2), 125.82 (CH), 128.34 (CH), 128.40 (CH),141.88 (C),
177.94 (C).
m/z, (El): 201 (M '\  30%), 83 (100%), 47 (21%). HRMS: 201.1518. C14H19N
requires 201.1517.
Data agrees with literature,
7-(4'-Fluorophenyl)-3,4,5,6-tetrahydro-2H-azepine 339f
Following general solid-phase Takeda reaction C, using N-[5,5-bis(phenylsulfanyl)pent-l- 
y]tritylamine 417 (535 mg, 0.984 mmol) and a kan of resin-bound 4-fluorobenzoic acid 30f 
(0.328 meq), the corresponding enol ether was formed. This was cleaved from resin by 
shaking the kan containing the resin-bound enol ether with TEA (4%) and EtgSiH (1%) in 
DCM (5 mL) for 2 h. The cleavage solution was then decanted, the kan washed with DCM 
and saturated ethereal HCl added to the combined organic phases to form the HCl salt. 
The solvent was then removed under reduced pressure and the residue washed with hexane 
to remove triphenylmethane to give the HCl salt, 6-(4'-fluorophenyl)-6- 
oxohexylammonium chloride 418f; (43.2 mg, 51%) as a grey solid; was the characterised 
before NaOH (4 M) was added to it followed by DCM. The organic phase was dried over 
sodium sulfate, filtered and concentrated under reduced pressure to give 7-(4'~ 
fluorophenyl)-3,4,5,6-tetrahydro-2H-azepine 339f (15.2 g 24%), as an orange oil. To 
ensure complete conversion to the imine the compound was placed under argon and heated 
at 65 °C for 4 h. At this the yield and NMR experiments were taken, which indicated 
alone was present.
6-(4'-FIuorophenyl)-6-oxohexylammoiiium chloride 418f
Vmax (KBr)/cm ‘: 2945 (CH;. CH;), 1678 (C=0), 1595 (aromatic-H).
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Sh (400 MHz: CD3OD): 1.45-1.53 [2H, m, NCH;(CH2)3], 1.70-1.80 (4H, m,
NCH2(CH2)3], 2.96 [2H, t, J  7.5 Hz, (CO CH;], 3.07 (2H, t, 7 7.1 Hz, NCH2), 7.22 (2H, t, 
7 8.7 Hz, H 3 and H-5'), 8.06-8.09 (2H, m, H 2  and H-6 ').
ôc (100 MHz: CD3OD): 24.66 (CH;), 27.03 (CH;), 28.45 (CH;), 39.01 (CH;,) 40.66
(CH;), 116.66 (d, 7 22 Hz, CH), 132.11 (d, 7 9.0 Hz, CH), 134.88 (d, 7 3.0 Hz, C), 167.19 
(d, 7 251 Hz, C), 200.61 (C).
m/z, (Cl): 210 (M+, 100%), 192 [(M"-H;0), 50%].
7-(4'-FluorophenyI)-3,4,5,6-tetrahydro-2H-azepine 339f
Vmax (NaCl) cm ': 2925 (CH;, CH;), 1632 (C=N).
Ô H  (400 MHz: CDCI3): 1.56-1.66 [4H, m, NCH;(CH;)3], 1.85-1.91 [2H, m,
NCH;(CH;)3], 2.82-2.88 (2H, m, NCCH;), 3.81-3.86 (2H, m, NCR;), 7.02-7.07 (2H, m, 
H 3 and H-5'), 7.67-7.72 (2H, m, H 2 and H-6 ').
ôc (100 MHz: CDCI3): 23.56 (CH;), 25.98 (CH;), 30.86 (CH;), 31.43 (CH;), 52.41
(CH;), 115.05 (d, 7  21 Hz, CH), 128.50 (d, 7 8.0 Hz, CH), 137.55 (d, 7 3.0 Hz, C), 163.60 
(d, 7  247 Hz, C).
m/z, (El): 191 (M'+, 10%), 83 (100%). HRMS: 191.1113. Ci;H,4NF requires
191.1110.
7-(Furan-3'-yl)-3,4,5,6-tetrahydro-2H-azepine 339g
4 1 8 g
3 3 9 g
Following general solid-phase Takeda reaction C, using N-[5,5-bis(phenylsulfanyl)pent-l- 
yl]tritylamine 417 (535 mg, 0.984 mmol) and a kan of resin-bound 3-furoic acid 30g 
(0.311 meq), the corresponding enol ether was formed. This was cleaved from resin by 
shaking the kan containing the resin-bound enol ether with TFA (4%) and EtgSiH (1%) in 
DCM (5 mL) for 2 h. The cleavage solution was then decanted, the kan washed with DCM 
and saturated ethereal HCl added to the combined organic phases to form the HCl salt.
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The solvent was then removed under reduced pressure and the residue washed with hexane 
to remove triphenylmethane to give the HCl salt, 6-(furan-3'-yl)-6-oxohexylammonium 
chloride 418g (30.3 mg; 45%), as a grey solid; which was the characterised before NaOH 
(4 M) was added to it followed by DCM. The organic phase was dried over sodium 
sulfate, filtered and concentrated under reduced pressure. To ensure complete conversion 
to the imine the compound was placed under argon and heated at 65 °C for 20 min. 
^HNMR spectroscopy showed incomplete conversion to the imine. Heating the NMR 
sample under argon for 40 min was tried but again incomplete conversion was attained. 
Finally the mixture was re-treated to a NaOH (4M) wash, the organic layer (CDCI3) dried 
over sodium sulfate and the organic layer passed through potassium carbonate but again a 
mixture of ketone 416g and imine 339g were obtained.
6-(Furan-3'-yl)-6-oxohexylammonium chloride 418g
Vmax (NaCiycm-': 3367 (-NH;+), 1671 (C=0).
5h (400 MHz: CD3OD): 1.32-1.69 [2H, m NCHzfCH;);], 1.56-1.69 [4H, m,
NCH;(CH;)3], 2.77 [2H, t, J  7.2 Hz, (CO)CH;], 2.84 (2H, t, J  7.6, NCH;), 6.67-6.67 (IH, 
m, H-5'), 7.50 (IH, t, J  1.7 Hz, H-4'), 8.26 (IH, s, H-6 ').
8 c (100 MHz: CD3OD): 24.77 (CH;), 26.98 (CH;), 28.41 (CH;), 40.59 (CH;), 40.64
(CH;), 109.21 (CH), 128.89 (C), 145.97 (CH), 149.99 (CH), 197.49 (C).
m/z, (El): 163 (M "-H ;0, 4%), 83 (100%), 47 (23%). HRMS: 163.0995.
C,oHi3NO requires (M‘*-H;0) 163.0997.
Evidence of imine: 7-(Furan-3'-yl)-3,4,5,6-tetrahydro-2H-azepine 339g
V m a x  (NaCl)/cm ' : 2925 ( C H ; ,  C H 3 ) ,  1629 (C=N).
6 h (400 MHz: CDCI3): 3.76-3.78 (2H, m, NCH;), 6.78-6.79 (IH, dd, J  0.8 and 1.8
Hz, H-5'), 7.41 (IH, t, J  1.7 Hz, H-4'), 7.71 (IH, s, H-6 ').
Sc (100 MHz; CDCI3): 23.69 (CH;), 26.25 (CH;), 31.35 (CH;), 31.92(CH;), 52.01
(CH;), 108.66 (CH), 129.32 (C), 142.53 (CH), 144.00 (CH), 167.85 (C).
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m/z, (El): 163 (M "\ 85%), 135 (100%), 120 (75%), 107 (72%), 94 (84%).
HRMS: 163.0998. C10H 13NO requires 163.0997.
7-Propyl-3,4,5,6-tetrahydro-2H-azepine 339]
418 j
Following general solid-phase Takeda reaction C, using A-[5,5-bis(phenylsulfanyl)pent-l- 
yl]-N-tritylamine 417 (535 mg, 0.984 mmol) and a kan of resin-bound butyric acid 30j 
containing 0.328 meq, the corresponding enol ether was formed. This was cleaved from 
resin by shaking the kan containing the resin-bound enol ether with TFA (4%) and Et3SiH 
(1%) in DCM (5 mL) for 2 h. At this time the cleavage mixture was decanted and the kan 
washed with DCM (x 3) the organic phases combined and ethereal HCl added. The 
solvent was removed under reduced pressure and the resultant salt washed with hexane to 
remove triphenylmethane. This gave 6-Oxononylammonium chloride 418j (27.9 mg, 48%) 
as a white solid 48% yield. This was converted to 7-propyl-3,4,5,6-tetrahydro-27/-azepine 
339j by addition of NaOH (4 M) followed by extraction with DCM. The organic phase 
was dried over sodium sulfate, filtered and carefully concentrated under reduced pressure, 
with CDCI3 added when the bulk of the DCM had been removed. This was concentrated 
under reduced pressure again to remove remaining DCM and the process repeated 3 times. 
This gave a sample for HNMR spectroscopy that indicated partial conversion to the imine 
(2:1 amino ketone to imine). The NMR sample was then decanted into a dry flask, flushed 
with argon, and heated to 60 °C for 20 min. At this point a NMR spectra were taken 
showing complete conversion to the imine. No yield was taken due to the compounds 
volatility.
6 -Oxo-nonyl-ammonium chloride
Vmax (NaCl in CDjODycm ': 2934 (CH;, C H 3 ) ,  2557 (-NH3') ,  1704 (0=0).
5h (400 MHz: CD3OD): 0.91 (3H, t, J  7.4 Hz, CH3CH2) 1.34-1.41 (2H, m, CH3CH;) 1.52- 
1.61 [4H, m, (CH;)3CH;N] 1.63-1.71 [2H, m, (CH;)3CH;N] 2.44 [2H, t, J  7.3 Hz, 
CH;(CO)CH;] 2.50 [2H, t, 77 .2  Hz, CH;(CO)CH;] 2.92 (2H, t, 77.6 Hz, CH;N).
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ôc (100 MHz: CD3OD): 14.07 (CH3), 18.26 (CH2), 24.13 (CH2), 26.99 (CH2), 28.40
(CH2), 40.62 (CH2), 43.03 (CH2), 45.48 (CH2), 213.68 (C).
m/z, (CI): 140 (M^ ^ O ,  100%). HRMS: 140.1439 CgHigN (M+-H2O) requires
140.1441.
7-Propyl-3,4,5,6-tetrahydro-2.H^-azepine 339j
Vmax (NaCl)/cm'^: 2925 ( C H 2 ,  C H 3 ) ,  1656 (C=N).
ÔH (400 MHz, C D C I 3 ) :  0.94 (3H, t, J  7.4 Hz, C H 3 C H 2 ) ,  1.40-1.46 (2H, m, C H 3 C H 2 ) ,
1.50-1.64 [4H, m, NCH2(CH2)3], 1.75-1.81 [2H, m, NCH2(CH2)3], 2.23 (2H, t, J  7.6 Hz, 
N C C H 2 C H 2 C H 3 ) ,  2.34-2.37 (2H, m, N C C H 2 ) ,  3.56-3.58 (2 H, m, N C H 2 ) .
ôc (100 MHz, CDCI3): 13.96 (CH3), 19.47 (CH2), 23.49 (CH2), 26.48 ( C H 2 ) ,  31.58
(CH2), 29.97 ( C H z ) ,  44.91 ( C H 2 ) ,  51.77 ( C H 2 ) ,  178.76 (C=N).
m/z, (El): 139 (M "\ 23%), 124 (40%), 111 (100%), 83 (70%). HRMS:
139.1360. C9H 17N requires 139.1361.
7-[Cyclohex-3'-en-1 -yl]-3,4,5,6-tetrahydro-2H-azepine 339k
Following general solid-phase Takeda reaction C, using N-{5,5-bis(phenylsulfanyl)pent-l- 
yl}tritylamine 417 (535 mg, 0.984 mmol) and a kan of resin-bound 3-cylcohexene-l- 
carboxylic acid 30k (0.328 meq), the corresponding enol ether was formed. This was 
cleaved from resin and cyclised using general cleavage method D and a ^HNMR and 
^^CNMR spectra obtained. This indicated that partial conversion to the imine had taken 
place (2:1 imine to amino ketone) so the NMR sample was concentrated under reduced 
pressure and re-subjected to a base wash with NaOH (4 M). This gave 7-[cyclohex-3'-en-
l-yl]-3,4,5,6-tetrahydro-2H-azepine 339k, (15.9 mg, 27%) as a yellow oil.
Vmax (NaCl)/cm'‘: 2924 (CH;, CHj), 1681 (C=N), 1448 (CH).
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g» (400 MHz: C D C I3 ) :  1.40-1.48 [2H, m, N C H 2 ( C H ; ) 3 ] ,  1.50-1.56 [3H, m,
NCH2(CH ;)3 ], 1.75-1.81 [2H. m, N C H 2 (C H 2 )3 , N C C H C H e q H a x C H ;] ,  1.88-1.91 (IH, m, 
NCCHCHeqHaxCHj), 2.10-2.12 (4H ,  m, N C C H C H 2 C H 2 , N C C H C H j C H C H ) ,  2.37-2.40 
(3H, m, N C C H C H 2 ,  N C C H 2 ) ,  3.59-3.61 (2H, m, N C H ; ) .  5.57-5.73 ( 2 H ,  m, C H = C H ) .
Ôc (100 MHz: CDCI3): 23.95 (CH;), 25.36 (CH;), 25.83 (CH;), 26.42 (CH;), 28.31
(CH;), 31.43 (CH;), 31.55 (CH;), 46.16 (CH), 51.75 (CH;), 126.12 (CH), 126.63 (CH), 
181.18(C).
m/z, (CI): 178 [(M-t-H)*, 100%], 177 (20%). HRMS: 178.1595. C,;H;oN
requires (M-rH)* 178.1596.
AI-[4-(1,3-Dithian-2-yl)-butyl]-Af-tritylamlne 409
409
Method A
H
P h
Pyridine sulphur trioxide (5.83 g, 36.6 mmol) was added to a solution of 4-(l,3-dithian-2- 
yl)butanol 282 (1.85 g, 9.64 mmol), triethylamine (9.0 mL, 64 mmol), and DMSO (6 .8  
mL, 96 mmol) in DCM (30 mL) and the solution stirred overnight. The reaction was 
quenched with water (20 mL) followed by aqueous sodium hydrogen carbonate solution 
and the aqueous layer extracted with DCM (3 x 100 mL). The organic phases were 
combined, washed with brine, dried over magnesium sulfate, filtered and concentrated 
under vacuum. This gave 4-(l,3-dithian-2-yl)butyraldehyde, 283 (2.72 g, 97%), which 
was used without further purification. 6 h (400 MHz: CDCI3): 1.76-1.97 [5H, m,
C H S C H z C H a x H e q ,  ( C H 2 ) 2 C H 2 C H O ] , 2.09-2.15 (IH, m, C H S C H z C H a x H e q ) ,  2.48 [2 H, t, J
6 .6  Hz, ( C H 2 ) 2 C H 2 C H 0 ] ,  2.81-2.92 (4H, m, C H S C H 2 ) ,  4.05 (2H, t, J  6 .6  Hz, C H S )  9.77 
(IH, s, C H O ) .  A portion of the crude aldehyde (1.13 g) was subjected to reductive 
amination conditions. Tritylamine (1.03 g, 3.97 mmol) was added to a solution of 
aldehyde (1.13 g) in dry MeOH (38 mL). Powdered 4 Â molecular sieves were added (200 
mg) and the mixture was heated under reflux overnight. After this time sodium 
cyanoborohydride (613 mg, 9.75 mmol) was added and the reaction left stirring for 4h. 
Water 30 mL) was added to quench the reaction and the methanol was removed on a rotary 
evaporator. Ethyl acetate was added to and the layers separated. The aqueous layer was 
extracted with ethyl acetate (x3). The combined organics were washed with water, brine 
then dried over sodium sulfate, filtered and concentrated under reduced pressure. Column
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chromatography (SiOz), hexane:DCM (2:1) gave a solid, which was then recrystallised in 
hot methanol to give N-[4-(l,3-dithian-2-yl)'butyl]-N-tritylamine 409 as prisms (521 mg, 
18% yield). An X-ray crystal structure was obtained to confirm the structure, please see 
appendix la .
M ethod B
4-(l,3-Dithian-2-yl)butyraldehyde oxime 410 (31.7 g 132 mmol) in THF (650 mL), was 
treated with LiAlH4 (25.1 g, 661 mmol) portion-wise at 0 °C. The reaction was stirred 
overnight. Water was added to quench the reaction, followed by NaOH (4 M) solution and 
the salts were filtered off. The aqueous phase was extracted with EtOAc (x 3) and the 
combined organics washed with brine and dried over sodium sulfate. The organic phase 
was then filtered and concentrated under reduced pressure to give crude 4-(l,3-dithian-2- 
yl-butyl)amine 411 (12.1 g). which was used directly in the next step. Product signals: Ôh 
(400 MHz: CDCI3): 1.43-1.50 [2H, m, (CH2)3CH2N], 1.51-1.62 [2H, m, (CH2)3CH2N],
1.74-1.80 [3H, m, (CH2)3CH2N and CHaxHeq(CH2)2S2], 1.81-1.92 [IH, m,
C H a x H e q ( C H 2 ) 2 S 2 ] ,  2 . 7 0  (2H, t, J  6.9 Hz, C H 2 N ) ,  2.80-2.92 [4H, m, (8 ^ 2)2], 4.06 [IH, t, 
J  6 .8  Hz, CH(SCH2)2]- Trityl chloride (19.0 g, 68.3 mmol) was added to a solution of 4- 
(1,3-dithian-2-yl-butyl)amine (11.9 g, 62.1 mmol) in pyridine (200 mL). This was left 
stirring under argon overnight. At this time the pyridine solvent was removed on rotary 
evaporator and ethyl acetate added. The organics were then washed with aqueous copper 
sulfate solution (0.5 M, x 3), brine, dried over sodium sulfate, filtered and concentrated 
under vacuum. The resultant red/brown solid was subjected to column chromatography on 
deactivated alumina (5% water added) eluted with hexane:DCM (2:1) to give amine 409 
as prisms (4.68 g, 20% yield over 4 steps from 4-(l,3-dithian-2-yl)butanol 282.
m.p. 115-117 °C.
Vmax (KBr)/cm ' : 3439 s (NH), 2933 s (CH;, CH;).
Ô h ( 4 0 0 M H z : C D C 1 3 ) :  1.50-1.52 [4H, m, ( C H ; ) ; C H ; N ] ,  1.68-1.73 (2H, m, C H ;
C H S ; ) ,  1.77-1.90 [IH, m, C H „ H e , ( C H ; ) ; S ; ] ,  2.05-2.13 (3H, m, C H ; N  and 
C H S C H ; C H a x H e q ) ,  2.76-2.88 (4H, m, C H S C H ; ) ,  4.01 (IH, t, 7 6 .8  Hz, C H S ) ,  7.15-7.19 
(3H, m, Ar-H), 7.23-7.33 (6 H, Ar-H), 7.46-7.48 (6 H, m, Ar-H).
Sc (100 MHz; CDCb): 24.48 (CH;), 26.00 (CH;), 30.48 (CH;), 35.45 (CH;), 43.31
(CH;), 47.58 (CH), 70.81 (C), 126.14 (CH), 127.74 (CH), 128.60 (CH), 146.22 (C).
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m/z, (FAB+/NOBA): 434 [(M+H)"^, 10%], 356 (55%), 243 (100%), 190 (6 8 %),
165 (48%), 105 (10%). HRMS: 434.1975. C27H32NS2: requires (M+H)^ 434.1976.
Microanalysis: C, 74.54; H, 7.19; N, 3.41%. C27H31NS2 requires C, 74.78;
H, 7.21; N, 3.23%
4-(1,3-Dithian-2-yl)butyraldehyde oxime 410
A solution of crude the 4-(l,3-dithian-2-yl)butyraldehyde 283 (2.50 g) in ethanol (73 mL) 
was added to a stirred solution of hydroxylamine hydrochloride (1.00 g, 14.5 mmol) and 
sodium acetate (1.94 g, 23.7 mmol) in water (7 mL) and the reaction mixture was heated 
under reflux overnight. The reaction mixture was then concentrated under vacuum and 
water and chloroform added. The aqueous layer was extracted with chloroform (x 3) and 
the combined organic phases washed with water and brine, dried over sodium sulfate, 
filtered and concentrated under vacuum. Recrystallisation from hot diethyl ether gave 4- 
( 1,3-Dithian-2-yl)butyraldehyde oxime 410 as a beige flaky solid (1.37 g 40% yield over 2 
steps from 4-(l,3-dithian-2-yl)butanol 282) as a mixture of geometrical isomers.
m.p. 100-102 °C.
Vmax (KBr)/cm ' : 3200 (OH) 2925 (CH;, CH;) 1662 (C=N).
8 h (400 MHz: CDCl;): 1.69-1.77 (2H, m, CH;CH;CHN), 1.79-1.85 [2H, m,
CH;(CH;);CHN], 1.86-1.92 (IH, m, CHSCH;CHaxHeq), 2.10-2.15 (IH, m, 
CHSCH;CHaxHeq), 2.39-2.44 (2H, m, CH;CHN), 2.81-2.93 [4H, m, CH(SCH;);], 4.07 
[IH, t, J 6.7 Hz, CH(SCH;);], 6.72 (IH, t, J 5.5 Hz, CHN), 7.23 (IH, s, OH).
Major isomer; ôc (100 MHz: CDCl;): 23.14 (CH;), 24.39 (CH;), 25.92 (CH;), 30.38
(CHi), 34.97 (CH2), 47.04 (CH), 152.23 (CH). Extra peaks due to minor isomer: 23.52 
(CH2), 28.96 (CH2), 34.67 (CH2), 151.57 (CH).
m/z, (Cl) : 206 [(M+H)\ 100%], 188 (35%), 148 (32%). HRMS: 206.0674.
CgHi6N0 S2: requires 206.0673.
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Microanalysis: C, 46.66; H, 7.27; N, 6.56%. C8H 15NOS2 requires C, 46.82; H,
7.37; N, 6.83%.
4-(1,3-Dithian-2-yl)butylamine 411
Method A
Following a procedure adapted from Molinski and co-w o r k e r s ^ 4-(l,3-dithian-2- 
yl)butyraldehyde oxime 410 (200 mg, 0.975 mmol) was dissolved in dry THF (10 mL) 
under argon. The solution was cooled to 0 °C and lithium aluminium hydride (185 mg,
4.88 mmol) was added portion-wise to the solution, taking care not to add too much at 
once to avoid a large exotherm. This was left stirring overnight and then was quenched by 
careful addition of water followed by aqueous NaOH (4M). The aqueous phase was 
extracted with ethyl acetate (x 3). The combined organic phases were washed with brine, 
dried over sodium sulfate, filtered and concentrated under vacuum. This gave amine 411 
as an orange oil (121 mg 65%) but further purification was not possible.
Method B
Following a procedure adapted from Demir et al sodium borohydride (134 mg, 3.54 
mmol) was added to a stirred solution of 4-(l,3-dithian-2-yl)butyraldehyde oxime 410 (100 
mg, 0.495 mmol) and molybdenum trioxide (153 mg, 1.06 mmol) in methanol (7 mL). A 
water bath was used to cool the exotherm and the reaction was left stirring overnight. The 
reaction mixture was then filtered through celite and washed with methanol. The solvent 
was removed, under vacuum, and aqueous KOH (20% solution) was added. This was 
extracted by DCM (x 3). The aqueous layer was saturated with sodium chloride and re­
extracted with DCM. The combined organics were washed with water, then brine, dried 
over sodium sulfate, filtered and concentrated under vacuum. This gave amine 411 as a 
yellow oil (60 mg 64% ). Further purification was not possible.
Product signals: ÔH (400 MHz: C D C I 3 ) :  1.43-1.50 [2H, m, , ( C H 2 ) 3 C H 2 N ]  1.51-1.62
[2H, m, (CH2)3CH2N] 1.74-1.80 [3H, m, (CH2)3CH2N and CHSCHzCHaxHeq] 1.81-1.92
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(IH, m, C H S C H z C H a x H e q )  2.70 (2H, t, J  6.9 Hz, C H 2 N )  2.80-2.92 (4H, m, C H S C H 2 )  4.06 
(IH, t, y 6 .8  Hz, C H S ) .
Tritylamine 413
NH2
Ph-fph
41 3
Following the procedure of Chadwick and co-workers Ammonia gas was condensed (600 
mL) using a cold finger and dry ice. Tritylchloride (30.0 g, 107 mmol) was added and the 
reaction stirred at -55 °C for 6  h. At this time the ammonia was allowed to evaporate and 
resulting white solid stirred with diethyl ether. The resulting solution was filtered and 
washed with 1 0 % aqueous sodium sulphate solution, filtered and concentrated under 
reduced pressure. This gave tritylamine 413 as a crystalline solid (26.5 g, 95%).
mp: 100 °C, literature: 103 ‘’C'*’
V m a x  (KBr)/cm ' : 3364 (-NH;), 3298 (-NH;).
5h (400 MHz: CDCb): 2.31 (2H, s, NH;), 7.18-7.30 (15H, m, Ar-H).
Sc (100 MHz: CDCl;): 66.19 (C), 126.55 (CH),127.86 (CH), 128.09 (CH), 148.58
(C).
m/z, (El): 259 (M'*, 8 %), 182 (100%), 104 (65%). HRMS: 259.1360.
C19H 17N requires 259.1361.
Microanalysis: C, 87.77; H, 6.57; N, 5.42%. C19H17N requires C, 87.99; H, 6.61;
N, 5.40%.
A^[5,5-Bis(phenyisuifanyi)pentyi]trityiamine 417
N Ph
Pyridine sulphur trioxide (49.4 g, 310 mmol) was added to a solution of 4,4- 
Bis(phenylsulfanyl)pentanol 276 (81.7 mmol), triethylamine (75 mL, 539 mmol), and 
D M S O  (58 mL, 810 mmol) in D C M  (270 mL) and the solution stirred overnight. The
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reaction was quenched with water followed by aqueous sodium hydrogen carbonate 
solution and the aqueous layer extracted with DCM (x 3). The organics were combined, 
washed with brine, dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. This gave crude 4,4-Bis(phenylsulfanyl)pentaldehyde 277 as a dark orange oil 
(30.64 g), which was used without further purification. 6 h (400 MHz, CDCI3): 1.83-
1.89 [2H, m, CH(CH2)2], 1.91-1.98 [2H, m, CH(CH2)2], 2.41 (2H, td, 7 7.1 Hz and 1.4 Hz, 
CH2CHO), 4.38 (IH, t, J  6.4 Hz, CHS2), 7.28-7.35 (6 H, m, Ar-H), 7.44-7.47 (4H, m, Ar- 
H), 9.71 (IH, t, J  1.5 Hz, CHO). Tritylamine (25.0 g, 96.4 mmol) was added to a solution 
containing a third of the crude aldehyde (10.11 g, 81.7 mmol) in MeOH (475 mL). 
Powdered 4 molecular sieves were added (1.6 g) and the mixture was heated under reflux 
overnight. After this time sodium cyanoborohydride (7.75 g, 123 mmol) was added and 
the reaction left stirring for 4 h. Water was added and the methanol was removed under 
reduced pressure. Ethyl acetate was added to dissolve the organic phases and the aqueous 
layer was extracted with ethyl acetate (x 3). The combined organics were washed with 
water, brine then dried over sodium sulfate, filtered and concentrated under reduced 
pressure. Column chromatography (AI2O3 deactivated), eluting with hexane - DCM (2:1), 
gave a thick oil, which crystallised on standing. The crystals were washed with hexane to 
give N-[5,5-bis(phenylsulfanyl)pentyl]tritylamine 417 as prisms (14.98 g, 34%). An X-ray 
crystal structure was obtained to confirm the structure, please see appendix lb .
m.p: 60-62 °C.
Vmax (KBr)/cm ': 3056 (NH), 2927 (CH;, CH;), 1581 (Ar-H).
Sh (400 MHz: CDCl;): 1.40-1.47 [2H, m, NCH;(CH;);], 1.54-1.66 [2H, m,
NCH;(CH;);], 1.78-1.83 (2H, m, SCHCH;), 2.08 (2H, t, J  7.0 Hz, NCH;), 4.37 (IH, t, J
6.7 Hz, CHS), 7.14-7.18 (3H, m, Ar-H), 7.21-7.31 (12H, m, Ar-H), 7.39-7.44 (lOH, m, 
Ar-H).
Sc (100 MHz: CDCl;): 24.80 (CH;), 30.25 (CH;), 35.77 (CH;), 43.26 (CH;), 58.33
(CH), 70.80 (C), 126.14 (CH), 127.60 (CH), 127.72 (CH), 128.36 (CH), 128.84 (CH), 
132.65 (CH), 134.24 (C), 146.19 (C).
m/z, (FAB+/NOBA): 546 [(M-t-H*), 8 %], 468 (16%), 302 (25%), 243 (100%), 165 (45). 
HRMS: 546.2294. C;6H;sNS; requires (M-t-H)"^ , 546.2289.
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Microanalysis: C, 79.17; H, 6.44; N, 2.56%. C36H35NS2 requires C, 79.22; H, 6.46;
N, 2.57%.
8-(A/;/V-Diethylamino)-6-oxooctylamine bishydrochloride sait 4191
Following general solid-phase Takeda reaction C, using N-{5,5-bis(phenylsulfanyl)pent-l- 
yl}tritylamine 417 (535 mg, 0.984 mmol) and a kan of resin-bound 3-(N,N-
diethylamino)propionic acid 30: (0.328 meq), the corresponding enol ether was formed. 
This was cleaved from resin by shaking the kan containing the resin-bound enol ether with 
TFA (4%) and EtsSiH (1%) in DCM (5 mL) for 2 h. The cleavage solution was then 
decanted, the kan washed with DCM and the solvent removed under reduced pressure. 
The residue was washed with hexane to remove triphenyl methane and DCM and saturated 
ethereal HCl added to form the HCl salt. The solvent was then removed under reduced 
pressure leaving 8-Diethylamino-6-oxooctylamine bishydrochloride salt 419: as an orange 
oil, (51.7 mg, 55%).
Vmax (NaCl in CD;OD)/cm ': 2946 (CH;, CH;) and (-NH;*), 1712 (C=0).
ÔH (400 MHz: CD;OD): 1.35 [6 H, t, J  7.2 Hz, (CH;CH;);N], 1.40-1.46 [2H, m,
NCH;(CH;);], 1.61-1.74 [4H, m, NCH;(CH;)3], 2.62 [2H, t, J  7.2 Hz, (CH;CH;);NCH;], 
2.95 [2H, t, J  7.6 Hz, NCH;CH;(CO)CH;], 3.07 [2H, t, J  6.7 Hz,
(CH;CH;);NCH;CH;(CO)], 3.24 [4H, q, J  7.2 Hz, (CH;CH;);N], 3.40 (2H, t, J  6.7 Hz, 
CH;NH;+).
8c (100 MHz: CD;OD): 9.33 (CH;), 23.82 (CH;), 26.88 (CH;), 28.29 (CH;), 37.43
(CH;), 40.74(CH;), 43.00 (CH;), 47.77 (CH;), 208.67 (C).
3-(1,3-Dlthlan-2-yl)proplonaldehyde oxime 426
426
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3 -(l,3 -Dithian-2 -yl)propionaldehyde 198 was prepared from 3 -( l,3 -dithian-2 -yl)propan-l- 
ol 197 (15.2 g, 85 mmol) in DCM (280 mL) under modified Swem oxidation conditions 
detailed previously, using pyridine sulphur trioxide (51.4 g, 323 mmol), triethylamine 
(78.0 mL, 561 mmol) and DMSO (60.0 mL, 850 mmol). The resultant aldehyde 198 was 
taken on without further purification. 5h (400 MHz: CDCI3): 1.82-1.96 (IH, m,
CHSCHzCHaxHeq), 2.08-2.16 (3H, m, CHSCHzCHaxHeq and CHCH2CH2CHO), 2.72 (2H, 
td, J  7.2 Hz, 1.0, CH2CHO), 2.84-2.87 (4H, m, CHSCH2 ), 4.05 (IH, t, J  7.0 Hz, CHS), 
9.81 (IH, s, CHO). 3-(l,3-Dithian-2-yl)-propionaldehyde in EtOH (425 mL) was added to 
a stirred solution of hydroxylamine hydrochloride and NaOAc in water (45 mL). The 
reaction was heated under reflux overnight. The solvent was then removed under reduced 
pressure and water and EtOAc added. The aqueous layer was then extracted (x 3) with 
EtOAc and the combined organics washed with brine, dried over sodium sulphate, filtered 
and concentrated under reduced pressure. The resultant orange oil was treated to 
recrystallisaion using hot diethyl ether, giving the E isomer pure as a white powder, this 
was characterised and the supernatant combined and retreated to the crystallisation 
conditions. This gave 3-(l,3-Dithian-2-yl)propionaldehyde oxime 426 as a beige powder 
with the major E  isomer crystallising out first. The supernatant contained a mixture E  and 
Z isomers with ratio 3:1, E  to Z. The combined yield of E and E/Z mixtures gave 6.53 g, 
40% yield over 2 steps. E isomer Characterisation:
m.p. 92-94 °C.
Vmax (KBr)/cm ‘ : 3207 (OH), 2902 (CH;, CH;), 1663 (C=N), 1321 (OH),
8h (400 MHz: CDCl;): 1.83-1.93 [IH, m, CHSCH;CHaxHeq], 1.96-2.01 (2H, m,
CHCH;CH;CHN), 2.09-2.17 (IH, m, CHSCH;CHaxH«,), 2.58-2.64 (2H, m,
CHCH;CH;CHN), 2.82-2.89 (4H, m, SCH;), 4.04 (IH, t, J  7.0 Hz, CHS;), 6.76 (IH, t, J  
5.4 Hz, CHNOH), 8.16 (IH, s, OH).
8 c (100 MHz: CDCl;): 22.47 (CH;), 25.82 (CH;), 30.22 (CH;), 31.79 (CH;), 46.84
(CH), 151.39 (CH).
m/z, (Cl): 192 [(M+H)+, 100%], 174 (43%). HRMS: 192.0514. C7H 14NOS;
requires (M-rH)*, 192.0517.
Data agrees with literature."’
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A/-[3-(1,3-Dithian-2-yl)propyl]-A/-tritylamine 428
N.^Ph 
4 2 8  Ph
L1AIH4 (5.20 g, 136 mmol) was added to a solution of 3-(l,3-dithian-2-yl}propionaldehyde 
oxime 426 (6.53 g, 34 mmol) in THF (340 mL) at 0 °C. This was left stirring overnight. 
Water was carefully added to quench followed by NaOH (4 M). The mixture was then 
extracted with EtOAc (x 4) and the combined organic phases washed with brine, dried over 
sodium sulfate, filtered and concentrated under reduced pressure. This gave 3-(l,3-dithian-
2-yl)propylamine 427 as a pale yellow oil (3.06 g, 51% ). This was taken directly on 
without further purification. Ôh (400 MHz, CDCI3): 1.63-1.70 [2H, m, (CH2)2CH2NH2], 
1.79-1.92 [3H, m, (CH2)2CH2NH2, CHSCH2CHaxHeq], 2.10-2.15 (IH, m,
CHSCH2CHaxHeq), 2.74 (2H, t, J  7.0, CH2NH2), 2.79-2.92 (4H, m, SCH2), 4.06 (IH, t, J  
6 .8 , CHS2). DMAP (90 mg, 0.689 mmol), EtgN (4.30 mL, 30.3 mmol) and trityl chloride 
(5.29 g, 19.0 mmol) were stirred in DCM (8  mL). This solution was added to the crude 3- 
( 1,3-dithian-2-yl)propylamine (3.06 g, 17.2 mmol) crude stirring in DCM (17 mL). The 
reaction was left stirring under argon overnight. Water was added to quench and the 
aqueous layer extracted with EtOAc (x 3). The combined organic phases were washed 
with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. 
Column chromatography was carried out on deactivated alumina eluting with hexane- 
DCM (2:1) to give a gum which was triturated with hot diethyl ether and hexane to give N- 
[3-(l,3-dithian-2-yl)propyl]tritylamine 428 as a solid (3.77 g, 26% over two steps from 
oxime 426).
m.p. 104-106 °C.
Vmax (KBr)/cm ‘ : 3436 (NH), 3019 (CH), 2934 (CH;), 1489 (-NH-), 1465 (CH).
5h (400 MHz: CDCb): 1.66-1.73 [2H, m, (CH;);CH;N], 1.81-1.91 [3H, m,
(CH;)2CH;N, CHSCH;CHaxHeq], 2.06-2.11 (IH, m, CHSCH;CHaxH^), 2.14 (2H, t, 7 6.7 
Hz, NCH;), 2.78-2.86 (4H, m, SCH;), 4.01 (IH, t, 7 6.9 Hz, CHS), 7.16-7.20 (3H, m, Ar- 
H), 7.25-7.33 (6 H, m, Ar-H), 7.45-7.48 (6 H, m, Ar-H).
Sc (100 MHz: CDCb): 26.02 (CH;), 27.78 (CH;), 30.45 (CH;), 33.23 (CH;), 42.89
(CH;), 47.53 (CH), 70.82 (C), 126.18 (CH), 127.76 (CH), 128.61 (CH), 146.14 (C).
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m/z, (CI): 420 [(M+H)\ 2%], 243 (100%), 178 (48%), 167 (30%). HRMS:
420.1823. C26H30NS2 requires (M+H)"" 420.1820.
Microanalysis: C, 74.20; H, 6.97; N, 3.41%. C26H29NS2 requires C, 74.42; H, 6.97;
N, 3.38%.
A/-[4,4-Bis(phenylsulfanyl)butyl]-A/-tritylamine 429
Pyridine sulphur trioxide (61.8 g, 388 mmol) was added to a solution of 4,4- 
Bis(phenylsulfanyl)butanol 182 (29.7 g, 102 mmol), triethylamine (94 mL, 674 mmol), and 
DMSO (72 mL, 1020 mmol) in DCM (340 mL) and the solution stirred overnight. The 
reaction was quenched with water followed by aqueous sodium hydrogen carbonate 
solution and the aqueous layer extracted with DCM. The organics were combined, washed 
with brine, dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. This, gave crude 4,4-Bis(phenylsulfanyl)butyraldehyde 183, containing large 
quantities of thiophenol, DMSO and triethylamine salts, as a dark orange oil (46.7 g 
>100%), which was used without further purification. Product signals: Ôh (400 MHz: 
CDCI3): 2.17 (2H, dt, J  13.9 Hz, 7.0 Hz, CH2CH2CHO), 2.81 (2H, t, J  7.1 Hz CH2CHO) 
4.77-4.79 (IH, m, CHS), 7.25-7.38 ( >8 H, m, Ar-H), 7.44-7.48 (>2H, m, Ar-H). A 
proportion (64%) of this mixture was taken on to the reductive amination step. 
Tritylamine (77.1 g, 297 mmol) was added to a solution containing a third of the crude 
aldehyde (65 mmol) in dry MeOH (380 mL). Powdered 4 angstrom molecular sieves were 
added (1.5 g) and the mixture was heated under reflux overnight. After this time sodium 
cyanoborohydride (6.2 g, 98.7 mmol) was added and the reaction left stirring for 4 h. 
Water was added and the methanol was removed under vacuum. Ethyl acetate was added 
to dissolve the organic phases and the aqueous layer was extracted 3 times with ethyl 
acetate. The combined organic phases were washed with water, brine then dried over 
sodium sulfate, filtered and concentrated under reduced pressure. Column 
chromatography, (2:1 hexane to DCM, Si0 2 ) gave a solid, which then recrystallised in 
methanol to give N-[4,4-Bis(phenylsulfanyl)butyl]-N-tritylamine 429 as needles 10.6 g 
31% yield. Rp( Si0 2 , hexane:DCM, 2:1) 0.54. An X-ray crystal structure was obtained to 
confirm the structure, please see appendix Ic.
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m.p. 98-100 °C.
V m a x  (KBr)/cm'^: 3053, 2934 ( % ,  CH3), 2856 (CH), 1467 (CH).
ÔH (400 MHz: CDCI3): 1.42 (IH, s, NH), 1.75-1.82 (2H, m, CH2CH2N), 1.90-1.95
(2H, m, CH2CH2CH2N), 2.10 (2H, t, J  6.5 Hz, CH2N), 4.38 (IH, t, J  6.62 Hz, CHCH2), 
7.16-7.21 (3H, m, Ar-H), 7.24-7.33 (12H, m, Ar-H), 7.38-7.52 (lOH, m, Ar-H).
ÔC (100 MHz: CDCI3): 28.12 (CH2), 33.44 (CH2), 42.74 (CH2), 58.34 (CH), 70.78
(C), 126.17 (CH), 127.71 (CH), 127.75 (CH), 128.56 (CH), 128.87 (CH), 132.86 (CH), 
134.06 (C), 146.07 (C).
m/z, (FAB+NOBA): 532 [(M+H)"", 8 %], 288 (20%), 243 (100%), 166 (15%). HRMS: 
532.2139. C35H34NS2: requires (M+H)"", 532.2133.
Microanalysis: C, 79.15; H, 6.13; N, 2.69%. C35H33NS2 requires C, 79.05; H, 6.25;
N, 2.63%.
4,4-Bis(phenylsulfanyl)butyraldehyde oxime 430
Pyridine sulfur trioxide (21.2 g, 133 mmol) was added to a solution of 4,4- 
bis(phenylsulfanyl)butan-l-ol 182 (10.2 g 35 mmol), triethylamine (32 mL, 231 mmol), 
and DMSO (25 mL, 350 mmol) in DCM (110 mL) and the solution stirred overnight. The 
reaction was quenched with water followed by aqueous sodium hydrogen carbonate 
solution and the aqueous layer extracted with DCM. The organics were combined, washed 
with brine, dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. A proton NMR was taken, and this showed pyridine present so the compound 
was dissolved in DCM and washed once with 1 M aq HCl, then with water followed by 
brine and then dried over sodium sulfate. The compound was then filtered and 
concentrated under reduced pressure. This gave 4 ,4-bis(phenylsulfanyl)butyraldehyde 183 
(8.25 g, 81%) which was taken on without further purification. Following an analogous 
procedure by Ikeda et a portion of the crude aldehyde (4.00 g) was then taken up in 
ethanol (75 mL). This was added to a stirred solution of sodium acetate and 
hydroxylamine hydrochloride in water (7.5 mL). It should be noted that the solubility of
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the aldehyde is very low in ethanol. The mixture was heated under reflux overnight. 
Following concentration of the reaction mixture on rotary evaporator, water and 
chloroform were added and the aqueous layer extracted (x 3). The combined organic 
phases were then washed with brine, dried over sodium sulfate, filtered and concentrated 
under reduced pressure. Column chromatography (Si0 2 )with gradient elution of DCM, 
then DCM-MeOH (95:5) and finally MeOD gave 4,4-Bis(phenylsulfanyl)butyraldehyde 
oxime 430 as a yellow oil (1.53 g 36%) as a (1:1) mixture of E  and Z geometrical isomers. 
This was sufficiently pure for the next step.
Vmax (NaCiycm-': 3255 (OH), 2915 (CH;), 1654 (C=N-),1438 (CH).
8 h (400 MHz: CDCb): 1.97-2.08 (2H^+^, m, CH;CH;CHN), 2.53 (2H^, dt, J  5.7 Hz,
7.5 Hz, CH;CHN), 2.7 (2H^ dt, J  5.5 Hz, 7.7 Hz, CH;CHN), 4.37 [ IH ^ , t, J  6.7 Hz, 
CH(SPh);], 4.42 [1H“ , t, J  6.7 Hz, CH(SPh);], 6.67 (IH ^  t, J  5.5, CHN), 7.28-7.33 
(6 H^*^, m, Ar-H), 7.39 (IH ^ t, J 5.7 Hz, CHN), 7.46-7.49 (4H^+^, m, Ar-H).
8 c (100 MHz: CDCb): 22.87 (CH;), 27.05 (CH;), 32.02 (CH;), 32.24 (CH;), 57.58
(CH), 58.03 (CH), 127.95 (CH), 129.07 (CH), 132.96 (CH), 133.69 (C), 150.78 (CH), 
151.23 (CH).
m/z, (El): 303 (M'*, 5%), 194 [(M'^-PhS"), 100%], 149 (35%), 109 (PhS 32%), 71
(42%). HRMS: 303.0750. CieHnNOS;: requires 303.0752.
4,4-Bis(phenylsulfanyl)butylamine 430b
Following a procedure designed for an analogous compound by Molinski, T. F. and co­
workers 4,4-bis(phenylsulfanyl)butyraldehyde oxime 430 (1.50 g, 4.95 mmol) was 
dissolved in dry THF (50 mL) and placed under argon. The solution was cooled to 0 °C 
and lithium aluminium hydride (770 mg, 19.8 mmol) was added portion-wise to the 
solution, taking care not to add too much at once to avoid a large exotherm. This was left 
stirring overnight. The reaction was quenched by careful addition of water followed by 
addition of aqueous NaOH (4 M). The aqueous phase was then extracted with ethyl acetate 
(x 3). The combined organics were washed with brine, dried over sodium sulfate, filtered
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and concentrated under vacuum to give the amine 430b as an orange oil (1.33 g 93%), 
further purification was not possible.
Product signals Ôh (400 MHz: CDCI3): 1.73-1.82 [2H,m, (CH2)2CH2N], 1.86-1.91 [2H, m, 
(CH2)2CH2N], 2.68 (2H, t, J  6 .8  Hz, CH2N), 4.41 [IH, t, J  6.5 Hz, (PhS)2CHCH2], 7.24- 
7.33 (6 H, m, Ar-H), 7.44-7.47 (4H, m, Ar-H).
2-Phenethylpiperidine 439
LiAlH4  (264 mg, 38.0 mmol) was added to a solution of 6-phenethyl-2,3,4,5-tetrahydro- 
pyridine 336d (0.328 mmol) freshly cleaved from resin using general cleavage method D, 
in THF (3 mL), portion-wise at 0 °C under argon. This was left stirring for 5 h 30 min. At 
this time water was added, followed by NaOH (4 M) and the mixture extracted with DCM 
(x 3). The combined organic phases were washed with brine, dried over sodium sulphate, 
and filtered. Ethereal HCl 2M (1 mL) was added and the solution concentrated under 
reduced pressure. The resultant solvent was treated to hot diethyl ether to remove 
triphenyl methanol. The salt was dissolved in chloroform and washed with NaOH (1 M) 
and brine, dried over sodium sulphate, filtered and concentrated under reduced pressure, to 
give 2-phenethylpiperidine 439 (17.8 mg, 29%) as a pale yellow oil.
Vmax (GG)/cm ‘: 2930 (CH;).
ÔH (400 MHz; CDCb): 1.07-1.17 [IH, m, NCH;(CH;);], 1.26-1.46 [3H, m,
NCH;(CH;);], 1.57-1.72 [4H, m, NCH(CH;);Ph], 1.77-1.81 (IH, m, NCH), 2.46-2.53 (IH, 
m, NCH;), 2.59-2.74 [3H, m, NCH;, NCHCH;(CH;)3], 3.09-3.06 (IH, m, NH).
5c (100 MHz: CDCb): 24.80 (CH;), 26.61 (CH;), 32.29 (CH;), 32.30 (CH;), 39.18
(CH;), 47.15 (CH;), 56.45 (CH), 125.71 (CH), 128.33 (CH), 142.35 (C).
m/z, (Cl): 190 [(M-hH)^, 100%]. HRMS: 190.1595. CisftoN requires (M-vH)+
190.1596.
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2-Propylpiperidinium chloride 440
6-Propyl-2,3,4,5-tetrahydropyridine 336j (0.328 mmol) freshly cleaved from resin using 
general cleavage method D, was dissolved in THF (3 mL) and treated with LiAlH4 at 0 
This was left stirring under argon overnight. At this point water was added drop-wise, 
followed by NaOH (4 M). The mixture was then extracted with DCM (x 4). The 
combined organics were washed with brine, dried over sodium sulphate and filtered. 
Saturated ethereal HCl was added and the product concentrated under reduced pressure. 
The resultant salt was purified by washing with acetone to give 2-propylpiperidinium 
chloride 440 (4.8 mg, 9%) as a solid.
Vmax (GG)/cm-': 2934 (CH2CH3), 2515 (NH;*).
Sh (400 MHz: CDCI3): 0.95 (3H, t, J  7.3 Hz, CH3CH;) 1.38-1.53 (3H, m, CH3CH;,
CH3CH;CHN)1.59-1.84 (3H, m, CH3CH2CHN, NCHCH;) 1.89-2.03 [4H, m,
NCH;(CH;);] 2.77-2.86 (IH, m, NCH;) 2.93 (IH, m, NCH;) 3.44-3.49 (IH, m, NCHCH;) 
9.21 (IH, s, NH) 9.52 (IH, s, NH).
Sc (100 MHz: CDClj): 13.74 (CH;), 18.61 (CH;), 22.26 (CH;), 22.45 (CH;), 28.20
(CH;), 35.35 (CH;), 44.74 (CH;), 57.21 (CH).
m/z, (Cl): 128 (M*, 100%), 71 (26%). HRMS; 128.1437. CjHisN requires
128.1439.
Data agrees with literature. 183
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Appendices
Crystal Structures
Data for ail three structures were collected at lOOK on a Nonius Kappa CCD 
diffractometer equipped with an Oxford Cryosystems low temperature device, and using 
graphite-monochromated Mo Ka radiation (À = 0.71073 A). The data were integrated using 
DENZO,' and an absorption correction based on the multi-scan method of Blessing" was 
applied. The structures were solved using SIR92,“‘ and refined using full matrix least 
squares on all data using CRYSTALS.’'' All non-hydrogen atoms were refined 
anisotropically. All hydrogen atoms except those bound to nitrogen were placed in 
geometrically calculated positions and refined as riding groups. Hydrogen atoms bound to 
nitrogen atoms were placed on the difference map and refined isotropically. SX018 solved 
in a non-centrosymmetric space group, and SX019 solved in a chiral space group; the 
absolute structure for each of these compounds was determined unambiguously by the 
refinement of a Flack parameter.''
For CIF file containing structure data please see accompanying CD.
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Appendix 1a: Crystal Structure
Crystal Structure of W-[^-(l,3-Dithian-2-yI)butyl]-W-tritylamine 409
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Appendix 1b: Crystal Structure
Crystal Structure of W-[5,5-Bis(phenylsulfanyl)pentyI]tritylamine 417
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Appendix 1c: Crystal Structure
Crystal Structure of A^-I4,4-Bis(phenylsuIfanyl)butyl]-A^-trityIamine 429
%
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Appendix 2a: Sample ^HNMR
Appendix 2b: Sample ^HNMR
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